1 00:00:06,600 --> 00:00:10,680 >>I WOULD LIKE TO WELCOME 2 00:00:10,680 --> 00:00:11,520 EVERYONE, PARTICULARLY THE 3 00:00:11,520 --> 00:00:14,040 MEMBERS TO THE NATIONAL CANCER 4 00:00:14,040 --> 00:00:15,440 ADVISORY BOARD OTHERWISE KNOWN 5 00:00:15,440 --> 00:00:18,760 AS NCAB, AS WELL AS NCAB 6 00:00:18,760 --> 00:00:19,840 EXOFFICIO MEMBERS STAFF, AND 7 00:00:19,840 --> 00:00:20,080 GUESTS. 8 00:00:20,080 --> 00:00:22,480 JUST A FEW NOTES. 9 00:00:22,480 --> 00:00:23,760 MEMBERSOF THE PUBLIC WHO MAY 10 00:00:23,760 --> 00:00:26,120 WISH TO EXPRESS THEIR VIEWS 11 00:00:26,120 --> 00:00:27,320 REGUARDING ANY ITEMS DISCUSSED 12 00:00:27,320 --> 00:00:29,040 DURING TODAY'S MEETING, MAY DO 13 00:00:29,040 --> 00:00:37,760 SO BY WRITING TO DR. PAULETTE 14 00:00:37,760 --> 00:00:39,000 GRAY, ANY STATEMENTS OR 15 00:00:39,000 --> 00:00:39,720 QUESTIONS SUBMITTED BY MEMBERS 16 00:00:39,720 --> 00:00:42,040 OF THE PUBLIC WILL RECEIVE 17 00:00:42,040 --> 00:00:42,600 CAREFUL CONSIDERATION. 18 00:00:42,600 --> 00:00:43,440 AS BOARD MEMBERS I WANT TO 19 00:00:43,440 --> 00:00:48,240 REMIND YOU THAT YOU MUST ABSENT 20 00:00:48,240 --> 00:00:49,280 YOURSELF VIRTUALLY DURING 21 00:00:49,280 --> 00:00:50,240 SPECIFIC DISCUSSIONS, WHENEVER 22 00:00:50,240 --> 00:00:51,840 YOUR PARTIC PAITIONZ IN 23 00:00:51,840 --> 00:00:53,760 DELIBERATIONS ON A PARTICULAR 24 00:00:53,760 --> 00:00:55,040 PRODUCT, PROGRAM, OR OTHER 25 00:00:55,040 --> 00:00:56,000 SPECIFIC MATTER WOULD CONSITUTE 26 00:00:56,000 --> 00:00:58,720 A CONFLICT OF INTEREST OR CREATE 27 00:00:58,720 --> 00:01:00,920 THE APPEARANCE OF 1. 28 00:01:00,920 --> 00:01:02,960 IT'S INCUMBENT UPON YOU TO 29 00:01:02,960 --> 00:01:04,240 ADVISE THE EXECUTIVE SECRETARY 30 00:01:04,240 --> 00:01:06,480 DR. GRAY TO ABSTAIN FROM ANY 31 00:01:06,480 --> 00:01:08,120 PARTICIPATION IN DISCUSSION OR 32 00:01:08,120 --> 00:01:09,480 ACTION REGUARDING THIS MATTER. 33 00:01:09,480 --> 00:01:12,040 IN LIGHT OF THE CURRENT POLICIES 34 00:01:12,040 --> 00:01:13,880 GOVERNING CONFLICT OF INTEREST 35 00:01:13,880 --> 00:01:15,840 BASED ON FINANCIAL HOLDINGS FOR 36 00:01:15,840 --> 00:01:16,720 SPECIAL GOVERNMENT EMPLOYEES 37 00:01:16,720 --> 00:01:17,880 WHICH INCLUDES ALL OF THE 38 00:01:17,880 --> 00:01:19,800 MEMBERS OF THE BOARD, WE MUST 39 00:01:19,800 --> 00:01:23,840 DEPEND ON YOU TO VOLUNTARILY 40 00:01:23,840 --> 00:01:24,880 ABSENT YOURSELF DURING ANY 41 00:01:24,880 --> 00:01:27,880 DISCUSSIONS OF MATTERS THAT 42 00:01:27,880 --> 00:01:29,000 COULD CONCEIVABLY IMPACT THE 43 00:01:29,000 --> 00:01:31,000 STATUS OF THOSE HOLDINGS AND WE 44 00:01:31,000 --> 00:01:32,640 HAVE TO TRUST YOUR JUDGMENT IN 45 00:01:32,640 --> 00:01:34,880 THESE INSTANCES AND PLEASE 46 00:01:34,880 --> 00:01:35,720 ABSENT ACCORDINGLY. 47 00:01:35,720 --> 00:01:37,720 DURING ANY CLOSED SESSION, ANY 48 00:01:37,720 --> 00:01:40,480 MATERIALS OR DISCUSSIONS OF 49 00:01:40,480 --> 00:01:41,160 CONFIDENTIAL NATURE DELIBERATED 50 00:01:41,160 --> 00:01:43,360 UPON TODAY ARE PRIVILEGED 51 00:01:43,360 --> 00:01:44,600 INFORMATION AND ARE MADE 52 00:01:44,600 --> 00:01:46,800 AVAILABLE TO YOU UPON A NEED TO 53 00:01:46,800 --> 00:01:48,080 KNOW BASIS, SUCH DELIBERATIONS 54 00:01:48,080 --> 00:01:50,280 ARE PRIVATE AND THEY'RE CONTENTS 55 00:01:50,280 --> 00:01:53,240 SHOULD NOT BE DIVULGED. 56 00:01:53,240 --> 00:01:58,000 SO ON THE AGENDA THERE ARE THE 57 00:01:58,000 --> 00:02:03,280 FUTURE MEETING DATES FOR YOUR 58 00:02:03,280 --> 00:02:03,520 REVIEW. 59 00:02:03,520 --> 00:02:12,600 WE DO NEED TO,A PROVE THE 60 00:02:12,600 --> 00:02:14,760 DIAGRAM 5-7 TWEND 22 JOINT 61 00:02:14,760 --> 00:02:15,200 BSA/NCAB SUMMARY. 62 00:02:15,200 --> 00:02:17,200 SO I NEED TO CALL FOR A MOTION 63 00:02:17,200 --> 00:02:18,840 TO,A PROVE THE MEETING SUMMARY. 64 00:02:18,840 --> 00:02:20,840 DO WE HAVE A MOTION? 65 00:02:20,840 --> 00:02:25,600 >>SO MOVED. 66 00:02:25,600 --> 00:02:26,200 >>SECOND? 67 00:02:26,200 --> 00:02:27,520 >>PLEASE OPEN YOUR MIC IF 68 00:02:27,520 --> 00:02:30,240 THERE'S A SECOND. 69 00:02:30,240 --> 00:02:30,520 >>SECOND. 70 00:02:30,520 --> 00:02:33,240 >>SO IT'S BEEN PROPERLY MOVED 71 00:02:33,240 --> 00:02:34,840 AND SECONDED, IS THERE ANY 72 00:02:34,840 --> 00:02:35,120 DISCUSSION? 73 00:02:35,120 --> 00:02:39,440 IF NOT, WE CAN VOTE ON APPROVAL 74 00:02:39,440 --> 00:02:40,320 OF THE MEETING SUMMARY. 75 00:02:40,320 --> 00:02:45,120 I WILL ASK IF THERE ARE ANY 76 00:02:45,120 --> 00:02:45,360 NAYS? 77 00:02:45,360 --> 00:02:51,120 DOES ANYONE NEED TO ABSENT? 78 00:02:51,120 --> 00:02:54,440 P A ULETTE, IT LOOKS AS IF WE 79 00:02:54,440 --> 00:03:00,480 HAVE A UNANIMOUS VOTE. 80 00:03:00,480 --> 00:03:00,760 >>OKAY. 81 00:03:00,760 --> 00:03:02,120 >>REGARDING QUORUM, BY LAW A 82 00:03:02,120 --> 00:03:03,200 QUORUM OF BOARD MEMBERS IS 83 00:03:03,200 --> 00:03:04,360 REQUIRED FOR EACH INSTANCE IN 84 00:03:04,360 --> 00:03:06,000 WHICH A VOTE MAY OCCUR WHETHER 85 00:03:06,000 --> 00:03:07,480 IN OPEN OR CLOSED SESSION. 86 00:03:07,480 --> 00:03:09,440 DURING THIS MEETING A MINIMUM OF 87 00:03:09,440 --> 00:03:11,280 10 APPOINTED MEMBERS MUST BE 88 00:03:11,280 --> 00:03:14,000 PRESENT TO VOICE THEIR VOTES. 89 00:03:14,000 --> 00:03:15,760 SINCE WE CAN'T PREDICT THE TIME 90 00:03:15,760 --> 00:03:17,720 OR OCCURRENCE OF ANY MOTION, 91 00:03:17,720 --> 00:03:19,920 YOUR PRESENCE DURING THE MEETING 92 00:03:19,920 --> 00:03:22,560 IS REALLY CRITICAL FOR ALL 93 00:03:22,560 --> 00:03:24,760 ASPECTS OF THE SEGMENTS OF THE 94 00:03:24,760 --> 00:03:26,880 MEETING. 95 00:03:26,880 --> 00:03:29,200 P A ULETTE, DO WE HAVE A QUORUM? 96 00:03:29,200 --> 00:03:30,760 >>YES, WE HAVE A QUORUM. 97 00:03:30,760 --> 00:03:34,440 >>AND TO INSURE WE REDUCE 98 00:03:34,440 --> 00:03:35,120 POTENTIAL INTERRUPTIONS DURING 99 00:03:35,120 --> 00:03:36,760 THE MEETING, PLEASE MAKE SURE 100 00:03:36,760 --> 00:03:38,520 THAT YOU MUTE YOUR MICROPHONES 101 00:03:38,520 --> 00:03:41,720 IF YOU'RE NOT TALKING AND REMAIN 102 00:03:41,720 --> 00:03:43,320 SO UNTIL RECOGNIZED BY EITHER 103 00:03:43,320 --> 00:03:52,040 ME, P A ULETTE, MONICA OR THE 104 00:03:52,040 --> 00:03:52,520 SPEAKER. 105 00:03:52,520 --> 00:03:54,160 WE WILL START THE MEETING, THE 106 00:03:54,160 --> 00:03:56,120 AGENDA WILL START WITH THE 107 00:03:56,120 --> 00:04:02,160 REPORT FROM THE NCI DIRECTOR, 108 00:04:02,160 --> 00:04:03,200 DR. MONICA BERTAGNOLLI, MONICA? 109 00:04:03,200 --> 00:04:04,920 >>THANK YOU SO MUCH JOHN AND 110 00:04:04,920 --> 00:04:06,640 I'M DELIGHTED TO BE WITH YOU ALL 111 00:04:06,640 --> 00:04:07,040 TODAY. 112 00:04:07,040 --> 00:04:08,080 A LOT'S HAPPENED SINCE WE LAST 113 00:04:08,080 --> 00:04:09,040 MET AND I WILL MOVE ALONG 114 00:04:09,040 --> 00:04:10,400 BECAUSE I HAVE A LOT TO COVER. 115 00:04:10,400 --> 00:04:13,440 IN ACCIDENT SLIDE, PLEASE. 116 00:04:13,440 --> 00:04:14,840 WE'RE GOING TO TALK ABOUT RECENT 117 00:04:14,840 --> 00:04:17,280 PROGRESS AND WHAT IT WILL TAKE 118 00:04:17,280 --> 00:04:19,840 TO SUSTAIN AND REALLY ACCELERATE 119 00:04:19,840 --> 00:04:21,600 IT, I LITTLE BIT ABOUT BUDGET 120 00:04:21,600 --> 00:04:23,160 OUTLOOK AND SOMETHING ABOUT 121 00:04:23,160 --> 00:04:24,640 NCAB'S ROLE IN THE NATIONAL 122 00:04:24,640 --> 00:04:27,520 CANCER PROGRAM. 123 00:04:27,520 --> 00:04:28,160 NEXT SLIDE. 124 00:04:28,160 --> 00:04:31,240 IT'S BEEN A BIG WEEK FOR 125 00:04:31,240 --> 00:04:35,080 PRESIDENT BIDEN'S COMMITMENT TO 126 00:04:35,080 --> 00:04:36,400 PROGRESS AGAINST CANCER, 127 00:04:36,400 --> 00:04:37,640 FEBRUARY 2nd MARKED THE 1 YEAR 128 00:04:37,640 --> 00:04:40,440 ANNIVERSARY SINCE THE PRESIDENT 129 00:04:40,440 --> 00:04:41,160 ANNOUNCED A REIGNITED CANCER 130 00:04:41,160 --> 00:04:42,120 MOONSHOT AND TUESDAY NIGHT WE 131 00:04:42,120 --> 00:04:44,280 HEARD IN THE STATE OF THE UNION 132 00:04:44,280 --> 00:04:46,480 ADDRESS THAT HE INTENDS TO GO 133 00:04:46,480 --> 00:04:49,840 BIG IN ORDER TO ACHIEVE BOLD 134 00:04:49,840 --> 00:04:50,880 GOALS WORTHY OF COMPARISON TO 135 00:04:50,880 --> 00:04:54,120 THE EFFORT THAT GOT US TO THE 136 00:04:54,120 --> 00:04:55,520 MOON IN 1969. 137 00:04:55,520 --> 00:04:57,920 A 50% REDUCTION IN CANCER 138 00:04:57,920 --> 00:05:00,320 MORTALITY IN 25 YEARS, AND ALSO 139 00:05:00,320 --> 00:05:04,760 TO END CANCER AS WE KNOW IT 140 00:05:04,760 --> 00:05:08,480 WHICH WE TAKE TO MEAN THAT ALL 141 00:05:08,480 --> 00:05:10,440 PEOPLE WITH CANCER LIVE FULL AND 142 00:05:10,440 --> 00:05:12,240 ACTIVE LIVES AND THAT CANCER IS 143 00:05:12,240 --> 00:05:13,520 PREVENTED AS MUCH AS POSSIBLE SO 144 00:05:13,520 --> 00:05:16,480 THAT MORE PEOPLE DON'T HAVE TO 145 00:05:16,480 --> 00:05:18,040 FACE THIS DIAGNOSIS. 146 00:05:18,040 --> 00:05:21,640 EVER SINCE FIRST TAKING ON THE 147 00:05:21,640 --> 00:05:23,920 CANCER MOONSHOT, DURING THE 148 00:05:23,920 --> 00:05:24,760 OBAMA ADMINISTRATION, NOW 149 00:05:24,760 --> 00:05:26,280 PRESIDENT BIDEN HAS BEEN 150 00:05:26,280 --> 00:05:27,680 UNWAVERING IN SUPPORT OF WHAT WE 151 00:05:27,680 --> 00:05:31,040 ALL SEEK TO DO. 152 00:05:31,040 --> 00:05:32,920 A SIGNIFICANT DIFFERENCE THOUGH 153 00:05:32,920 --> 00:05:39,680 IN THIS REIGNITED MOON SHOT IS A 154 00:05:39,680 --> 00:05:41,360 CALL BY FOR AN ALL OF GOVERNMENT 155 00:05:41,360 --> 00:05:44,040 AND ALL OF SOCIETY APPROACH. 156 00:05:44,040 --> 00:05:45,640 WITH CONCERN FOR THE PATIENT AT 157 00:05:45,640 --> 00:05:48,440 THE CENTER OF EVERYTHING THAT WE 158 00:05:48,440 --> 00:05:48,640 DO. 159 00:05:48,640 --> 00:05:51,440 SO OVER THE PAST--OVER THE FIRST 160 00:05:51,440 --> 00:05:52,960 YEAR OF THIS REIGNITED MOON SHOT 161 00:05:52,960 --> 00:05:54,720 WE HAVE TAKEN THIS VERY MUCH TO 162 00:05:54,720 --> 00:05:54,920 HEART. 163 00:05:54,920 --> 00:05:57,680 I WOULD LIKE TO SHARE 1 EXAMPLE. 164 00:05:57,680 --> 00:05:59,040 YOU SEE DOWN HERE IN THE BOTTOM 165 00:05:59,040 --> 00:06:04,520 LEFT OF THE SLIDE, CC-DIRECT 166 00:06:04,520 --> 00:06:09,680 WHICH STANDS FOR NCI'S NEW 167 00:06:09,680 --> 00:06:10,880 CHILDHOOD CENTER FOR DATA 168 00:06:10,880 --> 00:06:11,760 INTEGRATION AND RESEARCH 169 00:06:11,760 --> 00:06:14,120 EDUCATION AND CARE AND CLINICAL 170 00:06:14,120 --> 00:06:14,680 TRIALS. 171 00:06:14,680 --> 00:06:14,960 CC-DIRECT. 172 00:06:14,960 --> 00:06:18,320 IT'S A BIG DEAL FOR 2 REASONS. 173 00:06:18,320 --> 00:06:22,040 FIRST IT IS THE FIRST OF ITS 174 00:06:22,040 --> 00:06:24,640 KIND PUBLIC PRIVATE PARTNERSHIP 175 00:06:24,640 --> 00:06:28,880 THAT WILL DIRECTLY HELP FAMILIES 176 00:06:28,880 --> 00:06:31,840 FACING CHILDHOOD CANCER. 177 00:06:31,840 --> 00:06:34,640 NEXT SLIDE, PLEASE. 178 00:06:34,640 --> 00:06:36,760 SPECIFICALLY, IT WILL HELP 179 00:06:36,760 --> 00:06:40,440 FAMILIES WITH THE CHILD THAT HAS 180 00:06:40,440 --> 00:06:42,800 CANCER OBTAIN THEIR CHILD'S 181 00:06:42,800 --> 00:06:45,920 MEDICAL RECORD AND IF NEEDED 182 00:06:45,920 --> 00:06:48,040 ALSO CONNECT THE FAMILY AND 183 00:06:48,040 --> 00:06:52,080 CHILD TO EXCELLENT SPECIALTY 184 00:06:52,080 --> 00:06:52,280 CARE. 185 00:06:52,280 --> 00:06:55,080 DIRECT CONCERN AND CARE FOR 186 00:06:55,080 --> 00:06:55,840 PATIENT AND FAMILY. 187 00:06:55,840 --> 00:06:57,400 IT WILL ALSO PROVIDE THEM WITH 188 00:06:57,400 --> 00:06:59,080 THE OPPORTUNITY TO PARTICIPATE 189 00:06:59,080 --> 00:07:01,160 IN RESEARCH THROUGH CLINICAL 190 00:07:01,160 --> 00:07:03,880 TRIALS AND OTHER DATA SHARING 191 00:07:03,880 --> 00:07:04,360 INITIATIVES. 192 00:07:04,360 --> 00:07:07,680 CC-DIRECT HITS AT THE VERY HEART 193 00:07:07,680 --> 00:07:08,800 OF THE REIGNITED MOON SHOT 194 00:07:08,800 --> 00:07:12,360 BECAUSE ITS GOAL IS TO PROVIDE 195 00:07:12,360 --> 00:07:15,040 EVERY FAMILY AND CHILD WITH MUCH 196 00:07:15,040 --> 00:07:18,240 NEEDED SUPPORT SO THAT THEY CAN 197 00:07:18,240 --> 00:07:20,040 SUCCESSFULLY NAVIGATE A VERY 198 00:07:20,040 --> 00:07:21,600 COMPLEX HEALTHCARE SYSTEM AT A 199 00:07:21,600 --> 00:07:23,280 TIME OF GREAT PERSONAL STRESS. 200 00:07:23,280 --> 00:07:25,840 AND ALSO MAKE SURE THAT THEY ARE 201 00:07:25,840 --> 00:07:28,600 NOT LEFT OUT OF OPPORTUNITIES 202 00:07:28,600 --> 00:07:31,640 FOR RESEARCH. 203 00:07:31,640 --> 00:07:33,480 FOR EXAMPLE, CC-DIRECT WILL 204 00:07:33,480 --> 00:07:35,080 CENTRALLY COORDINATE A REQUEST 205 00:07:35,080 --> 00:07:38,280 TO PARTICIPATE IN NCI'S 206 00:07:38,280 --> 00:07:42,560 CHILDHOOD CANCER MOLECULAR 207 00:07:42,560 --> 00:07:43,400 CHARACTERIZATION INITIATIVE, A 208 00:07:43,400 --> 00:07:45,200 NATIONAL COLLABORATION THAT 209 00:07:45,200 --> 00:07:46,560 PROVIDES STATE-OF-THE-ART TO 210 00:07:46,560 --> 00:07:47,160 MOLECULAR CHARACTERIZATION AT 211 00:07:47,160 --> 00:07:50,560 THE TIME OF DIAGNOSIS AND HELPS 212 00:07:50,560 --> 00:07:52,400 PARTICIPANTS AND DOCTORS SELECT 213 00:07:52,400 --> 00:07:56,280 THE BEST AND MOST APPROPRIATE 214 00:07:56,280 --> 00:07:56,880 TREATMENT. 215 00:07:56,880 --> 00:07:58,560 WHEN FULLY IMPLEMENTED CC-DIRECT 216 00:07:58,560 --> 00:08:00,040 WILL LINK CHILDREN AND FAMILIES 217 00:08:00,040 --> 00:08:04,080 TO MANY MORE RESOURCES AND 218 00:08:04,080 --> 00:08:07,920 OPPORTUNITIES FOR RESEARCH 219 00:08:07,920 --> 00:08:08,480 PARTICIPATION. 220 00:08:08,480 --> 00:08:11,280 JUST THINK, HOW POWERFUL THIS 221 00:08:11,280 --> 00:08:13,320 NAVIGATION AND ENGAGEMENT 222 00:08:13,320 --> 00:08:17,480 PROGRAM WILL BE FOR THE 223 00:08:17,480 --> 00:08:21,360 APPROXIMATELY 15% OF KIDS AND 224 00:08:21,360 --> 00:08:22,280 ADOLESCENTS WHO CURRENTLY HAVE 225 00:08:22,280 --> 00:08:25,000 REAL DIFFICULTY WITH CARE ACCESS 226 00:08:25,000 --> 00:08:27,200 AND ALSO FOR CHILDREN WITH 227 00:08:27,200 --> 00:08:29,520 PARTICULARLY RARE TUMORS WHO 228 00:08:29,520 --> 00:08:31,640 NEED HIGHLY SPECIALIZED CARE AND 229 00:08:31,640 --> 00:08:34,960 A STRAIGHT PATH TO GETTING THEM 230 00:08:34,960 --> 00:08:35,200 THERE. 231 00:08:35,200 --> 00:08:37,480 SO THE REASON FOR HIGHLIGHTING 232 00:08:37,480 --> 00:08:39,920 THIS PROGRAM, IN PARTICULAR, IS 233 00:08:39,920 --> 00:08:42,560 THAT IT ALSO REPRESENTS A GROUND 234 00:08:42,560 --> 00:08:43,920 BREAKING RESPONSE TO THE CALL 235 00:08:43,920 --> 00:08:47,200 FOR AN ALL OF SOCIETY APPROACH. 236 00:08:47,200 --> 00:08:51,960 CC-DIRECT WAS NOT LAUNCHED WITH 237 00:08:51,960 --> 00:08:52,960 CANCER MOONSHOT FUNDING. 238 00:08:52,960 --> 00:08:54,400 INSTEAD IT IS A COLLABORATION 239 00:08:54,400 --> 00:08:56,320 BETWEEN NCI AND THE 7 OTHER 240 00:08:56,320 --> 00:08:58,480 ORGANIZATIONS LISTED ON THIS 241 00:08:58,480 --> 00:08:58,960 SLIDE. 242 00:08:58,960 --> 00:09:02,160 EACH OF THESE ORGANIZATIONS ARE 243 00:09:02,160 --> 00:09:06,120 INVESTED IN THE TRUEST SENSE OF 244 00:09:06,120 --> 00:09:08,080 THE WORD, CONTRIBUTING IN-KIND 245 00:09:08,080 --> 00:09:12,040 SUPPORT TO MAKE THIS PROGRAM A 246 00:09:12,040 --> 00:09:12,280 REALITY. 247 00:09:12,280 --> 00:09:14,560 IT IS THIS BROAD BASED 248 00:09:14,560 --> 00:09:16,280 INVESTMENT THAT WILL INSURE THE 249 00:09:16,280 --> 00:09:17,760 PROJECT'S SUCCESS. 250 00:09:17,760 --> 00:09:24,840 YOU WILL HEAR THIS RECURRING 251 00:09:24,840 --> 00:09:26,120 THEME THROUGHOUT ALL OF OUR 252 00:09:26,120 --> 00:09:26,360 WORK. 253 00:09:26,360 --> 00:09:27,440 NCI CAN'T DO THIS ALONE. 254 00:09:27,440 --> 00:09:29,480 WE NEED TO BE A HIGHLY EFFECTIVE 255 00:09:29,480 --> 00:09:31,480 CONVENER AND PARTNER IN ORDER TO 256 00:09:31,480 --> 00:09:33,840 ACHIEVE OUR GOALS. 257 00:09:33,840 --> 00:09:34,320 NEXT SLIDE, PLEASE. 258 00:09:34,320 --> 00:09:35,520 SO I JUST WANT TO ACKNOWLEDGE 259 00:09:35,520 --> 00:09:39,720 THAT WE HAVE SOME NEW NCAB 260 00:09:39,720 --> 00:09:41,040 MEMBERS, 6 NEW MEMBERS WERE 261 00:09:41,040 --> 00:09:42,240 APPOINTED BY THE PRESIDENT LAST 262 00:09:42,240 --> 00:09:45,080 WEEK, YOU SEE THEIR NAMES HERE, 263 00:09:45,080 --> 00:09:46,840 EACH BRINGS VERY IMPORTANT NEW 264 00:09:46,840 --> 00:09:47,880 EXPERTISE TO NCAB AND WE LOOK 265 00:09:47,880 --> 00:09:49,520 FORWARD TO WORKING WITH THEM. 266 00:09:49,520 --> 00:09:51,040 I UNDERSTAND THEY'RE NOT YET 267 00:09:51,040 --> 00:09:52,240 FULLY ONBOARDED AND SO, IN THE 268 00:09:52,240 --> 00:09:53,560 INTEREST OF TIME, WE WILL WAIT 269 00:09:53,560 --> 00:09:56,160 TO HAVE A FORMAL INTRODUCTION AT 270 00:09:56,160 --> 00:09:58,040 THE NEXT MEETING WHEN THEY WILL 271 00:09:58,040 --> 00:10:01,360 BE FORMALLY JOINING US. 272 00:10:01,360 --> 00:10:02,240 NEXT SLIDE, PLEASE. 273 00:10:02,240 --> 00:10:04,000 SO, STATE OF THE UNION, EARLIER 274 00:10:04,000 --> 00:10:05,040 THIS WEEK, PRESIDENT GAVE HIS 275 00:10:05,040 --> 00:10:07,760 STATE OF THE UNION ADDRESS AND 276 00:10:07,760 --> 00:10:10,440 IN IT HE SAID: WILL BE A TRULY 277 00:10:10,440 --> 00:10:11,600 AMERICAN MOMENT THAT RALLIES THE 278 00:10:11,600 --> 00:10:12,840 COUNTRY AND THE WORLD TOGETHER 279 00:10:12,840 --> 00:10:18,200 AND PROVES WE CAN STILL DO BIG 280 00:10:18,200 --> 00:10:18,440 THINGS. 281 00:10:18,440 --> 00:10:20,880 LET'S END CANCER AS WE KNOW IT, 282 00:10:20,880 --> 00:10:22,040 CURE SOME CANCERS ONCE AND FOR 283 00:10:22,040 --> 00:10:22,200 ALL. 284 00:10:22,200 --> 00:10:24,240 WE HAVE OUR MARCHING ORDERS FROM 285 00:10:24,240 --> 00:10:25,520 OUR COMMANDER IN CHIEF AND WE 286 00:10:25,520 --> 00:10:28,960 ARE RARING TO GO. 287 00:10:28,960 --> 00:10:30,200 NEXT SLIDE, PLEASE. 288 00:10:30,200 --> 00:10:34,360 WE GOT SOME GOOD NEWS FROM 289 00:10:34,360 --> 00:10:36,160 CONGRESS IN DECEMBER, ON THE 290 00:10:36,160 --> 00:10:38,000 29th PRESIDENT BIDEN SIGNED 291 00:10:38,000 --> 00:10:39,440 LEGISLATION THAT PROVIDED 292 00:10:39,440 --> 00:10:42,640 FUNDING FOR NCI, NIH AND OTHER 293 00:10:42,640 --> 00:10:44,440 FEDERAL AGENCIES 294 00:10:44,440 --> 00:10:45,440 SEPTEMBER 30th, 2023 AND 295 00:10:45,440 --> 00:10:46,800 CONGRESS ONCE AGAIN DEMONSTRATED 296 00:10:46,800 --> 00:10:49,280 ITS DEEP CONCERN FOR PEOPLE WITH 297 00:10:49,280 --> 00:10:55,280 CANCER AND STRONG COMMITMENT TO 298 00:10:55,280 --> 00:10:59,720 NCI RESEARCH WE RECEIVED A 299 00:10:59,720 --> 00:11:02,520 BUDGET INCREASE OF 408 MILLION, 300 00:11:02,520 --> 00:11:03,720 THAT'S A 386 MILLION INCREASE TO 301 00:11:03,720 --> 00:11:06,000 OUR BASE BUDGET, AND A 302 00:11:06,000 --> 00:11:09,640 22 MILLION INCREASE TO THE FINAL 303 00:11:09,640 --> 00:11:12,160 YEAR OF CANCER MOONSHOT 1.0 304 00:11:12,160 --> 00:11:15,400 FUNDING WHICH MEANT WE HAD A 305 00:11:15,400 --> 00:11:21,360 TOTAL OF $216 MILLION IN CANCER 306 00:11:21,360 --> 00:11:21,960 MOONSHOT FUNDING. 307 00:11:21,960 --> 00:11:23,360 THIS BASE INCREASE MAKES IT 308 00:11:23,360 --> 00:11:25,960 POSSIBLE TO FUND MORE COMPELLING 309 00:11:25,960 --> 00:11:27,120 INVESTIGATOR INITIATED CANCER 310 00:11:27,120 --> 00:11:29,080 RESEARCH AND TO CONTINUE TO 311 00:11:29,080 --> 00:11:31,000 SUPPORT KEY RESEARCH EFFORTS 312 00:11:31,000 --> 00:11:33,200 OUTSIDE OF THE RPG POOL, LIKE 313 00:11:33,200 --> 00:11:35,440 OUR CLINICAL TRIALS NETWORKS, 314 00:11:35,440 --> 00:11:37,920 CORE SUPPORT FOR NCI DESIGNATED 315 00:11:37,920 --> 00:11:40,280 CANCER CENTERS, TRAINING AND 316 00:11:40,280 --> 00:11:41,800 MORE. 317 00:11:41,800 --> 00:11:44,320 WE SHARED SPECIFICS ABOUT OUR 318 00:11:44,320 --> 00:11:46,160 PAY LINES AND THE MOST RECENT 319 00:11:46,160 --> 00:11:47,520 BOTTOM LINE POST, HERE ARE SOME 320 00:11:47,520 --> 00:11:48,600 OF THE DETAILS. 321 00:11:48,600 --> 00:11:51,360 THE RESEARCH PROGRAM GRANT POOL, 322 00:11:51,360 --> 00:11:55,840 IT IS RPG FUNDING THAT ALLOWS 323 00:11:55,840 --> 00:11:56,520 INVESTIGATORS, I THINK--LET'S GO 324 00:11:56,520 --> 00:11:58,880 TO THE NEXT SLIDE, PLEASE--THAT 325 00:11:58,880 --> 00:12:02,280 ALLOWS INVESTIGATORS THROUGH THE 326 00:12:02,280 --> 00:12:03,880 ENTIRE CANCER RESEARCH 327 00:12:03,880 --> 00:12:06,400 ENTERPRISE TO TURN THEIR 328 00:12:06,400 --> 00:12:08,680 INNOVATIVE NEW IDEAS INTO 329 00:12:08,680 --> 00:12:10,560 ANSWERS THAT DRIVE PROGRESS FOR 330 00:12:10,560 --> 00:12:12,440 OUR PATIENTS. 331 00:12:12,440 --> 00:12:15,080 PEER REVIEW, SETS A PRIORITY 332 00:12:15,080 --> 00:12:17,120 LEVEL FOR FUNDING FOR THE 333 00:12:17,120 --> 00:12:18,600 THOUSANDS OF PROPOSALS RECEIVED 334 00:12:18,600 --> 00:12:21,800 AND THE PAY LINE DICTATES THE 335 00:12:21,800 --> 00:12:24,000 NUMBER OF GRANTS THAT THE NCI 336 00:12:24,000 --> 00:12:24,800 BUDGET SUPPORTS. 337 00:12:24,800 --> 00:12:27,160 THE BIG NEWS HERE, IS THAT FOR 338 00:12:27,160 --> 00:12:31,520 2023, WE WERE ABLE TO INCREASE 339 00:12:31,520 --> 00:12:34,040 THE RO-1 PAY LINE TO THE 12th 340 00:12:34,040 --> 00:12:34,680 PERCENTILE. 341 00:12:34,680 --> 00:12:37,200 COMPARED TO THE 11th 342 00:12:37,200 --> 00:12:38,720 PERCENTILE IN 2022, THIS 343 00:12:38,720 --> 00:12:40,240 CONTINUES THE SUSTAINED PAY LINE 344 00:12:40,240 --> 00:12:42,520 INCREASES WE'VE BEEN ABLE TO 345 00:12:42,520 --> 00:12:43,480 MAKE SINCE 2019 WHEN THE PAY 346 00:12:43,480 --> 00:12:47,240 LINE WAS AT THE EIGHTH 347 00:12:47,240 --> 00:12:47,560 PERCENTILE. 348 00:12:47,560 --> 00:12:49,880 HERE AIAN FACT FOR YOU. 349 00:12:49,880 --> 00:12:52,080 --HERE'S A FACT FOR YOU: THE 350 00:12:52,080 --> 00:12:54,200 LAST TIME THAT THE RPG PAY LINE 351 00:12:54,200 --> 00:12:58,480 WAS 12% OR HIGHER WAS IN 2010. 352 00:12:58,480 --> 00:13:01,960 SO WE ARE NOW AT A 13 YEAR HIGH, 353 00:13:01,960 --> 00:13:04,680 NOT AS HIGH AS WE WANT BUT A 13 354 00:13:04,680 --> 00:13:07,000 YEAR HIGH IN OUR ABILITY TO FUND 355 00:13:07,000 --> 00:13:08,160 THESE VERY IMPORTANT GRANTS. 356 00:13:08,160 --> 00:13:09,880 WE ALL RAISED THE PAY LINE FOR 357 00:13:09,880 --> 00:13:12,680 EARLY STAGE INVESTIGATORS TO THE 358 00:13:12,680 --> 00:13:16,600 17th PERCENTILE, UP 1% AND 359 00:13:16,600 --> 00:13:17,480 THESE--TOGETHER THESE PAY LINE 360 00:13:17,480 --> 00:13:19,000 INCREASES AS WELL AS SOME OTHERS 361 00:13:19,000 --> 00:13:21,040 WILL FUND MORE THAN A HUNDRED 362 00:13:21,040 --> 00:13:25,120 ADDITIONAL RO-1 AND ESI AWARDS 363 00:13:25,120 --> 00:13:25,480 THAN LAST YEAR. 364 00:13:25,480 --> 00:13:28,200 THROUGH THESE DECISIONS WE HAVE 365 00:13:28,200 --> 00:13:30,840 REAFFIRMED OUR COMMITMENT TO 366 00:13:30,840 --> 00:13:32,640 DISTRIBUTING FEDERAL FUNDING TO 367 00:13:32,640 --> 00:13:35,200 RESEARCHERS WHOSE WORK SO 368 00:13:35,200 --> 00:13:36,880 SUCCESSFULLY ESTABLISHES THE 369 00:13:36,880 --> 00:13:39,160 FOUNDATION FOR PROGRESS IN 370 00:13:39,160 --> 00:13:42,680 CANCER PREVENTION TREATMENT AND 371 00:13:42,680 --> 00:13:43,600 CONTROL. 372 00:13:43,600 --> 00:13:44,480 NEXT SLIDE. 373 00:13:44,480 --> 00:13:45,760 I KNOW YOU ALL PROBABLY SEEN 374 00:13:45,760 --> 00:13:47,960 THIS SLIDE ON THE WEBSITE. 375 00:13:47,960 --> 00:13:49,600 IT'S A CHALLENGE, IT'S AN 376 00:13:49,600 --> 00:13:50,760 ILLUSTRATION OF THE CHAL ENK WE 377 00:13:50,760 --> 00:13:52,320 FACE EVERY TIME WE RAISE THE PAY 378 00:13:52,320 --> 00:13:52,520 LINE. 379 00:13:52,520 --> 00:13:56,560 IT MEANS THAT DUE TO OUTYEAR 380 00:13:56,560 --> 00:13:57,840 COSTS INCURRED BY EACH INCREASE, 381 00:13:57,840 --> 00:13:59,400 WE NEED TO SEE AN INCREASE IN 382 00:13:59,400 --> 00:14:03,400 OUR FUNDING IN THE YEARS THAT 383 00:14:03,400 --> 00:14:04,400 FOLLOW TO MAINTAIN THAT PAY LINE 384 00:14:04,400 --> 00:14:06,800 AND TO PAY FOR THE GRANTS THAT 385 00:14:06,800 --> 00:14:07,920 WE'VE ALREADY FUNDED. 386 00:14:07,920 --> 00:14:09,040 WE HAVE OTHER IMPORTANT 387 00:14:09,040 --> 00:14:11,560 COMMITMENTS THAT ARE FUNDED 388 00:14:11,560 --> 00:14:13,560 OUTSIDE THE RPG POOL, SO JUST 389 00:14:13,560 --> 00:14:17,760 THE NATIONAL CLINICAL TRIALS 390 00:14:17,760 --> 00:14:19,440 NETWORK, NCOR, THE COMPREHENSIVE 391 00:14:19,440 --> 00:14:20,600 CANCER CENTERS, GLOBAL HEALTH 392 00:14:20,600 --> 00:14:24,160 AND PROGRAMS LIKE THE RAS 393 00:14:24,160 --> 00:14:25,640 INITIATIVE AND WE NEED TO 394 00:14:25,640 --> 00:14:33,720 ADDRESS THE RISING COSTS OF 395 00:14:33,720 --> 00:14:34,320 CONDUCTING BIOMEDICAL RESEARCH 396 00:14:34,320 --> 00:14:34,640 OVERALL. 397 00:14:34,640 --> 00:14:36,320 THAT MEANS WE NEED SIGNIFICANT 398 00:14:36,320 --> 00:14:37,520 INCREASES IN BUDGETS IN 399 00:14:37,520 --> 00:14:39,600 SUBSEQUENT YEARS IN ORDER TO BE 400 00:14:39,600 --> 00:14:41,240 ABLE TO COVER THOSE OUTYEAR 401 00:14:41,240 --> 00:14:43,440 COSTS AND MAINTAIN OUR SUPPORT 402 00:14:43,440 --> 00:14:46,680 FOR NEW RO-1S. 403 00:14:46,680 --> 00:14:49,240 EVEN THIS YEAR, WITH A 404 00:14:49,240 --> 00:14:52,120 408 MILLION-DOLLAR INCREASE, 405 00:14:52,120 --> 00:14:53,120 RISING COSTS MEANT THAT TO 406 00:14:53,120 --> 00:14:58,480 INCREASE THE PAY LINE, WE TO PAY 407 00:14:58,480 --> 00:14:59,120 MOST CONTINUING NONCOMPETING 408 00:14:59,120 --> 00:14:59,680 GRANTS. 409 00:14:59,680 --> 00:15:02,640 THAT IS YEARS 2-5 OF A TYPICAL 5 410 00:15:02,640 --> 00:15:04,600 YEAR GRANT AT 98%. 411 00:15:04,600 --> 00:15:07,640 NOT THE FULL AMOUNT. 412 00:15:07,640 --> 00:15:09,080 WE ALSO CONSIDERABLY TIGHTENED 413 00:15:09,080 --> 00:15:12,560 OUR BELTS AT NCI ONCE COVERING 414 00:15:12,560 --> 00:15:14,880 INCREASED BASE LINE COSTS, WE 415 00:15:14,880 --> 00:15:18,160 ALSO HAD OUR DIVISIONS, OFFICES 416 00:15:18,160 --> 00:15:23,560 AND CENTERS TAKE A 2% CUT AND WE 417 00:15:23,560 --> 00:15:25,760 ALLOCATED FOR A GREAT AMOUNT OF 418 00:15:25,760 --> 00:15:27,960 THE NEW FUNDING TO CRITICAL 419 00:15:27,960 --> 00:15:32,040 INFRASTRUCTURE NEEDS THAT WE 420 00:15:32,040 --> 00:15:33,240 JUST CAN'T DELAY, SUCH AS 421 00:15:33,240 --> 00:15:35,080 INFORMATION TECHNOLOGY THAT WILL 422 00:15:35,080 --> 00:15:38,000 FURTHER EXPAND DATA SHARING 423 00:15:38,000 --> 00:15:39,240 ACCESS ACROSS THE ENTIRE 424 00:15:39,240 --> 00:15:39,800 RESEARCH COMMUNITY. 425 00:15:39,800 --> 00:15:44,400 THIS IS A BIG PRIORITY FOR US 426 00:15:44,400 --> 00:15:45,080 AND FOR OUR COMMUNITY. 427 00:15:45,080 --> 00:15:46,920 AND WE USED SOME OF THIS YEAR'S 428 00:15:46,920 --> 00:15:56,280 EXTRA FUNDING TO MAKE SURE IT IS 429 00:15:56,280 --> 00:15:56,720 SUPPORTED. 430 00:15:56,720 --> 00:15:58,040 MISS HOLOHAN WILL PRESENT MORE 431 00:15:58,040 --> 00:15:59,920 ON THIS AND WHAT THAT COULD MEAN 432 00:15:59,920 --> 00:16:01,520 FOR OUR SESSION, NEXT SLIDE. 433 00:16:01,520 --> 00:16:03,960 LAST TIME I MENTIONED THE 434 00:16:03,960 --> 00:16:05,520 NATIONAL CANCER PLAN, NCI LEADS 435 00:16:05,520 --> 00:16:06,480 A NATIONAL CANCER PROGRAM 436 00:16:06,480 --> 00:16:08,360 REQUIRED BY THE NATIONAL CANCER 437 00:16:08,360 --> 00:16:11,400 ACT OF 1971 THAT CALLS FOR 438 00:16:11,400 --> 00:16:12,000 COLLABORATION ACROSS LOCAL, 439 00:16:12,000 --> 00:16:14,800 FEDERAL AND STATE GOVERNMENTS, 440 00:16:14,800 --> 00:16:16,960 ALL OF THE MANY AGENCIES, 441 00:16:16,960 --> 00:16:18,360 ORGANIZATIONS, AND OTHER GROUPS 442 00:16:18,360 --> 00:16:22,320 THAT PLAY A ROLE IN OUR PROGRESS 443 00:16:22,320 --> 00:16:23,080 AGAINST CANCER. 444 00:16:23,080 --> 00:16:26,240 THAT IS THE REASON THAT WE ARE 445 00:16:26,240 --> 00:16:30,040 NOW CREATING A NATIONAL CANCER 446 00:16:30,040 --> 00:16:30,240 PLAN. 447 00:16:30,240 --> 00:16:32,240 THIS IS DIFFERENT FROM THE 448 00:16:32,240 --> 00:16:35,000 ANNUAL PLAN AND BUDGET THAT NCI 449 00:16:35,000 --> 00:16:38,360 RELEASES EVERY YEAR WHICH WE USE 450 00:16:38,360 --> 00:16:41,080 TO CALL THAT ANNUAL PLAN IS USED 451 00:16:41,080 --> 00:16:43,200 TO FOCUS ATTENTION ON PROMISING 452 00:16:43,200 --> 00:16:46,000 NEW NCI REPORTED RESEARCH AND 453 00:16:46,000 --> 00:16:49,000 AREAS THAT YEAR AND PROVIDE OUR 454 00:16:49,000 --> 00:16:51,000 BEST PROFESSIONAL JUDGMENT ON 455 00:16:51,000 --> 00:16:53,760 THE FUNDING NEEDED OVER THAT 456 00:16:53,760 --> 00:16:57,120 FISCAL--THE FISCAL YEAR THAT 457 00:16:57,120 --> 00:16:57,360 FOLLOWS. 458 00:16:57,360 --> 00:17:00,040 INSTEAD, THE NATIONAL CANCER 459 00:17:00,040 --> 00:17:01,920 PLAN IS A LONG RANGE PLANNING 460 00:17:01,920 --> 00:17:04,880 DOCUMENT, 1 THAT WILL GUIDE OUR 461 00:17:04,880 --> 00:17:05,680 WORK FOR YEARS. 462 00:17:05,680 --> 00:17:08,280 IT IS THE RESPONSE TO THE 463 00:17:08,280 --> 00:17:10,920 CHALLENGE THAT WE REDUCE CANCER 464 00:17:10,920 --> 00:17:15,680 MORTALITY BY 50% IN 25 YEARS. 465 00:17:15,680 --> 00:17:17,160 AN ANNUAL PLAN WILL NOT GET US 466 00:17:17,160 --> 00:17:19,400 THERE, WE NEED LONG RANGE 467 00:17:19,400 --> 00:17:19,680 PLANNING. 468 00:17:19,680 --> 00:17:21,080 AND ALSO NEED IT TO END CANCER 469 00:17:21,080 --> 00:17:23,680 AS WE KNOW IT. 470 00:17:23,680 --> 00:17:25,400 WE WILL CONTINUE WITH OUR ANNUAL 471 00:17:25,400 --> 00:17:27,280 PLAN TO ALIGN AND FOCUS OUR 472 00:17:27,280 --> 00:17:29,160 PRIORITIES WITHIN A GIVEN YEAR, 473 00:17:29,160 --> 00:17:30,560 BUT NOW, I WOULD LIKE TO GIVE 474 00:17:30,560 --> 00:17:33,560 YOU AN UPDATE ON WHERE WE ARE 475 00:17:33,560 --> 00:17:35,320 WITH THE NATIONAL BROADER, 476 00:17:35,320 --> 00:17:36,280 LONG-TERM NATIONAL CANCER PLAN 477 00:17:36,280 --> 00:17:36,480 TODAY. 478 00:17:36,480 --> 00:17:39,040 OVER THE LAST COUPLE MONTHS, 479 00:17:39,040 --> 00:17:41,120 I'VE WORKED VERY CLOSELY WITH 480 00:17:41,120 --> 00:17:44,600 NCI LEADERS TO PUT TOGETHER THE 481 00:17:44,600 --> 00:17:44,800 PLAN. 482 00:17:44,800 --> 00:17:45,800 IT EMBRACES THE IDEA THAT 483 00:17:45,800 --> 00:17:49,360 EVERYONE HAS A ROLE TO PLAY, 484 00:17:49,360 --> 00:17:51,960 ACROSS FEDERAL AGENCIES AS WELL 485 00:17:51,960 --> 00:17:53,800 AS INDUSTRY, UNIVERSITIES, 486 00:17:53,800 --> 00:17:54,680 ADVOCACY GROUPS, NONPROFITS, 487 00:17:54,680 --> 00:17:58,000 EVEN CAREGIVERS AND PATIENTS. 488 00:17:58,000 --> 00:18:00,960 OUR INTENT IS THAT WHEN ANY 489 00:18:00,960 --> 00:18:02,840 ORGANIZATION OR PERSON LOOKS AT 490 00:18:02,840 --> 00:18:05,680 THIS PLAN, THEY WILL SEE WHERE 491 00:18:05,680 --> 00:18:08,400 THEY FIT AS A CONTRIBUTOR TO 492 00:18:08,400 --> 00:18:10,040 PROGRESS AND THEY WILL ALSO BE 493 00:18:10,040 --> 00:18:14,360 ABLE TO SEE THE FULL PICTURE OF 494 00:18:14,360 --> 00:18:16,240 THE MANY INTERRELATED ACTIONS 495 00:18:16,240 --> 00:18:19,440 NEEDED TO END CANCER AS WE KNOW 496 00:18:19,440 --> 00:18:19,600 IT. 497 00:18:19,600 --> 00:18:21,400 TO MAKE SURE THAT THIS PLAN 498 00:18:21,400 --> 00:18:23,280 REALLY WORKS FOR EVERYONE, AND 499 00:18:23,280 --> 00:18:25,600 NOT JUST NCI, WE'RE GETTING--NOW 500 00:18:25,600 --> 00:18:27,720 GETTING INPUT FROM A WIDE RANGE 501 00:18:27,720 --> 00:18:29,280 OF STAKEHOLDERS ACROSS NIH, THE 502 00:18:29,280 --> 00:18:31,040 DEPARTMENT OF HEALTH AND HUMAN 503 00:18:31,040 --> 00:18:32,720 SERVICES, THE WHITE HOUSE, 504 00:18:32,720 --> 00:18:35,360 OFFICE OF SCIENCE AND TECHNOLOGY 505 00:18:35,360 --> 00:18:38,240 POLICY, THE CANCER CABINET, AND 506 00:18:38,240 --> 00:18:40,960 VARIOUS OTHER ORGANIZATIONS AND 507 00:18:40,960 --> 00:18:41,200 GROUPS. 508 00:18:41,200 --> 00:18:43,720 WE WILL DISCUSS THE PLAN IN 509 00:18:43,720 --> 00:18:45,880 DETAIL WITH YOU OF COURSE VERY 510 00:18:45,880 --> 00:18:48,640 SOON SO THAT YOU CAN PROVIDE 511 00:18:48,640 --> 00:18:49,000 YOUR INPUT. 512 00:18:49,000 --> 00:18:50,440 ONCE WE FINALIZE IT, THE PLAN 513 00:18:50,440 --> 00:18:52,880 WILL BE COMMUNICATED TO THE WIDE 514 00:18:52,880 --> 00:18:54,720 PUBLIC THROUGH OUR WEBSITE, 515 00:18:54,720 --> 00:18:58,000 SOCIAL MEDIA, OUR PARTNERS, NEWS 516 00:18:58,000 --> 00:18:59,920 OUTLET AND NEWS OUTLETS AND AT A 517 00:18:59,920 --> 00:19:00,720 VARIETY OF EVENTS. 518 00:19:00,720 --> 00:19:03,760 WE WILL START THIS SPRING AND 519 00:19:03,760 --> 00:19:04,920 CONTINUE THROUGHOUT THE YEAR SO 520 00:19:04,920 --> 00:19:07,560 IT'S COMING VERY SOON. 521 00:19:07,560 --> 00:19:09,400 FINALLY, NOTHING IN THIS PLAN 522 00:19:09,400 --> 00:19:10,280 WILL SURPRISE YOU. 523 00:19:10,280 --> 00:19:12,760 I MEAN, OF COURSE, AS MEMBERS OF 524 00:19:12,760 --> 00:19:16,160 THE NCAB, YOU ARE ALL ACUTELY 525 00:19:16,160 --> 00:19:18,320 AWARE OF EVERYTHING THAT WE NEED 526 00:19:18,320 --> 00:19:21,000 TO DO TO END CANCER AS WE KNOW 527 00:19:21,000 --> 00:19:24,320 IT, BUT IT IS INTENDED TO COVER 528 00:19:24,320 --> 00:19:26,520 ALL THE BASES AND IT ALSO 529 00:19:26,520 --> 00:19:28,320 INCLUDES MANY GOALS THAT HAVE 530 00:19:28,320 --> 00:19:29,960 ALREADY BEEN ARTICULATED BY YOU 531 00:19:29,960 --> 00:19:31,680 AND OTHERS, BY THE PRESIDENT, 532 00:19:31,680 --> 00:19:34,400 THE BLUE RIBBON PANEL OF THE 533 00:19:34,400 --> 00:19:37,000 FIRST CANCER PANELS OF THE 534 00:19:37,000 --> 00:19:37,800 CANCER MOONSHOT, THE PRESIDENT'S 535 00:19:37,800 --> 00:19:40,200 CANCER PANEL AND BY YOU ALL. 536 00:19:40,200 --> 00:19:44,280 WHAT THIS DOES IS PUT ALL OF 537 00:19:44,280 --> 00:19:45,720 THESE IMPORTANT GOALS AND 538 00:19:45,720 --> 00:19:47,320 OBJECTIVES INTO A FRAMEWORK THAT 539 00:19:47,320 --> 00:19:50,200 WILL HELP US SEE THE FULL RANGE 540 00:19:50,200 --> 00:19:53,480 OF WHAT IS NECESSARY, BE ABLE TO 541 00:19:53,480 --> 00:19:54,800 STRATEGIZE AND MOST IMPORTANT 542 00:19:54,800 --> 00:19:59,960 WORK TOGETHER. 543 00:19:59,960 --> 00:20:00,560 NEXT SLIDE. 544 00:20:00,560 --> 00:20:02,560 SO WHATEVER THE FUTURE HOLDS FOR 545 00:20:02,560 --> 00:20:04,640 OUR BUDGET, NCI CONTINUES ITS 546 00:20:04,640 --> 00:20:05,960 IMPORTANT WORK MAKING BEST USE 547 00:20:05,960 --> 00:20:07,800 OF WHATEVER RESOURCES WE HAVE 548 00:20:07,800 --> 00:20:08,000 TODAY. 549 00:20:08,000 --> 00:20:11,920 AND I WOULD LIKE TO GIVE YOU A 550 00:20:11,920 --> 00:20:12,800 FEW HIGHLIGHTS. 551 00:20:12,800 --> 00:20:14,240 THESE EXAMPLES WERE CHOSEN TO 552 00:20:14,240 --> 00:20:15,480 REPRESENT PARTICULAR AREAS OF 553 00:20:15,480 --> 00:20:18,400 FOCUS, THE FIRST INVOLVES 554 00:20:18,400 --> 00:20:19,040 CLINICAL TRIALS. 555 00:20:19,040 --> 00:20:21,240 AS WE CONVEYED IN OUR 2024 556 00:20:21,240 --> 00:20:23,080 ANNUAL PLAN AND BUDGET, WE NEED 557 00:20:23,080 --> 00:20:27,280 AT A MIN NUM TO DOUBLE ACCRUAL 558 00:20:27,280 --> 00:20:29,600 TO CLINICAL TRIALS, TO PRODUCE 559 00:20:29,600 --> 00:20:31,960 THE PREVENTION, DETECTION AND 560 00:20:31,960 --> 00:20:34,920 TREATMENT MEASURES THAT WILL END 561 00:20:34,920 --> 00:20:35,400 CANCER SUFFERING. 562 00:20:35,400 --> 00:20:37,360 WE JUST DON'T HAVE ENOUGH PEOPLE 563 00:20:37,360 --> 00:20:38,920 PARTICIPATING IN TRIALS TO MAKE 564 00:20:38,920 --> 00:20:42,760 THE RAPID PROGRESS WE NEED AND 565 00:20:42,760 --> 00:20:44,400 THOSE WHO HAVE BEEN UNDERSERVED 566 00:20:44,400 --> 00:20:47,600 AS NOT BEEN ABLE TO BENEFIT FROM 567 00:20:47,600 --> 00:20:48,640 TRIALS THE SAME AS THOSE WHO 568 00:20:48,640 --> 00:20:50,120 HAVE BEEN ABLE TO PARTICIPATE. 569 00:20:50,120 --> 00:20:51,960 SO WE NEED TO MAKE IT POSSIBLE 570 00:20:51,960 --> 00:20:53,480 FOR EVERY SINGLE PERSON WITH 571 00:20:53,480 --> 00:20:57,080 CANCER OR AT RISK FOR CANCER TO 572 00:20:57,080 --> 00:21:00,320 HAVE A REALISTIC OPPORTUNITY TO 573 00:21:00,320 --> 00:21:02,520 PARTICIPATE IN RESEARCH EMPHASIS 574 00:21:02,520 --> 00:21:02,920 ON REALISTIC. 575 00:21:02,920 --> 00:21:05,760 AND WE NEED TO THINK 576 00:21:05,760 --> 00:21:06,360 DIFFERENTLY. 577 00:21:06,360 --> 00:21:07,400 WE JUST HAVEN'T GONE FAR ENOUGH 578 00:21:07,400 --> 00:21:10,000 TO MAKE CLINICAL TRIALS EASY FOR 579 00:21:10,000 --> 00:21:11,040 PEOPLE TO PARTICIPATE IN SO THAT 580 00:21:11,040 --> 00:21:14,480 WE CAN GET RESULTS MUCH FASTER. 581 00:21:14,480 --> 00:21:18,320 LAST JULY, A NEW TRIAL WAS 582 00:21:18,320 --> 00:21:21,920 CONCEIVED TO DO EXACTLY THIS, 583 00:21:21,920 --> 00:21:22,840 LAST JULY. 584 00:21:22,840 --> 00:21:26,520 WHAT EMERGED NOW IN FEBRUARY, 585 00:21:26,520 --> 00:21:27,680 THAT'S PRETTY QUICK TIMELINE, IS 586 00:21:27,680 --> 00:21:31,680 THE TRIAL FOR PEOPLE WITH LUNG 587 00:21:31,680 --> 00:21:32,720 CANCER, THE PRAGMATIC TRIAL 588 00:21:32,720 --> 00:21:37,960 WHICH IS A COLLABORATION BETWEEN 589 00:21:37,960 --> 00:21:40,680 NCI, NATIONAL CLINICAL TRIALS 590 00:21:40,680 --> 00:21:42,600 NETWORK, FDA, LILLY, MERK, AND 591 00:21:42,600 --> 00:21:44,040 THE LUNG MAP INVESTIGATORS, THE 592 00:21:44,040 --> 00:21:50,760 RESEARCH QUESTION IS WHETHER THE 593 00:21:50,760 --> 00:21:55,040 COMBINATION OF RAMUCIRUMAB, PLUS 594 00:21:55,040 --> 00:21:56,760 PEMBRLIZUMAB VERSUS STANDARD OF 595 00:21:56,760 --> 00:21:58,760 CARE FOR PARTICIPANTS PREVIOUSLY 596 00:21:58,760 --> 00:22:01,040 TREATED WITH IMUGOLOGY WHOSE 597 00:22:01,040 --> 00:22:01,880 DISEASE PROGRESSED AFTER 598 00:22:01,880 --> 00:22:02,240 IMMUNOTHERAPY. 599 00:22:02,240 --> 00:22:03,920 A VERY STRAIGHT FORWARD 600 00:22:03,920 --> 00:22:05,120 REGISTRATION TRIAL WAS DESIGNED 601 00:22:05,120 --> 00:22:06,760 TO DEEMERGING IF THIS DRUG 602 00:22:06,760 --> 00:22:08,000 COMBINATION HELPS THESE PATIENTS 603 00:22:08,000 --> 00:22:08,960 LIVE LONGER. 604 00:22:08,960 --> 00:22:10,400 THE TEAM PULLED OUT ALL THE 605 00:22:10,400 --> 00:22:12,960 STOPS AND SHOWED THAT A TRIAL 606 00:22:12,960 --> 00:22:15,280 COULD BE VERY QUICKLY DEVELOPED, 607 00:22:15,280 --> 00:22:18,000 WHAT MADE ALL THE DIFFERENCE WAS 608 00:22:18,000 --> 00:22:22,000 THE WILLINGNESS OF ALL PARTIES, 609 00:22:22,000 --> 00:22:24,000 GOVERNMENT, INDUSTRY, AND 610 00:22:24,000 --> 00:22:26,040 ACADEMIC COLLABORATORS TO WORK 611 00:22:26,040 --> 00:22:27,040 TOGETHER AND ELIMINATE ALL OF 612 00:22:27,040 --> 00:22:31,040 THE DELAYS THAT NORMALLY 613 00:22:31,040 --> 00:22:31,840 CHALLENGE MULTISTAKEHOLDER 614 00:22:31,840 --> 00:22:32,200 COLLABORATIONS. 615 00:22:32,200 --> 00:22:33,600 AND NOW WE'RE READY TO OPEN THIS 616 00:22:33,600 --> 00:22:35,080 SIMPLE BUT VERY IMPORTANT TRIAL 617 00:22:35,080 --> 00:22:39,120 ACROSS THE NATION AND FOCUS ON 618 00:22:39,120 --> 00:22:40,480 RAPIDLY ENGAGING PATIENTS 619 00:22:40,480 --> 00:22:41,760 PARTICULARLY THOSE WHO ARE TOO 620 00:22:41,760 --> 00:22:44,920 OFTEN LEFT OUT OF CLINICAL 621 00:22:44,920 --> 00:22:47,160 TRIALS, THOSE WITH ADVERSE 622 00:22:47,160 --> 00:22:47,840 SOCIAL DETERMINANTS OF HEALTH 623 00:22:47,840 --> 00:22:50,240 WHO ARE ALSO THE PEOPLE AT 624 00:22:50,240 --> 00:22:51,760 GREATEST RISK FOR SMALL CELL 625 00:22:51,760 --> 00:22:55,160 LUNG CANCER IN THE FIRST PLACE. 626 00:22:55,160 --> 00:22:58,160 SO THE NEXT STEP IS TO MAKE THIS 627 00:22:58,160 --> 00:23:02,160 KIND OF INNOVATION, INCLINICAL 628 00:23:02,160 --> 00:23:06,280 TRIALS DESIGN AND OPERATIONAL 629 00:23:06,280 --> 00:23:06,960 EFFECTIVENESS COMMON PLACE. 630 00:23:06,960 --> 00:23:09,080 TO DO THIS, I AM DELIGHTED TO 631 00:23:09,080 --> 00:23:11,280 ANNOUNCE THAT IN COLLABORATION 632 00:23:11,280 --> 00:23:14,120 WITH FDA, AND THE EXTRAMURAL 633 00:23:14,120 --> 00:23:15,000 CANCER CLINICAL RESEARCH 634 00:23:15,000 --> 00:23:20,800 COMMUNITY, WE HAVE CREATED A 635 00:23:20,800 --> 00:23:21,800 CLINICAL TRIAL INNOVATION UNIT. 636 00:23:21,800 --> 00:23:24,840 THIS UNIT IS NOT INTENDED TO 637 00:23:24,840 --> 00:23:27,360 REPLACE THE CURRENT VERY ACTIVE 638 00:23:27,360 --> 00:23:29,280 AND CRITICAL STUDY DESIGN AND 639 00:23:29,280 --> 00:23:30,400 APPROVAL PROCESSES OF THE 640 00:23:30,400 --> 00:23:33,920 NATIONAL CLINICAL TRIALS 641 00:23:33,920 --> 00:23:37,360 NETWORK, INSTEAD, THE UNIT WILL 642 00:23:37,360 --> 00:23:40,880 SELECT HIGH PRIORITY STUDIES 643 00:23:40,880 --> 00:23:42,280 DEEMED PARTICULARLY AMENABLE TO 644 00:23:42,280 --> 00:23:44,680 RADICALLY NEW STUDY DESIGNS AND 645 00:23:44,680 --> 00:23:46,120 OPERATIONAL PROCEDURES. 646 00:23:46,120 --> 00:23:50,080 AND THEN, ENGAGE THE PARTNERS 647 00:23:50,080 --> 00:23:52,800 NECESSARY TO BREAK THE MOLD AND 648 00:23:52,800 --> 00:23:54,520 FORGE A NEW PATH. 649 00:23:54,520 --> 00:23:59,400 VERY HARD TO DO THAT UNDER OUR 650 00:23:59,400 --> 00:24:01,240 CURRENTLY VERY ACTIVE, IN OUR 651 00:24:01,240 --> 00:24:03,600 CURRENT VERY ACTIVE MECHANISMS 652 00:24:03,600 --> 00:24:05,320 FOR CLINICAL TRIAL DESIGN AND 653 00:24:05,320 --> 00:24:05,680 APPROVAL. 654 00:24:05,680 --> 00:24:09,520 THE UNIT WILL BE CO-DIRECTED BY 655 00:24:09,520 --> 00:24:11,040 DR. SHEILA PRINDEVILLE, WHO IS 656 00:24:11,040 --> 00:24:12,720 DIRECTOR OF NCI'S CLINICAL 657 00:24:12,720 --> 00:24:14,000 COORDINATING CENTER FOR CLINICAL 658 00:24:14,000 --> 00:24:15,880 TRIALS AND DR. MICHAEL MORRIS 659 00:24:15,880 --> 00:24:17,400 FROM MEMORIAL SLOAN KETTERRING 660 00:24:17,400 --> 00:24:19,360 CANCER CENTER, BOTH OF WHOM WILL 661 00:24:19,360 --> 00:24:20,840 BE NONVOTING MEMBERS OF THE 662 00:24:20,840 --> 00:24:21,520 UNIT. 663 00:24:21,520 --> 00:24:23,840 AND I WILL EMPHASIZE, ALL 664 00:24:23,840 --> 00:24:26,160 ASPECTS OF CLINICAL TRIALS ARE 665 00:24:26,160 --> 00:24:29,200 ON THE TABLE. 666 00:24:29,200 --> 00:24:31,080 STUDY ELIGIBILITY, COMPARATOR 667 00:24:31,080 --> 00:24:33,040 ARMS, END POINTS, DIAGNOSTICS 668 00:24:33,040 --> 00:24:35,520 STUDY DATA COLLECTION 669 00:24:35,520 --> 00:24:36,600 PROCEDURES, PARTICIPANT 670 00:24:36,600 --> 00:24:37,040 ENGAGEMENT STRATEGIES, 671 00:24:37,040 --> 00:24:39,680 EVERYTHING, THAT CAN BE ADAPTED 672 00:24:39,680 --> 00:24:43,480 TO ACHIEVE MORE AND FASTER 673 00:24:43,480 --> 00:24:47,560 BENEFIT FOR PATIENTS, IS OPEN TO 674 00:24:47,560 --> 00:24:47,920 INNOVATION. 675 00:24:47,920 --> 00:24:49,680 WE ANTICIPATE THE SUCCESSFUL 676 00:24:49,680 --> 00:24:50,680 APPROACHES DEVELOPED BY THIS 677 00:24:50,680 --> 00:24:52,960 UNIT WILL THEN TRANSITION TO 678 00:24:52,960 --> 00:24:54,520 BECOME MAIN STREAM BUT THAT THE 679 00:24:54,520 --> 00:24:56,440 NEED FOR INNOVATION WILL ALWAYS 680 00:24:56,440 --> 00:24:58,240 CONTINUE AND I'M VERY HAPPY TO 681 00:24:58,240 --> 00:25:00,640 TELL YOU THAT THIS UNIT WILL 682 00:25:00,640 --> 00:25:03,520 BEGIN ITS WORK THIS MONTH. 683 00:25:03,520 --> 00:25:07,200 THE OTHER AREA I WOULD LIKE TO 684 00:25:07,200 --> 00:25:08,080 HIGHLIGHT INVOLVES DATA. 685 00:25:08,080 --> 00:25:11,600 WE WON'T IMPROVE OUR 686 00:25:11,600 --> 00:25:12,600 UNDERSTANDING OF CANCER BIOLOGY 687 00:25:12,600 --> 00:25:15,480 AND WHAT MEASURE WORKS BEST 688 00:25:15,480 --> 00:25:19,800 AGAINST IT WITHOUT DATA. 689 00:25:19,800 --> 00:25:20,760 ESPECIALLY PRACTICES POPULATIONS 690 00:25:20,760 --> 00:25:25,080 LONG UNDER REPRESENTED IN OUR 691 00:25:25,080 --> 00:25:25,800 DATA COLLECTIONS. 692 00:25:25,800 --> 00:25:27,320 WE'RE MAKING GREAT HEAD WAY TO 693 00:25:27,320 --> 00:25:29,680 GET MUCH NEEDED DATA INTO THE 694 00:25:29,680 --> 00:25:30,320 HANDS OF SCIENTISTS. 695 00:25:30,320 --> 00:25:34,200 YOU ALL KNOW HOW CHALLENGING AND 696 00:25:34,200 --> 00:25:37,160 FRANKLY COSTLY THIS IS. 697 00:25:37,160 --> 00:25:39,160 I'M TRULY EXCITED ABOUT THE 698 00:25:39,160 --> 00:25:40,600 CHILDHOOD CANCER DATA 699 00:25:40,600 --> 00:25:45,560 INITIATIVE, CCDI, YOU SEE IT ON 700 00:25:45,560 --> 00:25:46,960 THE TOP RIGHT. 701 00:25:46,960 --> 00:25:49,480 ITS PROGRESS, IT'S MADE 702 00:25:49,480 --> 00:25:50,640 TREMENDOUS PROGRESS TO PROVIDE 703 00:25:50,640 --> 00:25:52,520 DATA THAT HAS HISTORICALLY BEEN 704 00:25:52,520 --> 00:25:54,200 VERY CHALLENGING FOR RESEARCHERS 705 00:25:54,200 --> 00:25:56,800 TO ACCESS, THIS YEAR GREG 706 00:25:56,800 --> 00:25:58,800 [INDISCERNIBLE] WHO HAS TAKEN 707 00:25:58,800 --> 00:26:01,120 CHARGE OF CCDI, HAS TAKEN TIME 708 00:26:01,120 --> 00:26:02,400 AND LEADING THE CHILDREN'S 709 00:26:02,400 --> 00:26:04,120 ONCOLOGY GROUP AND ALSO WORKING 710 00:26:04,120 --> 00:26:07,040 AT FDA, IN DECEMBER THE CCDI 711 00:26:07,040 --> 00:26:07,600 MOLECULAR TARGETS PLATFORM, 712 00:26:07,600 --> 00:26:12,120 WHICH IS A TOOL THAT CATALOGS 713 00:26:12,120 --> 00:26:13,240 AND CHARACTERIZES, MOLECULAR 714 00:26:13,240 --> 00:26:14,680 EVENTS INVOLVED IN THE GROWTH 715 00:26:14,680 --> 00:26:17,560 AND SPREAD OF CHILDHOOD CANCERS 716 00:26:17,560 --> 00:26:19,880 WAS UPDATED WITH ADDITIONAL DATA 717 00:26:19,880 --> 00:26:23,080 AND SOFTWARE, AND IN JANUARY, 718 00:26:23,080 --> 00:26:24,840 THE CHILDHOOD CANCER DATA 719 00:26:24,840 --> 00:26:30,320 CATALOG ADDED 5 NEW RESOURCES, 3 720 00:26:30,320 --> 00:26:34,200 ANALYTICAL TOOLS AND 46 NOW DATA 721 00:26:34,200 --> 00:26:34,640 SETS. 722 00:26:34,640 --> 00:26:38,120 ON MARCH 24th, NCI WILL HOST 723 00:26:38,120 --> 00:26:39,320 AN ANNUAL SYMPOSIUM WHICH WILL 724 00:26:39,320 --> 00:26:40,720 GATHER EXPERTS FROM AROUND THE 725 00:26:40,720 --> 00:26:43,000 COUNTRY TO DISCUSS CCI'S 726 00:26:43,000 --> 00:26:45,040 PROGRESS, HIGHLIGHT THE NEW 727 00:26:45,040 --> 00:26:48,400 RESOURCES AVAILABLE TO THE 728 00:26:48,400 --> 00:26:49,800 BROADEST POSSIBLE COMMUNITY AND 729 00:26:49,800 --> 00:26:52,120 DISCUSS OPPORTUNITIES FOR THE 730 00:26:52,120 --> 00:26:52,360 FUTURE. 731 00:26:52,360 --> 00:26:53,960 THERE'S A LOT MORE TO COME IN 732 00:26:53,960 --> 00:26:56,680 THE VERY NEAR FUTURE THROUGH 733 00:26:56,680 --> 00:26:59,680 THIS TRANSFORMATIVE PROGRAM THAT 734 00:26:59,680 --> 00:27:02,280 PROVIDES A FIRST OF THE KIND 735 00:27:02,280 --> 00:27:04,640 PLATFORM FOR NATIONWIDE DATA 736 00:27:04,640 --> 00:27:05,880 SHARING AND RESEARCH 737 00:27:05,880 --> 00:27:08,720 COLLABORATION ON BEHALF OF 738 00:27:08,720 --> 00:27:09,920 CHILDREN AND ADOLESCENTS IN 739 00:27:09,920 --> 00:27:13,040 YOUNG ADULTS WITH CANCER. 740 00:27:13,040 --> 00:27:15,480 NEXT COMMENT, WE'RE CELEBRATING 741 00:27:15,480 --> 00:27:17,680 THE 50th ANNIVERSARY OF 742 00:27:17,680 --> 00:27:21,240 SURVEILLANCE, EPIDEMIOLOGY AND 743 00:27:21,240 --> 00:27:24,760 END RESULTS PROGRAM OR SEER. 744 00:27:24,760 --> 00:27:26,680 SEER IS AN INDENSE PENNIBLE TOOL 745 00:27:26,680 --> 00:27:28,440 IN THE FIGHT AGAINST CANCER. 746 00:27:28,440 --> 00:27:31,440 IT COVERS ALMOST HALF THE 747 00:27:31,440 --> 00:27:32,480 POPULATION THROUGH PARTICIPATING 748 00:27:32,480 --> 00:27:34,040 CANCER REG TREES AND AN 749 00:27:34,040 --> 00:27:35,520 ANNOUNCEMENT OF SEER DATA 750 00:27:35,520 --> 00:27:36,960 PROVIDES US WITH OUR REPORT 751 00:27:36,960 --> 00:27:38,680 CARD, TELLS US WHERE WE STAND 752 00:27:38,680 --> 00:27:40,560 WITH VARIOUS CANCERS BY POWERING 753 00:27:40,560 --> 00:27:42,960 IMPORTANT REPORTS LOAMACYIC THE 754 00:27:42,960 --> 00:27:43,800 CANCER TRENDS PROGRESS REPORT 755 00:27:43,800 --> 00:27:44,920 AND THE ANNUAL REPORT TO THE 756 00:27:44,920 --> 00:27:47,200 NATION ON THE STATUS OF CANCER. 757 00:27:47,200 --> 00:27:48,520 THROUGHOUT THE REST OF THE YEAR, 758 00:27:48,520 --> 00:27:52,560 YOU WILL SEE A SERIES OF 759 00:27:52,560 --> 00:27:53,480 INFORMATION ON SEER'S 760 00:27:53,480 --> 00:27:55,640 CONTRIBUTION TO CANCER RESEARCH 761 00:27:55,640 --> 00:27:57,600 AND PUBLIC HEALTH ONLINE, ON 762 00:27:57,600 --> 00:28:01,040 SOCIAL MEDIA AND AT VARIOUS 763 00:28:01,040 --> 00:28:02,800 EVENTS. 764 00:28:02,800 --> 00:28:04,760 I WILL REMIND YOU SEER CAN DO 765 00:28:04,760 --> 00:28:05,240 MORE. 766 00:28:05,240 --> 00:28:09,880 WE CAN EXPAND AND FURTHER 767 00:28:09,880 --> 00:28:11,440 EMPOWER SEER TO GO BROADER, 768 00:28:11,440 --> 00:28:14,360 COVER EVEN MORE AND HELP US 769 00:28:14,360 --> 00:28:17,720 REALLY ADDRESS THE NEEDS OF OUR 770 00:28:17,720 --> 00:28:20,880 UNDERREPRESENTED POPULATION. 771 00:28:20,880 --> 00:28:23,160 THIS IS SOMETHING THAT--A GOAL 772 00:28:23,160 --> 00:28:27,040 TO WHICH WE ASPIRE. 773 00:28:27,040 --> 00:28:27,520 NEXT SLIDE, PLEASE. 774 00:28:27,520 --> 00:28:29,440 THE BEST NEWS I CAN SHARE IS 775 00:28:29,440 --> 00:28:30,840 THAT NCI KEEPS PRODUCING THE 776 00:28:30,840 --> 00:28:32,480 KIND OF RESULTS WE REALLY NEED. 777 00:28:32,480 --> 00:28:33,800 SO WE STILL HAVE A LOT MORE 778 00:28:33,800 --> 00:28:35,520 PROGRESS TO MAKE A LOT MORE 779 00:28:35,520 --> 00:28:37,360 PROGRESS IN HOW WE TREAT AND 780 00:28:37,360 --> 00:28:38,840 PREVENT CANCER. 781 00:28:38,840 --> 00:28:40,040 WE MADE IMPORTANT PROGRESS EVEN 782 00:28:40,040 --> 00:28:41,040 SINCE OUR LAST MEETING IN 783 00:28:41,040 --> 00:28:41,320 DECEMBER. 784 00:28:41,320 --> 00:28:43,400 SO I THOUGHT I WOULD SHARE 785 00:28:43,400 --> 00:28:44,720 HIGHLIGHTS. 786 00:28:44,720 --> 00:28:47,080 ON THE TREATMENT SIDE, IN 2021, 787 00:28:47,080 --> 00:28:50,680 WE SAW THE FIRST FDA APPROVAL 788 00:28:50,680 --> 00:28:53,960 FOR KRAS, FOR TUMORS WITH KRAS 789 00:28:53,960 --> 00:28:55,760 MUTATIONS THAT WAS THE G12 790 00:28:55,760 --> 00:28:57,200 C-MUTATION WHICH IS THE MOST 791 00:28:57,200 --> 00:28:58,560 COMMON IN LUNG CANCER. 792 00:28:58,560 --> 00:29:01,600 WE MAY BE NOW, ON THE PATH TO A 793 00:29:01,600 --> 00:29:04,800 TREATMENT FOR G12 D-MUTATIONS. 794 00:29:04,800 --> 00:29:05,520 COMMON IN PANCREATIC CANCER 795 00:29:05,520 --> 00:29:09,160 WHICH HAS BEEN A REAL STRUGGLE 796 00:29:09,160 --> 00:29:12,160 FOR PATIENTS AND PROVIDERS 797 00:29:12,160 --> 00:29:12,960 ALIKE. 798 00:29:12,960 --> 00:29:15,920 AN NCI FUNDED STUDY SHOWED THAT 799 00:29:15,920 --> 00:29:21,400 A NEW DRUG KNOWN AS MRTX1133, 800 00:29:21,400 --> 00:29:30,360 SHRANK TUMORS OR HALTED THEIR 801 00:29:30,360 --> 00:29:31,960 GROWTH WITH KRAS MUTATIONS. 802 00:29:31,960 --> 00:29:34,440 WE EXPECT TO SEE THIS REALLY 803 00:29:34,440 --> 00:29:35,600 EXCITING RESULT TRANSLATE INTO 804 00:29:35,600 --> 00:29:36,760 HUMAN STUDIES. 805 00:29:36,760 --> 00:29:38,800 NEXT, A PHASE 2 TRIAL LED BY 806 00:29:38,800 --> 00:29:40,080 NCI'S DIVISION OF CANCER 807 00:29:40,080 --> 00:29:43,440 TREATMENT AND DIAGNOSIS, RESULT 808 00:29:43,440 --> 00:29:43,600 E 809 00:29:43,600 --> 00:29:48,240 D IN THE FIRST FDA 810 00:29:48,240 --> 00:29:49,160 TREATMENT OF ALVEOLAR SARCOMA 811 00:29:49,160 --> 00:29:55,520 FOR ADULT ANDS CHILDREN 2 YEARS 812 00:29:55,520 --> 00:29:58,120 AND OLDER, ATIZALUZAMAB. 813 00:29:58,120 --> 00:29:59,560 NEXT FOR A SERIES OF 814 00:29:59,560 --> 00:30:00,280 COLLABORATIONS BETWEEN THE 815 00:30:00,280 --> 00:30:01,720 AMERICAN SOCIETY OF CLINICAL 816 00:30:01,720 --> 00:30:04,360 ONCOLOGY WAS PUBLISHED IN JCO 817 00:30:04,360 --> 00:30:04,960 ONCOLOGY PRACTICE. 818 00:30:04,960 --> 00:30:07,360 I URGE YOU TO TAKE A ELECTRIC AT 819 00:30:07,360 --> 00:30:10,400 THIS. 820 00:30:10,400 --> 00:30:11,840 IT INCLUDED 15 PEER REVIEWED 821 00:30:11,840 --> 00:30:13,280 PUBLICATIONS ON THE TOPIC OF 822 00:30:13,280 --> 00:30:16,640 TEAM BASED CANCER CARE. 823 00:30:16,640 --> 00:30:17,440 THEY DESCRIBED SIGNIFICANTLY 824 00:30:17,440 --> 00:30:20,760 INCREASED INVOLVEMENT OF ADVANCE 825 00:30:20,760 --> 00:30:21,640 PRACTICE PROVIDERS IN CANCER 826 00:30:21,640 --> 00:30:26,480 CARE, IN RESPONSE TO INCREASED 827 00:30:26,480 --> 00:30:30,640 PATIENT DEMAND AND AN INADEQUATE 828 00:30:30,640 --> 00:30:32,920 NUMBER OF ONCOLOGIST NUMBERS IN 829 00:30:32,920 --> 00:30:36,320 OUR WORKFORCE AND INCREASING 830 00:30:36,320 --> 00:30:36,960 COMPLEXITY. 831 00:30:36,960 --> 00:30:41,120 ALSO WAS A INCREASE IN PARTIC 832 00:30:41,120 --> 00:30:41,600 PLAN TO ANALYZE BY AGES 833 00:30:41,600 --> 00:30:42,560 ROUTINELY PARTICIPATING IN AN 834 00:30:42,560 --> 00:30:44,200 INDIVIDUAL PATIENT'S CARE 835 00:30:44,200 --> 00:30:46,400 INCLUDING PHARMACISTS, ONCOLOGY, 836 00:30:46,400 --> 00:30:47,920 NUTRITIONISTS, PALLIATIVE CARE 837 00:30:47,920 --> 00:30:48,880 SPECIALIST, SOCIAL WORKERS, 838 00:30:48,880 --> 00:30:51,480 NURSE NAVIGATORS AND MANY 839 00:30:51,480 --> 00:30:51,720 OTHERS. 840 00:30:51,720 --> 00:30:53,680 A BIG THEME THROUGHOUT THIS 841 00:30:53,680 --> 00:30:57,240 SERIES IS THAT CANCER CARE IS 842 00:30:57,240 --> 00:30:58,040 BECOMING INCREASINGLY COMPLEX 843 00:30:58,040 --> 00:30:59,560 AND THAT UNDERSTANDING THE 844 00:30:59,560 --> 00:31:01,120 DYNAMICS OF CANCER CARE DELIVERY 845 00:31:01,120 --> 00:31:04,000 AT ALL LEVELS, IS REQUIRED FOR 846 00:31:04,000 --> 00:31:05,120 SUCCESSFUL CLINICAL RESEARCH AND 847 00:31:05,120 --> 00:31:09,200 ALSO FOR THE IMPLEMENTATION OF 848 00:31:09,200 --> 00:31:12,440 NEW ADVANCES IN CANCER CARE AND 849 00:31:12,440 --> 00:31:12,760 PREVENTION. 850 00:31:12,760 --> 00:31:15,080 IN PREVENTION, A PHASE 1 851 00:31:15,080 --> 00:31:16,600 CLINICAL TRIAL INVOLVED 852 00:31:16,600 --> 00:31:17,560 RESEARCHERS FROM NCI'S CENTER 853 00:31:17,560 --> 00:31:19,840 FOR CANCER RESEARCH AND THE 854 00:31:19,840 --> 00:31:22,600 FREDERICK NATIONAL LAB AND 855 00:31:22,600 --> 00:31:25,440 SHOWED THAT A COMBINATION DOSE 856 00:31:25,440 --> 00:31:27,280 OF [INDISCERNIBLE] MAY BE 857 00:31:27,280 --> 00:31:29,520 EFFECTIVE IN PREVENTING BRAIN 858 00:31:29,520 --> 00:31:31,880 METASTASIS FOR PATIENTS WITH 859 00:31:31,880 --> 00:31:34,960 HER-2 POSITIVE BREAST CANCER. 860 00:31:34,960 --> 00:31:36,480 THIS STUDY OF--THIS STUDY SHOWED 861 00:31:36,480 --> 00:31:39,320 THAT 83% OF PATIENTS 862 00:31:39,320 --> 00:31:41,480 DEMONSTRATED NO NEW BRAIN 863 00:31:41,480 --> 00:31:43,080 METASTASIS WITH TREATMENT AND WE 864 00:31:43,080 --> 00:31:45,280 LOOK FORWARD TO SEEING THIS 865 00:31:45,280 --> 00:31:47,800 IMPORTANT PHASE 1 RESULT MOVING 866 00:31:47,800 --> 00:31:48,160 FORWARD. 867 00:31:48,160 --> 00:31:49,440 FINALLY, WE KNOW THAT DRINKING 868 00:31:49,440 --> 00:31:50,840 ALCOHOL CAN INCREASE THE CANCER 869 00:31:50,840 --> 00:31:54,680 RISK OF SEVERAL CANCER TYPES. 870 00:31:54,680 --> 00:31:55,600 BUT ANOTHER ILLUSTRATION OF HOW 871 00:31:55,600 --> 00:32:00,920 WE NEED TO GET OUR KNOWLEDGE 872 00:32:00,920 --> 00:32:02,200 TRANSLATED TO PEOPLE, NOT JUST 873 00:32:02,200 --> 00:32:03,920 TO OTHER RESEARCHERS WAS A STUDY 874 00:32:03,920 --> 00:32:06,400 LED BY NCI'S DIVISION OF CANCER 875 00:32:06,400 --> 00:32:08,040 CONTROL AND POPULATION SCIENCES 876 00:32:08,040 --> 00:32:10,320 FOUND THAT MOST PERSONS WEREN'T 877 00:32:10,320 --> 00:32:12,440 AWARE OF THIS CONNECTION. 878 00:32:12,440 --> 00:32:13,160 THEY CONCLUDED THAT NUMEROUS 879 00:32:13,160 --> 00:32:14,920 CHANGES NEED TO BE MADE TO RAISE 880 00:32:14,920 --> 00:32:17,520 PUBLIC AWARENESS OF THIS FACT 881 00:32:17,520 --> 00:32:20,000 BECAUSE AND WE KNOW THAT 882 00:32:20,000 --> 00:32:21,640 AWARENESS DOESN'T GUARANTEE 883 00:32:21,640 --> 00:32:23,080 ACTION, WILL NEED FURTHER 884 00:32:23,080 --> 00:32:28,040 RESEARCH TO SOLVE THESE 885 00:32:28,040 --> 00:32:28,360 CHALLENGES. 886 00:32:28,360 --> 00:32:29,240 NEXT SLIDE. 887 00:32:29,240 --> 00:32:30,720 SO FINALLY, THANK YOU SO MUCH 888 00:32:30,720 --> 00:32:32,240 FOR BEING HERE TODAY, THIS IS 889 00:32:32,240 --> 00:32:33,880 JUST A BRIEF SNAPSHOT OF WHAT'S 890 00:32:33,880 --> 00:32:34,160 GOING ON. 891 00:32:34,160 --> 00:32:36,560 I KNOW THAT YOU ALL LEAD VERY 892 00:32:36,560 --> 00:32:39,200 DEMANDING LIVES AND WE SINCERELY 893 00:32:39,200 --> 00:32:41,320 APPRECIATE THE EXPERTISE THAT 894 00:32:41,320 --> 00:32:45,120 YOU CONTRIBUTE TO HELP NCI 895 00:32:45,120 --> 00:32:46,880 ACHIEVE ITS MISSION. 896 00:32:46,880 --> 00:32:48,560 FINALLY, A PERSONAL NOTE OF 897 00:32:48,560 --> 00:32:51,320 THANKS TO ALL OF YOU WHO REACHED 898 00:32:51,320 --> 00:32:54,200 OUT WITH YOUR EXPRESSIONS OF 899 00:32:54,200 --> 00:32:57,160 SUPPORT DURING MY OWN RECENT 900 00:32:57,160 --> 00:32:57,920 CANCER DIAGNOSIS. 901 00:32:57,920 --> 00:33:02,000 MY TREATMENT IS GOING VERY WELL, 902 00:33:02,000 --> 00:33:05,600 OF COURSE, WE ALL HAVE TO BE 903 00:33:05,600 --> 00:33:07,120 VERY HUMBLE IN THE FACE OF THIS 904 00:33:07,120 --> 00:33:10,760 DISEASE BUT THANKS TO EARLY 905 00:33:10,760 --> 00:33:13,520 DETECTION AND THE KNOWLEDGE 906 00:33:13,520 --> 00:33:17,080 PROVIDED BY DECADES OF NCI 907 00:33:17,080 --> 00:33:20,320 SUPPORTED RESEARCH, MY OWN 908 00:33:20,320 --> 00:33:23,520 PERSONAL LONG-TERM PROGNOSIS IS 909 00:33:23,520 --> 00:33:23,880 EXCELLENT. 910 00:33:23,880 --> 00:33:26,240 I'M VERY GRATEFUL TO NCI 911 00:33:26,240 --> 00:33:26,560 RESEARCHERS. 912 00:33:26,560 --> 00:33:28,120 I LOOK FORWARD TO YOUR 913 00:33:28,120 --> 00:33:29,800 QUESTIONS. 914 00:33:29,800 --> 00:33:37,160 BACK TO YOU DR. CARPTEN. 915 00:33:37,160 --> 00:33:37,880 >>THANKS MONICA, THAT'S 916 00:33:37,880 --> 00:33:38,720 OUTSTANDING AND THANKS FOR 917 00:33:38,720 --> 00:33:40,120 SHARING ALL THAT INFORMATION. 918 00:33:40,120 --> 00:33:45,960 I WILL OPEN THE FLOOR FOR 919 00:33:45,960 --> 00:33:46,560 QUESTIONS FOR THE DIRECTOR. 920 00:33:46,560 --> 00:33:49,280 I GUESS I, I WILL START, WE HAVE 921 00:33:49,280 --> 00:33:51,560 PROBABLY I THINK 10-12 MINUTES 922 00:33:51,560 --> 00:33:54,080 FOR Q&A. 923 00:33:54,080 --> 00:33:55,560 SO, I THINK, YOU KNOW 1 OF THE 924 00:33:55,560 --> 00:33:56,920 THINGS THAT HAS COME UP, I THINK 925 00:33:56,920 --> 00:34:00,600 WE'RE ALL SEEING IT MORE AND 926 00:34:00,600 --> 00:34:02,200 MORE, SOME DECISIONS AROUND 927 00:34:02,200 --> 00:34:03,200 PROSTATE CANCER SCREENING AND 928 00:34:03,200 --> 00:34:06,680 YOU KNOW RECENT ARTICLES SHOWING 929 00:34:06,680 --> 00:34:08,640 THERE'S A SIGNIFICANT INCREASE 930 00:34:08,640 --> 00:34:09,840 IN ADVANCED PROSTATE CANCER AND 931 00:34:09,840 --> 00:34:11,400 SO, WHAT ARE YOUR THOUGHTS, 932 00:34:11,400 --> 00:34:12,200 RIGHT? 933 00:34:12,200 --> 00:34:15,440 HOW DOES THE NCI GET INVOLVED IN 934 00:34:15,440 --> 00:34:16,360 MITIGATING THIS SITUATION? 935 00:34:16,360 --> 00:34:17,880 AND I UNDERSTAND SO THERE'S THE 936 00:34:17,880 --> 00:34:20,520 PLAN AND THERE'S SORT OF THE 937 00:34:20,520 --> 00:34:24,120 LONG-TERM GOALS OF SORT OF 938 00:34:24,120 --> 00:34:24,880 ADVANCING NCI STRATEGICALLY BUT 939 00:34:24,880 --> 00:34:27,240 THEN WHEN WE SEE THINGS LIKE 940 00:34:27,240 --> 00:34:30,160 THIS HAPPEN, RIGHT, HOW DOES THE 941 00:34:30,160 --> 00:34:33,920 NCI JUMP IN, RIGHT, AND GO INTO 942 00:34:33,920 --> 00:34:36,680 LIKE WARP SPEED MODE, LET'S CALL 943 00:34:36,680 --> 00:34:38,560 IT THAT, TO REALLY TRY TO FIGURE 944 00:34:38,560 --> 00:34:40,440 OUT HOW WE MITIGATE THESE TYPES 945 00:34:40,440 --> 00:34:40,840 OF SITUATIONS? 946 00:34:40,840 --> 00:34:42,120 >>YEAH, I LOVE THIS QUESTION 947 00:34:42,120 --> 00:34:45,720 BECAUSE IT ILLUSTRATES, YOU 948 00:34:45,720 --> 00:34:47,560 KNOW, WE HAVE TO ATTACK IT AT 949 00:34:47,560 --> 00:34:48,200 ALL LEVELS. 950 00:34:48,200 --> 00:34:48,880 OKAY? 951 00:34:48,880 --> 00:34:49,880 SO YOU KNOW, FIRST OF ALL, 952 00:34:49,880 --> 00:34:51,520 THAT'S WHY WE NEED OUR REPORT 953 00:34:51,520 --> 00:34:52,960 CARD, THAT'S WHY WE NEED TO KNOW 954 00:34:52,960 --> 00:34:56,080 WHAT'S HAPPENING ON A POPULATION 955 00:34:56,080 --> 00:34:56,920 LEVEL, ABSOLUTELY CRITICAL THAT 956 00:34:56,920 --> 00:34:58,840 WE CONTINUE TO GET THAT 957 00:34:58,840 --> 00:35:01,680 FEEDBACK, AND GET GOOD FEEDBACK 958 00:35:01,680 --> 00:35:03,200 THAT SHOWS US WHICH 959 00:35:03,200 --> 00:35:05,760 SUBPOPULATIONS, WHICH AS YOU 960 00:35:05,760 --> 00:35:09,560 KNOW WELL, ARE A REAL--ALSO A 961 00:35:09,560 --> 00:35:11,400 REAL SPECIFIC CONCERN IN 962 00:35:11,400 --> 00:35:11,800 PROSTATE CANCER. 963 00:35:11,800 --> 00:35:14,400 YOU KNOW WHERE WE REALLY NEED TO 964 00:35:14,400 --> 00:35:15,440 FOCUS OUR ATTENTION AND THEN WE 965 00:35:15,440 --> 00:35:19,640 ATTACK IT WITH THE SAME 3 966 00:35:19,640 --> 00:35:23,160 PRONGED ATTACK THAT WE ALWAYS 967 00:35:23,160 --> 00:35:25,000 DO, UNDERSTANDING THE BASIC 968 00:35:25,000 --> 00:35:29,320 MECHANISMS OF EARLY TUMOR 969 00:35:29,320 --> 00:35:30,880 DEVELOPMENT, NEXT, TRANSLATING 970 00:35:30,880 --> 00:35:33,040 THAT UNDERSTANDING INTO 971 00:35:33,040 --> 00:35:36,560 EFFECTIVE NEW METHODS FOR 972 00:35:36,560 --> 00:35:36,800 DETECTION. 973 00:35:36,800 --> 00:35:38,640 I MEAN I KNOW WE ALL HAVE EYES 974 00:35:38,640 --> 00:35:42,200 ON THE NEW MOLECULAR 975 00:35:42,200 --> 00:35:44,800 MULTICANCKER DETECTION TESTS; 976 00:35:44,800 --> 00:35:46,160 YOU KNOW WHO KNOWS FOR PROSTATE 977 00:35:46,160 --> 00:35:49,320 CANCER WE MAY NEED A VERY 978 00:35:49,320 --> 00:35:51,440 SPECIFIC PROSTATE CANCER 979 00:35:51,440 --> 00:35:55,640 MOLECULAR DETECTION TEST, WE 980 00:35:55,640 --> 00:35:57,080 DON'T KNOW THAT WE WILL NOT 981 00:35:57,080 --> 00:35:59,680 ASSUME, SO WE WILL TAKE THAT 982 00:35:59,680 --> 00:36:05,120 BIOLOGY USE IT TO DEVELOP 983 00:36:05,120 --> 00:36:05,840 DETECTION AND DIAGNOSTICS AND 984 00:36:05,840 --> 00:36:07,920 THEN WE HAVE TO TAKE THAT AND 985 00:36:07,920 --> 00:36:14,080 TRANSLATE IT INTO EFFECTIVE 986 00:36:14,080 --> 00:36:15,600 PREVENTION AND PREVENTION BUT 987 00:36:15,600 --> 00:36:16,920 WHEN NECESSARY, WHICH WILL 988 00:36:16,920 --> 00:36:18,240 ALWAYS BE NECESSARY TREATMENT 989 00:36:18,240 --> 00:36:19,200 APPROACHES, YOU KNOW AND SO I'M 990 00:36:19,200 --> 00:36:21,720 NOT GOING TO SPEAK TO ALL THE 991 00:36:21,720 --> 00:36:24,560 DETAILS BUT YOU KNOW YOU RALLY 992 00:36:24,560 --> 00:36:26,440 THE COMMUNITY, YOU MAKE SURE 993 00:36:26,440 --> 00:36:29,280 YOU'RE NOT ATTACKING THE PROBLEM 994 00:36:29,280 --> 00:36:31,440 FROM ANY 1 LENS. 995 00:36:31,440 --> 00:36:33,280 OH, GHEES, I FORGOT THE VERY 996 00:36:33,280 --> 00:36:35,560 LAST 1 AND PROBABLY THE MOST 997 00:36:35,560 --> 00:36:36,640 IMPORTANT WONGS WE HAVE 998 00:36:36,640 --> 00:36:38,120 STRATEGIES FOR WHAT WE KNOW 999 00:36:38,120 --> 00:36:40,040 WORKS, THEN WE NEED TO MAKE SURE 1000 00:36:40,040 --> 00:36:40,760 IT HAPPENS. 1001 00:36:40,760 --> 00:36:45,280 WE NEED TO MAKE SURE THAT THE 1002 00:36:45,280 --> 00:36:47,000 PEOPLE WHO NEED THE NEW 1003 00:36:47,000 --> 00:36:48,120 SCREENING METHODS OR PREVENTION 1004 00:36:48,120 --> 00:36:50,000 METHODS OR TREATMENT METHODS 1005 00:36:50,000 --> 00:36:52,680 ACTUALLY RECEIVE THEM. 1006 00:36:52,680 --> 00:36:54,120 SO YOU KNOW THAT APPROACH, 1007 00:36:54,120 --> 00:36:55,960 SOMETHING LIKE THIS, HAS TO BE 1008 00:36:55,960 --> 00:37:01,760 ATTACKED AT ALL LEVELS BY REALLY 1009 00:37:01,760 --> 00:37:02,920 DEDICATED ANDA FAINKLY I HEARD 1010 00:37:02,920 --> 00:37:04,800 THIS IN THE SUBCOMMITTEE REPORT 1011 00:37:04,800 --> 00:37:06,520 THIS MORNING AND BOY DID IT 1012 00:37:06,520 --> 00:37:08,040 RESONATE WITH ME, YOU DON'T 1013 00:37:08,040 --> 00:37:11,160 INVITE THE PREVENTION 1014 00:37:11,160 --> 00:37:13,480 RESEARCHERS TO THE TABLE ONLY 1015 00:37:13,480 --> 00:37:20,440 AFTER YOU KNOW SOMEBODY HAS 1016 00:37:20,440 --> 00:37:22,840 DECIDED EVERYTHING THEY KNOW 1017 00:37:22,840 --> 00:37:23,880 ABOUT THE MOLECULAR BIOLOGY OR 1018 00:37:23,880 --> 00:37:25,080 EVERYTHING THEY KNOW ABOUT THE 1019 00:37:25,080 --> 00:37:25,400 TREATMENT. 1020 00:37:25,400 --> 00:37:27,000 YOU NEED TO LET EVERYBODY IN ALL 1021 00:37:27,000 --> 00:37:27,520 THE TIME. 1022 00:37:27,520 --> 00:37:29,400 I'M A HUGE BELIEVENER CROSS 1023 00:37:29,400 --> 00:37:30,240 FERTILIZATION OF ALL THESE 1024 00:37:30,240 --> 00:37:30,840 DIFFERENT DISCIPLINES THAT ARE 1025 00:37:30,840 --> 00:37:33,720 REQUIRED TO GET US TO THE FINISH 1026 00:37:33,720 --> 00:37:33,920 LINE. 1027 00:37:33,920 --> 00:37:36,920 >>THANKS MONICA AND AGAIN, YOU 1028 00:37:36,920 --> 00:37:38,760 KNOW BLURT OUT THE WORD 1029 00:37:38,760 --> 00:37:39,600 INTEGRATION AND I THINK THE 1030 00:37:39,600 --> 00:37:41,720 OTHER THING WE HAVE TO THINK 1031 00:37:41,720 --> 00:37:42,360 ABOUT IS RISK. 1032 00:37:42,360 --> 00:37:46,320 I THINK SOME OF THE MOST--I 1033 00:37:46,320 --> 00:37:48,280 WOULD SAY THE DEEPEST 1034 00:37:48,280 --> 00:37:49,760 INFORMATION ON UNDERSTANDING 1035 00:37:49,760 --> 00:37:54,880 GENERATED ETDIC RISK AND 1036 00:37:54,880 --> 00:37:56,160 CANCER---GENETIC RISK AND CANCER 1037 00:37:56,160 --> 00:37:57,800 AND THERE'S BEEN TONS OF WORK 1038 00:37:57,800 --> 00:38:00,160 AROUND THAT AND HOW DO WE 1039 00:38:00,160 --> 00:38:01,840 INTEGRATE THESE 2 MODEL. 1040 00:38:01,840 --> 00:38:03,240 I SEE HANDS AND I WILL START 1041 00:38:03,240 --> 00:38:05,000 WITH ALEXIA AND THEN I WILL GO 1042 00:38:05,000 --> 00:38:05,240 TO ANN. 1043 00:38:05,240 --> 00:38:06,440 >>THANK YOU VERY MUCH. 1044 00:38:06,440 --> 00:38:07,880 THANK YOU MONICA THAT WAS A 1045 00:38:07,880 --> 00:38:08,640 WONDERFUL REPORT AND THANKS FOR 1046 00:38:08,640 --> 00:38:10,160 ALL YOU DO AND THE EXCITEMENT 1047 00:38:10,160 --> 00:38:11,480 AND ENERGY THAT YOU'RE BRINGING. 1048 00:38:11,480 --> 00:38:14,320 IME SO GLAD YOU'RE DOING WELL, 1049 00:38:14,320 --> 00:38:14,800 ALSO. 1050 00:38:14,800 --> 00:38:16,680 SO I HAVE TO COMMENTS. 1051 00:38:16,680 --> 00:38:19,880 FIRST OF ALL, WE ARE NOT AS A 1052 00:38:19,880 --> 00:38:21,760 NATION BOUNCING BACK FROM COVID 1053 00:38:21,760 --> 00:38:24,920 IN TERMS OF CANCER SCREENING AND 1054 00:38:24,920 --> 00:38:28,840 UPTICK OF HPV VACCINE. 1055 00:38:28,840 --> 00:38:31,280 WE JUST HAD AN ARTICLE PUBLISHED 1056 00:38:31,280 --> 00:38:32,600 IN JCO THE OTHER DAY THAT 1057 00:38:32,600 --> 00:38:35,200 QUANTIFIES SOME OF THAT AT LEAST 1058 00:38:35,200 --> 00:38:38,040 HERE AND I'M EXTREMELY CONCERNED 1059 00:38:38,040 --> 00:38:42,080 AS HAS BEEN ECHOED BEFORE, THE 1060 00:38:42,080 --> 00:38:44,040 CANCER STATISTICS REPORT SHOWED 1061 00:38:44,040 --> 00:38:46,560 A 65% DECREASE IN CERVICAL 1062 00:38:46,560 --> 00:38:49,280 CANCER INCIDENTS IN THE FIRST 1063 00:38:49,280 --> 00:38:53,880 COHORT OF WOMEN THAT GOT THAT 1064 00:38:53,880 --> 00:38:56,000 VACCINE THAT IS TREMENDOUS, 1065 00:38:56,000 --> 00:38:57,080 TREMENDOUS SHOWING WE CAN 1066 00:38:57,080 --> 00:38:58,280 PREVENT CANCER BUT I DON'T THINK 1067 00:38:58,280 --> 00:39:00,880 THAT'S SUSTAINED AND WE KNOW 1068 00:39:00,880 --> 00:39:03,200 THAT THAT HAS DECREASED SINCE 1069 00:39:03,200 --> 00:39:03,400 COVID. 1070 00:39:03,400 --> 00:39:05,360 SO, I THINK THAT HAS TO BE AT 1071 00:39:05,360 --> 00:39:05,920 THE FOREFRONT. 1072 00:39:05,920 --> 00:39:10,320 THERE ARE TESTS WE KNOW WORK AND 1073 00:39:10,320 --> 00:39:11,840 WE'VE GOTTA INCREASE THEIR 1074 00:39:11,840 --> 00:39:12,200 UPTAKE. 1075 00:39:12,200 --> 00:39:15,800 THE SECOND POINT, I LOVE THIS 1076 00:39:15,800 --> 00:39:17,080 CLINICAL TRIAL INNOVATION UNIT. 1077 00:39:17,080 --> 00:39:20,560 COULD I JUST MAYBE SUGGEST THAT 1078 00:39:20,560 --> 00:39:22,920 WHEN YOU'RE TALKING ABOUT 1079 00:39:22,920 --> 00:39:26,640 INNOVATIVE METHODS THAT A ALSO 1080 00:39:26,640 --> 00:39:28,600 FOCUS ON INNOVATIVE STRATEGIES 1081 00:39:28,600 --> 00:39:30,680 TO INCREASE ACCRUAL UNDER 1082 00:39:30,680 --> 00:39:31,840 REPRESENTED MINORITIES TO 1083 00:39:31,840 --> 00:39:33,280 TRIALS. 1084 00:39:33,280 --> 00:39:34,480 YOU KNOW, THERE ARE THINGS THAT 1085 00:39:34,480 --> 00:39:35,920 WE CAN DO, WE SHOULD BE DOING 1086 00:39:35,920 --> 00:39:38,120 AND WE'RE NOT DOING. 1087 00:39:38,120 --> 00:39:40,640 AND THIS INNOVATION UNIT WOULD 1088 00:39:40,640 --> 00:39:42,360 BE THE BEST--REALLY GREAT PLACE 1089 00:39:42,360 --> 00:39:44,240 TO FOCUS THAT, SO JUST COMMENTS 1090 00:39:44,240 --> 00:39:45,480 FOR CONSIDERATION, THANK YOU. 1091 00:39:45,480 --> 00:39:49,360 THANK YOU SO MUCH. 1092 00:39:49,360 --> 00:39:51,360 >>ALL RIGHT, AND MILO, I DID 1093 00:39:51,360 --> 00:39:52,960 SEE YOUR HAND. 1094 00:39:52,960 --> 00:39:54,480 >>GO AHEAD,. 1095 00:39:54,480 --> 00:39:57,520 >>NO, THANK YOU, ELECTRA, THANK 1096 00:39:57,520 --> 00:39:59,280 YOU AND I AGREE WITH YOUR 1097 00:39:59,280 --> 00:39:59,880 COMMENTS THERE. 1098 00:39:59,880 --> 00:40:00,920 THEY ARE VERY HIGH LEVEL 1099 00:40:00,920 --> 00:40:02,360 CONCERNS FOR US AND YOU KNOW WE 1100 00:40:02,360 --> 00:40:03,800 CAN NEVER FORGET, ON THE FIRST 1 1101 00:40:03,800 --> 00:40:04,880 WE CAN NEVER FORGET THAT WE 1102 00:40:04,880 --> 00:40:05,720 MIGHT KNOW WHAT'S THE RIGHT 1103 00:40:05,720 --> 00:40:07,680 THING TO DO OR REALLY BELIEVE IN 1104 00:40:07,680 --> 00:40:11,120 IT BUT IT'S GOT TO GET TO PEOPLE 1105 00:40:11,120 --> 00:40:11,720 OR WE'VE FAILED. 1106 00:40:11,720 --> 00:40:15,120 WE'VE FAILED. 1107 00:40:15,120 --> 00:40:16,800 AND WE'RE NOT--NCI'S NOT A CARE 1108 00:40:16,800 --> 00:40:18,040 DELIVERY ORGANIZATION BUT WE 1109 00:40:18,040 --> 00:40:21,320 BETTER BE DOING THE RESEARCH 1110 00:40:21,320 --> 00:40:25,400 THAT SHOWS HOW CARE DELIVERY CAN 1111 00:40:25,400 --> 00:40:30,720 BE ACCOMPLISHED IN WAYS THAT 1112 00:40:30,720 --> 00:40:32,680 ACHIEVE EQUITY AND MAXIMUM 1113 00:40:32,680 --> 00:40:36,360 UPTAKE OF WHAT WORKS. 1114 00:40:36,360 --> 00:40:37,000 >>OKAY, GREAT. 1115 00:40:37,000 --> 00:40:40,160 LET'S GO TO ANN AND THEN MILO, 1116 00:40:40,160 --> 00:40:41,680 AND THEN KAREN IF WE HAVE TIME 1117 00:40:41,680 --> 00:40:43,080 BECAUSE WE HAVE ABOUT 5 MINUTES 1118 00:40:43,080 --> 00:40:44,960 SO IF YOU CAN KEEP YOUR 1119 00:40:44,960 --> 00:40:47,000 QUESTIONS QUICK, THAT WOULD BE 1120 00:40:47,000 --> 00:40:47,240 GREAT. 1121 00:40:47,240 --> 00:40:51,960 >>SO MONICA JUST A QUICK 1122 00:40:51,960 --> 00:40:52,240 QUESTION. 1123 00:40:52,240 --> 00:40:54,080 THE PRESIDENT SAID SOMETHING A 1124 00:40:54,080 --> 00:40:55,320 COUPLE NIGHTS AGO THAT I'M 1125 00:40:55,320 --> 00:40:56,440 CONFUSED ABOUT AND I WONDER IF 1126 00:40:56,440 --> 00:40:58,080 YOU HAVE A BETTER IDEA, HE SAID 1127 00:40:58,080 --> 00:41:00,160 HE WANTS TO BRING CANCER 1128 00:41:00,160 --> 00:41:01,360 RESEARCH INFRASTRUCTURE INTO THE 1129 00:41:01,360 --> 00:41:02,440 21st CENTURY, DO YOU HAVE ANY 1130 00:41:02,440 --> 00:41:04,520 IDEA WHAT THAT MEANS? 1131 00:41:04,520 --> 00:41:06,320 I'M CURIOUS, WHAT YOU'RE 1132 00:41:06,320 --> 00:41:08,160 THINKING ABOUT THAT BECAUSE THAT 1133 00:41:08,160 --> 00:41:10,160 OPENS UP A WHOLE NEW WORLD IN 1134 00:41:10,160 --> 00:41:14,360 TERMS OF INFRASTRUCTURE AND I'M 1135 00:41:14,360 --> 00:41:15,880 JUST WONDERING, MAYBE 1136 00:41:15,880 --> 00:41:17,440 [INDISCERNIBLE] WILL KNOW MORE 1137 00:41:17,440 --> 00:41:18,880 ABOUT THIS THAN THE REST OF US 1138 00:41:18,880 --> 00:41:20,760 BUT USUALLY WE'RE NOT IN THE 1139 00:41:20,760 --> 00:41:22,800 INFRASTRUCTURE SENSE THAT WE'RE 1140 00:41:22,800 --> 00:41:23,440 BUILDING BUILDINGS, RIGHT-- 1141 00:41:23,440 --> 00:41:27,160 >>WE HAVE A BUILDING--COUPLE 1142 00:41:27,160 --> 00:41:30,080 FLOODS AT OUR NIH BUILDING AND 1143 00:41:30,080 --> 00:41:33,240 WE WOULD LOVE TO SEE THAT 1144 00:41:33,240 --> 00:41:33,760 RADICALLY MODERNIZED. 1145 00:41:33,760 --> 00:41:34,560 NO, I HEAR YOU. 1146 00:41:34,560 --> 00:41:36,960 YOU KNOW I WILL TELL YOU WHAT IT 1147 00:41:36,960 --> 00:41:41,720 MEANS FOR ME AT NCI. 1148 00:41:41,720 --> 00:41:49,240 I THINK, YOU KNOW THE MOST RAPID 1149 00:41:49,240 --> 00:41:50,640 INCREASE IN DEMAND FOR 1150 00:41:50,640 --> 00:41:53,960 INFRASTRUCTURE FOR US HAS BEEN 1151 00:41:53,960 --> 00:41:54,440 INFORMATION TECHNOLOGY. 1152 00:41:54,440 --> 00:41:56,440 YOU KNOW INFORMATION TECHNOLOGY, 1153 00:41:56,440 --> 00:42:01,640 DATA, DATA STORAGE CAPABILITY, 1154 00:42:01,640 --> 00:42:02,600 DATAAN LYTICS, IT'S EXTENSIVE 1155 00:42:02,600 --> 00:42:03,200 PARADIGM AND DIFFICULT TO 1156 00:42:03,200 --> 00:42:04,880 INTEGRATE THE DATA SETS THAT WE 1157 00:42:04,880 --> 00:42:08,120 NEED SO, RIGHT THERE, THAT IS A 1158 00:42:08,120 --> 00:42:10,600 CRITICAL INFRASTRUCTURE NEED WE 1159 00:42:10,600 --> 00:42:14,040 HAVE THAT FRANKLY IS VERY 1160 00:42:14,040 --> 00:42:14,280 COSTLY. 1161 00:42:14,280 --> 00:42:16,480 YOU KNOW, 1 OF THE THINGS 1162 00:42:16,480 --> 00:42:18,880 THAT--YOU WILL HEAR ME SAY THIS 1163 00:42:18,880 --> 00:42:19,920 MANY TIMES. 1164 00:42:19,920 --> 00:42:24,800 WE HAVE UNBELIEVABLE INFORMATION 1165 00:42:24,800 --> 00:42:25,760 TECHNOLOGY AVAILABLE THAT'S OUT 1166 00:42:25,760 --> 00:42:26,440 THERE. 1167 00:42:26,440 --> 00:42:29,160 WE DON'T HAVE IT AVAILABLE THE 1168 00:42:29,160 --> 00:42:33,680 WAY IT NEEDS TO BE TO EVERY 1169 00:42:33,680 --> 00:42:35,000 SINGLE RESEARCHER. 1170 00:42:35,000 --> 00:42:39,440 SO THAT'S--IF YOU ASK ME WHAT 1171 00:42:39,440 --> 00:42:40,560 INFRASTRUCTURE DO YOU NEED WOB 1172 00:42:40,560 --> 00:42:43,000 THING THAT WILL BE FIRST ON MY 1173 00:42:43,000 --> 00:42:44,400 LIST IS INFORMATION DATA SHARING 1174 00:42:44,400 --> 00:42:45,720 TECHNOLOGY, ET CETERA AND I KNOW 1175 00:42:45,720 --> 00:42:49,040 HE SHARES THAT VIEW BECAUSE 1176 00:42:49,040 --> 00:42:51,600 THAT'S ALSO 1 OF HIS CENTRAL 1177 00:42:51,600 --> 00:42:52,680 THEMES AND FINALLY THE REASON I 1178 00:42:52,680 --> 00:42:54,200 WILL SAY IS THAT THE INFORMATION 1179 00:42:54,200 --> 00:42:55,680 THAT IS CRUCIAL IS BECAUSE WE 1180 00:42:55,680 --> 00:43:06,160 NEED IT TO WORK TOGETHER. 1181 00:43:06,160 --> 00:43:08,560 >>AS YOU KNOW THAT'S THE 1182 00:43:08,560 --> 00:43:09,280 PRESIDENT'S INTEREST IN MOON 1183 00:43:09,280 --> 00:43:11,280 SHOT 1 AND 2, BUT I THINK IT'S 1184 00:43:11,280 --> 00:43:12,480 GOTTEN THE EXECUTIVE BRANCH'S 1185 00:43:12,480 --> 00:43:13,560 ATTENTION THAT RGTD COUNTRIES 1186 00:43:13,560 --> 00:43:14,720 ARE INVESTING MORE IN SOME OF 1187 00:43:14,720 --> 00:43:16,160 THESE KEY AREAS AND WE BETTER 1188 00:43:16,160 --> 00:43:20,480 CATCH UP, WE BETTER NOT GET 1189 00:43:20,480 --> 00:43:21,080 BEHIND. 1190 00:43:21,080 --> 00:43:21,960 AND LAST CONGRATTULESS ON YOUR 1191 00:43:21,960 --> 00:43:23,360 WELL BEING, YOU'RE LOOKING 1192 00:43:23,360 --> 00:43:25,200 WONDERFUL BUT I NEED TO POINT 1193 00:43:25,200 --> 00:43:26,360 OUT SOMETHING THAT YOU KNOW 1194 00:43:26,360 --> 00:43:27,640 BREAST CANCER MORE THAN ANY 1195 00:43:27,640 --> 00:43:29,200 OTHER DISEASE HAS REALLY 1196 00:43:29,200 --> 00:43:31,800 RECEIVED SUPPORT FROM NCI IN SO 1197 00:43:31,800 --> 00:43:33,600 MANY DIFFERENT WAYS AND IT 1198 00:43:33,600 --> 00:43:35,560 REALLY SHOWS, AND IF YOU PUT THE 1199 00:43:35,560 --> 00:43:37,760 RESOURCES THERE, THINGS HAPPEN. 1200 00:43:37,760 --> 00:43:40,960 SO YOU'RE LOOKING GREAT. 1201 00:43:40,960 --> 00:43:41,720 >>THANKS. 1202 00:43:41,720 --> 00:43:42,320 GREAT. 1203 00:43:42,320 --> 00:43:43,360 SO LET'S NILO. 1204 00:43:43,360 --> 00:43:44,880 >>YEAH, I ALSO WANTED TO JUST 1205 00:43:44,880 --> 00:43:46,440 ASK A QUESTION ABOUT THE 1206 00:43:46,440 --> 00:43:47,480 CLINICAL TRIALS INNOVATION UNIT 1207 00:43:47,480 --> 00:43:49,000 WHICH SOUNDS VERY EXCITING BUT 1 1208 00:43:49,000 --> 00:43:52,320 OF THE THINGS THAT I THINK WOULD 1209 00:43:52,320 --> 00:43:56,720 BE GREAT IF IT COULD BE UNDER 1210 00:43:56,720 --> 00:43:57,680 ITS PERVIEW FOR EXPIRATION IS 1211 00:43:57,680 --> 00:44:00,240 THAT WE'RE NOW SEEING MORE 1212 00:44:00,240 --> 00:44:01,240 APPROVALS FOR BIOMARKER DRIVEN 1213 00:44:01,240 --> 00:44:04,120 DRUGS BASED ON VERY POWERFUL 1214 00:44:04,120 --> 00:44:05,280 RESPONSES IN SINGLE ARM STUDIES 1215 00:44:05,280 --> 00:44:07,840 BUT THEN THE FDA REQUIRES THESE 1216 00:44:07,840 --> 00:44:10,240 CONFIRMATION STUDIES THAT ARE 1217 00:44:10,240 --> 00:44:11,440 RANDOMIZED AND IN SMALL SUBSETS 1218 00:44:11,440 --> 00:44:12,960 OF PATIENTS AND THIS IS 1219 00:44:12,960 --> 00:44:14,320 PARTICULARLY TRUE IN SMALL 1220 00:44:14,320 --> 00:44:17,320 SUBSETS OF RARE TUMORS, THOSE 1221 00:44:17,320 --> 00:44:18,880 ARE NEARLY IMPOSSIBLE TO DO AND 1222 00:44:18,880 --> 00:44:21,520 ESPECIALLY TRUE IF WE HAVE 1223 00:44:21,520 --> 00:44:23,720 REDUNDANT DRUG DEVELOPMENT IN 1224 00:44:23,720 --> 00:44:24,800 THAT SPACE, SO IN 1225 00:44:24,800 --> 00:44:26,720 [INDISCERNIBLE] WHICH IS A 1226 00:44:26,720 --> 00:44:28,160 PARTICULAR SOFTMARRY FOR ME, 1227 00:44:28,160 --> 00:44:36,080 WE'VE JUST SEEN AN FGP INHIBITOR 1228 00:44:36,080 --> 00:44:37,560 PULLED FROM THE MARKET AFTER 1229 00:44:37,560 --> 00:44:38,440 APPROVAL BECAUSE THEY COULDN'T 1230 00:44:38,440 --> 00:44:39,840 GET IT DONE AND OTHERS ARE 1231 00:44:39,840 --> 00:44:41,400 PONDERING THIS AS WELL, SO I 1232 00:44:41,400 --> 00:44:43,680 LOLLED FOR THEM TO LOOK AT 1233 00:44:43,680 --> 00:44:45,760 INNOVATIVE WAYS TO GET THE 1234 00:44:45,760 --> 00:44:47,240 CONFIRMATION THEY NEED BUT 1235 00:44:47,240 --> 00:44:48,800 WITHOUT REQUIRING THESE 1236 00:44:48,800 --> 00:44:50,400 RANDOMIZED TRIALS THAT AREN'T 1237 00:44:50,400 --> 00:44:51,440 REASONABLE OR APPROPRIATE FOR 1238 00:44:51,440 --> 00:44:54,120 SMALL SUBSETS OF PATIENTS. 1239 00:44:54,120 --> 00:44:54,800 >>WELL, YOU HAVE--THANK YOU 1240 00:44:54,800 --> 00:44:55,960 VERY MUCH FOR THAT. 1241 00:44:55,960 --> 00:45:01,680 YOU HAVE JUST ARTICULATED A 1242 00:45:01,680 --> 00:45:02,760 PERFEBLGHT UNIT AND THE RIGHT 1243 00:45:02,760 --> 00:45:04,560 PEOPLE AROUND THE TABLE, IT'S 1244 00:45:04,560 --> 00:45:06,560 NCI, IT'S FDA AND IT'S THE 1245 00:45:06,560 --> 00:45:09,200 CLINICAL, THE EXTRAMURAL 1246 00:45:09,200 --> 00:45:10,000 CLINICAL TRIALS COMMUNITY. 1247 00:45:10,000 --> 00:45:12,040 SO THAT'S THE RIGHT TEAM TO TAKE 1248 00:45:12,040 --> 00:45:14,120 SOMETHING LIKE THIS ON, ALL OF 1249 00:45:14,120 --> 00:45:15,440 THEM TOGETHER, SO THAT'S A 1250 00:45:15,440 --> 00:45:16,920 PERFECT QUESTION TO BE BROUGHT 1251 00:45:16,920 --> 00:45:22,680 TO THIS NEW UNIT. 1252 00:45:22,680 --> 00:45:24,560 >>YEAH, THAT'S CLOSE TO MY 1253 00:45:24,560 --> 00:45:26,080 HEART TO, THE RARE CANCER SPACE, 1254 00:45:26,080 --> 00:45:30,800 AND WE WILL ENTERTAIN DR. WING 1255 00:45:30,800 --> 00:45:31,560 FIELD'S QUESTION. 1256 00:45:31,560 --> 00:45:33,520 >>THANK YOU JOHN, APPRECIATE 1257 00:45:33,520 --> 00:45:33,720 THAT. 1258 00:45:33,720 --> 00:45:34,960 HI, MONICA GOOD TO SEE YOU, I 1259 00:45:34,960 --> 00:45:37,800 LOVE THE IDEA OF THE CC-DIRECT. 1260 00:45:37,800 --> 00:45:39,760 I LOVE THAT. 1261 00:45:39,760 --> 00:45:40,560 NAVIGATING THESE ADOLESCENTINGS 1262 00:45:40,560 --> 00:45:41,600 THESE CHILDREN THROUGH THEIR 1263 00:45:41,600 --> 00:45:42,960 CANCER DIAGNOSIS ALONG WITH 1264 00:45:42,960 --> 00:45:44,440 THEIR FAMILIES, WOULDN'T THAT BE 1265 00:45:44,440 --> 00:45:46,080 LOVELY IF WE CAN GET THAT FOR 1266 00:45:46,080 --> 00:45:48,240 ALL OF OUR PATIENTS, 1 THING THE 1267 00:45:48,240 --> 00:45:49,440 PRESIDENT MENTIONED IN THE MOON 1268 00:45:49,440 --> 00:45:51,120 SHOT IS THIS CONCEPT OF HAVING 1269 00:45:51,120 --> 00:45:51,840 ALL HANDS ON DECK. 1270 00:45:51,840 --> 00:45:53,960 AND AS YOU KNOW 1 OF THE HUGEST 1271 00:45:53,960 --> 00:45:57,120 BARRIERS TO NOT ONLY CANCER 1272 00:45:57,120 --> 00:45:59,200 CARE, BUT PREVENTION AND ENTER 1273 00:45:59,200 --> 00:46:00,280 INTO CLINICAL TRIALS IS THAT THE 1274 00:46:00,280 --> 00:46:02,640 FACT WE DON'T HAVE A UNIFIED 1275 00:46:02,640 --> 00:46:03,800 INSURANCE AND HEALTHCARE SYSTEMS 1276 00:46:03,800 --> 00:46:05,440 THAT ALLOWS FOR PATIENTS FROM 1277 00:46:05,440 --> 00:46:06,720 UNDERSERVE BACKGROUNDS TO GET 1278 00:46:06,720 --> 00:46:07,920 ACCESS TO CARE, SO HAS THAT AT 1279 00:46:07,920 --> 00:46:11,120 ALL BEEN A TOPIC OF THE LARGER 1280 00:46:11,120 --> 00:46:12,760 GROUP THAT YOU KNOW OF IN TERMS 1281 00:46:12,760 --> 00:46:15,160 OF THINKING ABOUT HOW ALL PARTS 1282 00:46:15,160 --> 00:46:17,600 OF GOVERNMENT CAN BE HANDS ON 1283 00:46:17,600 --> 00:46:18,800 DECK, BECAUSE AGAIN IF WE LOOK 1284 00:46:18,800 --> 00:46:21,760 AT MEDICATE WITH A 30% PAYMENT, 1285 00:46:21,760 --> 00:46:24,080 IT REALLY DOES CAUSE AN 1286 00:46:24,080 --> 00:46:25,560 INFRASTRUCTURE CHALLENGE FOR 1287 00:46:25,560 --> 00:46:27,040 CANCER CENTERS THAT ARE 1288 00:46:27,040 --> 00:46:27,760 ACCEPTING MEDICAID SO I DON'T 1289 00:46:27,760 --> 00:46:29,160 KNOW WHAT SOME OF THAT 1290 00:46:29,160 --> 00:46:32,760 DISCUSSION WOULD BE AND I KNOW 1291 00:46:32,760 --> 00:46:34,760 WE DON'T HAVE TIME SO JUST VERY 1292 00:46:34,760 --> 00:46:36,280 QUICKLY TO SAY, I KNOW AND YOU 1293 00:46:36,280 --> 00:46:37,720 DO TOO THAT THIS IS VERY MUCH A 1294 00:46:37,720 --> 00:46:40,320 CONCERN OF THE PRESIDENT AND 1295 00:46:40,320 --> 00:46:42,160 ANDLET CANCER CABINET WHICH IS, 1296 00:46:42,160 --> 00:46:43,160 YOU KNOW WHICH IS ALL OF 1297 00:46:43,160 --> 00:46:45,240 GOVERNMENT, I CAN TELL YOU AT 1298 00:46:45,240 --> 00:46:47,040 NCI'S ROLE IS, WE HAVE--I CAN 1299 00:46:47,040 --> 00:46:48,760 TELL YOU, NOT MY JOB, NO, NO, 1300 00:46:48,760 --> 00:46:50,600 NO, WE HAVE A VERY IMPORTANT 1301 00:46:50,600 --> 00:46:50,800 ROLE. 1302 00:46:50,800 --> 00:46:55,120 WE BRING THE DATA THAT SHOWS, 1303 00:46:55,120 --> 00:46:56,560 HERE'S WHAT HAPPENS TO CANCER 1304 00:46:56,560 --> 00:46:57,840 DEATH RATES IN STATES THAT DO, 1305 00:46:57,840 --> 00:47:00,640 YOU KNOW THAT EXPAND MEDICAID. 1306 00:47:00,640 --> 00:47:06,280 WE BRING, WE HAVE TO BRING THE 1307 00:47:06,280 --> 00:47:07,760 DATA THAT JUSTIFIES WHY THIS 1308 00:47:07,760 --> 00:47:09,440 NEEDS TO HAPPEN AND I KNOW 1309 00:47:09,440 --> 00:47:10,240 THAT'S REALLY DIFFICULT WORK BUT 1310 00:47:10,240 --> 00:47:12,560 YOU KNOW THOSE WHO ARE TAKING 1311 00:47:12,560 --> 00:47:15,200 THAT ON ARE MAKING A GREAT 1312 00:47:15,200 --> 00:47:17,640 CONTRIBUTION AND THAT'S OUR JOB. 1313 00:47:17,640 --> 00:47:18,440 BRING THE DATA. 1314 00:47:18,440 --> 00:47:20,680 >>THAT'S A GREAT, GREAT, POINT. 1315 00:47:20,680 --> 00:47:21,600 THANKS KAREN. 1316 00:47:21,600 --> 00:47:23,920 THANKS MONICA, THIS IS JUST THE 1317 00:47:23,920 --> 00:47:24,480 BEGINNING, RIGHT? 1318 00:47:24,480 --> 00:47:26,000 WE'VE GOT A LOT OF WORK TO DO, A 1319 00:47:26,000 --> 00:47:27,320 LOT OF WORK AHEAD OF US AND 1320 00:47:27,320 --> 00:47:29,640 WE'RE HERE TO HELP. 1321 00:47:29,640 --> 00:47:32,000 SO MOVING RIGHT ALONG ON THE 1322 00:47:32,000 --> 00:47:33,640 AGENDA, NEXT UP IS THE 1323 00:47:33,640 --> 00:47:35,360 LEGISLATIVE REPORT WHICH WILL BE 1324 00:47:35,360 --> 00:47:41,680 BROUGHT TO US BY MK HOLOHAN. 1325 00:47:41,680 --> 00:47:41,840 MK? 1326 00:47:41,840 --> 00:47:42,440 >>HI, EVERYONE. 1327 00:47:42,440 --> 00:47:42,800 GOOD AFTERNOON. 1328 00:47:42,800 --> 00:47:44,320 THANK YOU FOR THE OPPORTUNITY TO 1329 00:47:44,320 --> 00:47:44,720 SPEAK WITH YOU. 1330 00:47:44,720 --> 00:47:46,720 I WANTED TO REMIND YOU ABOUT A 1331 00:47:46,720 --> 00:47:47,800 DETAILED LEGISLATE UPDATE IN 1332 00:47:47,800 --> 00:47:48,480 YOUR MEETING MATERIALS, I AM 1333 00:47:48,480 --> 00:47:50,880 HAPPY TO TALK WITH YOU OR YOUR 1334 00:47:50,880 --> 00:47:52,480 STAFF IF YOU HAVE SPECIFIC 1335 00:47:52,480 --> 00:47:52,760 QUESTIONS. 1336 00:47:52,760 --> 00:47:54,120 IN THE TIME WE HAVE TODAY, I 1337 00:47:54,120 --> 00:47:55,640 WOULD HAVE AN ABBREVIATED 1338 00:47:55,640 --> 00:47:56,000 COVERAGE HERE. 1339 00:47:56,000 --> 00:47:59,120 CAN I GET THE NEXT SLIDE, 1340 00:47:59,120 --> 00:47:59,360 PLEASE. 1341 00:47:59,360 --> 00:48:03,680 SO I WILL TALK ABOUT LEADERSHIP 1342 00:48:03,680 --> 00:48:05,680 CHANGES IN THE 118th CONGRESS, 1343 00:48:05,680 --> 00:48:07,680 I WILL TALK ON DEBT NOAKSES THAT 1344 00:48:07,680 --> 00:48:10,680 HAVE BEEN DONE, THE FY24 1345 00:48:10,680 --> 00:48:12,160 APPROPRIATIONS PROCESS AND WHAT 1346 00:48:12,160 --> 00:48:13,320 WE EXPECT WILL HAPPEN THERE AND 1347 00:48:13,320 --> 00:48:14,520 THEN WE WILL TOUCH ON OVERSIGHT 1348 00:48:14,520 --> 00:48:16,520 AND THAT WILL BE A BIG PART OF 1349 00:48:16,520 --> 00:48:17,720 THIS CONGRESS AND NIH WILL BE 1350 00:48:17,720 --> 00:48:19,880 PART OF A LOT OF THOSE 1351 00:48:19,880 --> 00:48:22,240 DISCUSSIONS. 1352 00:48:22,240 --> 00:48:22,960 NEXT SLIDE PLEASE. 1353 00:48:22,960 --> 00:48:26,040 SO THIS IS OUR NEW LEADERSHIP IN 1354 00:48:26,040 --> 00:48:29,200 CONGRESS, WE HAVE HERE, THE 1355 00:48:29,200 --> 00:48:32,000 HOUSE AND SENATE TAPPED--EACH 1356 00:48:32,000 --> 00:48:35,280 CHAMBER HAS A UNIQUE POSITION. 1357 00:48:35,280 --> 00:48:37,000 THE SPEAKER OF THE HOUSE IS 1358 00:48:37,000 --> 00:48:38,520 OBVIOUSLY ONLY JUST IN THE 1359 00:48:38,520 --> 00:48:42,120 HOUSE, THE SENATE HAS A 1360 00:48:42,120 --> 00:48:43,760 PRESIDENT PROTEMPORY WHICH IS 1361 00:48:43,760 --> 00:48:45,280 SENATOR PATTY MURRAY, IT IS 1362 00:48:45,280 --> 00:48:47,720 USUALLY THE MOST SENIOR SENATOR, 1363 00:48:47,720 --> 00:48:49,640 IN THIS CASE SHE IS 1 OF THE 1364 00:48:49,640 --> 00:48:50,960 MOST SENIOR SENATORS SO THIS 1365 00:48:50,960 --> 00:48:52,800 PERSON IS, THE VICE PRESIDENT IS 1366 00:48:52,800 --> 00:48:54,560 FIRST IN LINE FOR THE SUCCESSION 1367 00:48:54,560 --> 00:48:55,840 OF THE PRESIDENT, THEN THE 1368 00:48:55,840 --> 00:48:58,320 SPEAKER OF THE HOUSE, THEN THE 1369 00:48:58,320 --> 00:48:59,120 PRESIDENT PROTEMPORY, AND WE 1370 00:48:59,120 --> 00:49:00,640 HAVE NEW LEADER AND GENERATIONAL 1371 00:49:00,640 --> 00:49:02,400 CHANGES ON THE HOUSE DEMOCRAT 1372 00:49:02,400 --> 00:49:02,800 SIDE. 1373 00:49:02,800 --> 00:49:04,920 WE HAVE EXPERIENCED 1374 00:49:04,920 --> 00:49:06,640 LEGISLATORRINGS THROUGHOUT BOTH 1375 00:49:06,640 --> 00:49:08,240 PARTIES AND BOTH CHAMBERS HERE 1376 00:49:08,240 --> 00:49:10,040 SO WE ANTICIPATE THAT 1377 00:49:10,040 --> 00:49:11,200 THEY--THESE PEOPLE REALLY HAVE 1378 00:49:11,200 --> 00:49:13,720 BEEN SEASONED AND THEY HAVE BEEN 1379 00:49:13,720 --> 00:49:16,880 HAVING LEADERSHIP POSITIONS FOR 1380 00:49:16,880 --> 00:49:17,120 SOMETIME. 1381 00:49:17,120 --> 00:49:19,640 AS I THINK EVERYONE KNOWS 1382 00:49:19,640 --> 00:49:21,240 SPEAKER MCCARTHY BECAME SPEAKER 1383 00:49:21,240 --> 00:49:22,920 HAVE QUITE A SLOG, THERE ARE 15 1384 00:49:22,920 --> 00:49:24,520 VOTES FOR THEM TO GET THE VOTES 1385 00:49:24,520 --> 00:49:25,600 HE NEEDED TO BECOME SPEAKER AND 1386 00:49:25,600 --> 00:49:28,160 HE MADE A LOT OF CONCESSIONS IN 1387 00:49:28,160 --> 00:49:30,040 ORDER TO GET THOSE VOTES TO SOME 1388 00:49:30,040 --> 00:49:31,440 OF THE MORE CONSERVATIVE MEMBERS 1389 00:49:31,440 --> 00:49:32,160 OF HIS PARTY. 1390 00:49:32,160 --> 00:49:34,360 WE WILL FOCUS ON A COUPLE HERE. 1391 00:49:34,360 --> 00:49:37,480 ONE OF THEM WAS TO--HE PLEDGED 1392 00:49:37,480 --> 00:49:39,640 TO CUT SPENDING LEVELS TO TD 1393 00:49:39,640 --> 00:49:40,440 FY22 FUNDING LEVEL. 1394 00:49:40,440 --> 00:49:43,280 THAT'S TIED TO THE DEBT LIMIT. 1395 00:49:43,280 --> 00:49:45,040 THEN HE ALSO PLEDGED THAT THERE 1396 00:49:45,040 --> 00:49:48,120 WOULD BE NO BIG OMNIBUS SPENDING 1397 00:49:48,120 --> 00:49:48,840 BILLS. 1398 00:49:48,840 --> 00:49:49,880 IT'S SORT OF UNDERSTANDABLE, 1399 00:49:49,880 --> 00:49:51,680 THESE ARE LIKE 4000 PAGES, A LOT 1400 00:49:51,680 --> 00:49:53,440 OF MEMBERS ARE FRUSTRATED BY THE 1401 00:49:53,440 --> 00:49:54,840 AMOUNT OF TIME THAT THEY'RE 1402 00:49:54,840 --> 00:49:56,480 GIVEN TO REVIEW THESE DOCUMENTS. 1403 00:49:56,480 --> 00:49:57,680 THEY'RE ALWAYS SORT OF LAST 1404 00:49:57,680 --> 00:49:59,720 MINUTE, YOU KNOW THERE'S A C. 1405 00:49:59,720 --> 00:50:00,920 R., FUNDINGS' ABOUT TO RUN OUT, 1406 00:50:00,920 --> 00:50:02,280 BUT WE'RE GOING TO RETURN IT 1407 00:50:02,280 --> 00:50:06,120 THAT IN A LITTLE BIT. 1408 00:50:06,120 --> 00:50:06,720 NEXT SLIDE, PLEASE. 1409 00:50:06,720 --> 00:50:08,080 AND SOME OF THESE CONCESSIONS 1410 00:50:08,080 --> 00:50:09,520 WILL HAVE CONCRETE EFFECTS ON 1411 00:50:09,520 --> 00:50:12,080 THE APPROPRIATION PROCESS AND 1412 00:50:12,080 --> 00:50:13,720 THAT'S WHY I BRING THEM UP HERE. 1413 00:50:13,720 --> 00:50:15,120 SO THE DEBT SEALING. 1414 00:50:15,120 --> 00:50:17,200 WE HAVE SEEN DEBT SEALING SHOW 1415 00:50:17,200 --> 00:50:18,680 DOWNS BEFORE. 1416 00:50:18,680 --> 00:50:20,440 CONGRESS HAS PASSED 20 DEBT 1417 00:50:20,440 --> 00:50:21,080 LIMIT INCREASES SINCE 2001. 1418 00:50:21,080 --> 00:50:23,320 THERE HAVE BEEN OVER A HUNDRED 1419 00:50:23,320 --> 00:50:24,760 SINCE THE EARLY 1900S, THE ISSUE 1420 00:50:24,760 --> 00:50:28,480 HERE IS THAT THERE'S--THE DEBT 1421 00:50:28,480 --> 00:50:30,920 CEILING PRESENTS A LEVERAGING 1422 00:50:30,920 --> 00:50:31,240 OPPORTUNITY. 1423 00:50:31,240 --> 00:50:33,320 MOSTLY, YOU KNOW WHEN WE'VE SEEN 1424 00:50:33,320 --> 00:50:35,480 BUDGET DEALS, DEFICIT REDUCTION, 1425 00:50:35,480 --> 00:50:36,240 REDUCTION LEGISLATION, - IT IS 1426 00:50:36,240 --> 00:50:37,560 NONAPOPTOTIC THE A COINCIDENCE 1427 00:50:37,560 --> 00:50:38,760 THAT THEY TYPICALLY HAPPEN IN 1428 00:50:38,760 --> 00:50:41,480 PARALLEL TO A DEBT LIMIT VOTE. 1429 00:50:41,480 --> 00:50:43,000 THIS GRAPHIC I THOUGHT WAS 1430 00:50:43,000 --> 00:50:45,840 INTERESTING, IT SHOWS THE VOTES 1431 00:50:45,840 --> 00:50:48,440 FOR THE DEBT LIMIT CEILING, HOW 1432 00:50:48,440 --> 00:50:49,240 PARTIES VOTE WHEN THEIR PARTY IS 1433 00:50:49,240 --> 00:50:50,640 IN THE WHITE HOUSE AND YOU CAN 1434 00:50:50,640 --> 00:50:54,280 SEE THAT BOTH PARTIES WILL 1435 00:50:54,280 --> 00:50:56,280 SUPPORT THE LIMIT INCREASES IN A 1436 00:50:56,280 --> 00:50:57,880 HIGHER PROPORTION WHEN THEIR 1437 00:50:57,880 --> 00:50:59,960 PARTY IS IN THE WHITE HOUSE AT 1438 00:50:59,960 --> 00:51:03,120 THAT TIME BUT YOU KNOW THIS 1439 00:51:03,120 --> 00:51:05,320 BECOMES AN ISSUE OF 1440 00:51:05,320 --> 00:51:07,040 PRESIDENTING, IT BECOMES AN 1441 00:51:07,040 --> 00:51:08,960 ISSUE OF PARTY PRIORITIES. 1442 00:51:08,960 --> 00:51:11,080 THE MAJORITY PARTY AND THE 1443 00:51:11,080 --> 00:51:12,800 WHITE HOUSE ALWAYS WANTS A CLEAN 1444 00:51:12,800 --> 00:51:13,640 DEBT LIMIT INCREASE. 1445 00:51:13,640 --> 00:51:15,160 THEY DON'T WANT TO HAVE TO BE 1446 00:51:15,160 --> 00:51:16,920 MAKING DEALS ABOUT SPENDING 1447 00:51:16,920 --> 00:51:19,000 PRIORITIES AND POSSIBLY, YOU 1448 00:51:19,000 --> 00:51:21,760 KNOW SACRIFICES SOME TOOLS THEY 1449 00:51:21,760 --> 00:51:24,240 HAVE TO ADVANCE THEIR OWN AGENDA 1450 00:51:24,240 --> 00:51:26,560 AND PRIORITIES IN ORDER TO 1451 00:51:26,560 --> 00:51:28,880 PREVENT THE U.S. BREECHING THEIR 1452 00:51:28,880 --> 00:51:31,120 OBLIGATIONS ON DEBT THAT'S 1453 00:51:31,120 --> 00:51:33,120 ALREADY BEEN INCURRED BUT WE DO 1454 00:51:33,120 --> 00:51:34,440 SEE THESE PARALLEL WITH 1455 00:51:34,440 --> 00:51:35,040 DIFFERENT BUDGET FIGHTS. 1456 00:51:35,040 --> 00:51:37,400 WE HEARD THE WHITE HOUSE TALK 1457 00:51:37,400 --> 00:51:38,600 ABOUT WE'RE NOT NEGOTIATING ON 1458 00:51:38,600 --> 00:51:40,440 THE DEBT LIMIT BUT THEY'VE 1459 00:51:40,440 --> 00:51:41,160 ALREADY BEGAN DEBT NEGOTIATIONS 1460 00:51:41,160 --> 00:51:43,360 SO THERE'S NO WAY AROUND THIS. 1461 00:51:43,360 --> 00:51:44,560 WE DON'T KNOW HOW THIS IS GOING 1462 00:51:44,560 --> 00:51:45,160 TO PLAY OUT. 1463 00:51:45,160 --> 00:51:46,920 IT WOULD NOT BE SURPRISING IF WE 1464 00:51:46,920 --> 00:51:51,320 SAW SOME SORT OF 2 YEAR BUDGET 1465 00:51:51,320 --> 00:51:51,800 DEAL. 1466 00:51:51,800 --> 00:51:54,440 YOU KNOW THE X-DATE, THE DATE BY 1467 00:51:54,440 --> 00:51:55,840 WHICH THE TREASURY SAYS THE 1468 00:51:55,840 --> 00:51:57,120 EXTRAORDINARY MEASURES THAT 1469 00:51:57,120 --> 00:51:57,720 THEY'RE USING THAT THEY'RE 1470 00:51:57,720 --> 00:51:59,320 ALREADY USING TO TRY TO MAKE 1471 00:51:59,320 --> 00:52:01,080 SURE WE CAN MEET OUR DEBT 1472 00:52:01,080 --> 00:52:04,640 OBLIGATIONS, THOSE ARE 1473 00:52:04,640 --> 00:52:05,680 ANTICIPATED AND PROJECTED TO TO 1474 00:52:05,680 --> 00:52:06,880 BE DONE BY JUNE OR JULY. 1475 00:52:06,880 --> 00:52:08,400 SO THIS IS ALL GOING TO REALLY 1476 00:52:08,400 --> 00:52:09,720 HIT IN THE SUMMER AND SO THE 1477 00:52:09,720 --> 00:52:11,520 SPRING IS GOING TO BE A SPRINT 1478 00:52:11,520 --> 00:52:13,880 IN LOTS OF WAYS OF TRYING TO GET 1479 00:52:13,880 --> 00:52:15,600 TO SOME SORT OF NEGOTIATION 1480 00:52:15,600 --> 00:52:17,240 WHERE THEY CAN GET A DEBT LIMIT 1481 00:52:17,240 --> 00:52:19,000 VOTE AND GET SOME SORT OF 1482 00:52:19,000 --> 00:52:23,760 SPENDING DEAL THAT'S FEASIBLE. 1483 00:52:23,760 --> 00:52:24,400 NEXT SLIDE, PLEASE. 1484 00:52:24,400 --> 00:52:26,600 SO SOME OF THE PEOPLE WHO WILL 1485 00:52:26,600 --> 00:52:30,240 BE IN THE DRIVING SEATS FOR THIS 1486 00:52:30,240 --> 00:52:31,080 NEGOTIATION IN THE SPRING ARE 1487 00:52:31,080 --> 00:52:32,520 THE WOMEN YOU SEE HERE IN THIS 1488 00:52:32,520 --> 00:52:34,960 PICTURE, AND THIS IS REALLY KIND 1489 00:52:34,960 --> 00:52:36,080 OF A REMARKABLE TIME. 1490 00:52:36,080 --> 00:52:37,880 FOR THE FIRST TIME THE LEADERS 1491 00:52:37,880 --> 00:52:43,200 OF THE HOUSE AND SENATE PROARGZS 1492 00:52:43,200 --> 00:52:43,720 COMMITTEES, DEMCRATE AND 1493 00:52:43,720 --> 00:52:45,320 REPUBLICANS ARE ALL WOMEN AS IS 1494 00:52:45,320 --> 00:52:50,080 THE OMB DIRECTOR, I THINK MISS 1495 00:52:50,080 --> 00:52:51,720 YOUNG IS THE FIRST APRICK AN 1496 00:52:51,720 --> 00:52:53,320 AMERICAN WOMAN TO RUN OMB, SHE 1497 00:52:53,320 --> 00:52:55,280 IS ALSO A LONG TIME HOUSE 1498 00:52:55,280 --> 00:52:56,920 APPROPRIATION STAFFER SO SHE 1499 00:52:56,920 --> 00:52:58,880 KNOWS THIS PROCESS BACKWARDS AND 1500 00:52:58,880 --> 00:52:59,800 FORWARDS, THE 4 MEMBERS HERE ON 1501 00:52:59,800 --> 00:53:02,600 THE LEFT IN THE RED JACKET IS 1502 00:53:02,600 --> 00:53:05,240 SUSAN COLLINS OF MAINE, SHE WILL 1503 00:53:05,240 --> 00:53:08,680 BE THE RANKING MEMBER ON THE 1504 00:53:08,680 --> 00:53:09,880 APPROPRIATIONS COMMITTEE IN THE 1505 00:53:09,880 --> 00:53:10,520 SENATE. 1506 00:53:10,520 --> 00:53:12,400 SENATE PATTY MURRAY OVER NEXT TO 1507 00:53:12,400 --> 00:53:13,760 THE RIGHT, SENATOR FROM 1508 00:53:13,760 --> 00:53:15,160 WASHINGTON LONG TIME MEMBER OF 1509 00:53:15,160 --> 00:53:19,000 THE SENATE, SHE HAS BEEN THE TOP 1510 00:53:19,000 --> 00:53:22,560 RANKING DEMOCRAT ON THE HHS IN 1511 00:53:22,560 --> 00:53:24,160 THE SENATE, YOUNG IS IN THE 1512 00:53:24,160 --> 00:53:28,080 MIDDLE AND TO THE RIGHT IS KAY 1513 00:53:28,080 --> 00:53:29,840 GRANGER, A LONG TIME CHAIR OF 1514 00:53:29,840 --> 00:53:32,000 THE HOUSE, SHE IS THE FULL CHAIR 1515 00:53:32,000 --> 00:53:33,880 OF THE HOUSE APPROPRIATIONS 1516 00:53:33,880 --> 00:53:36,160 COMMITTEE, A JOB THAT ROSA HAD 1517 00:53:36,160 --> 00:53:37,440 UNTIL THE MIDTERMS AND THESE 1518 00:53:37,440 --> 00:53:39,640 HAVE ALL WORKS TOGETHER SINCE 1519 00:53:39,640 --> 00:53:41,400 THE 1990S SO THEY REALLY KNOW 1520 00:53:41,400 --> 00:53:46,240 HOW TO GET THINGS DONE AND 1521 00:53:46,240 --> 00:53:49,800 THERE'S AN OLD JOKE IN D. C. AND 1522 00:53:49,800 --> 00:53:50,520 PARTIES DEMOCRATS AND 1523 00:53:50,520 --> 00:53:51,560 APPROPRIATORS I DON'T KNOW WHERE 1524 00:53:51,560 --> 00:53:52,720 THIS CAME FROM BUT YOU HEAR IT 1525 00:53:52,720 --> 00:53:54,400 FROM TIME TO TIME. 1526 00:53:54,400 --> 00:53:56,240 THERE'S SOME RATIONAL TO THIS 1527 00:53:56,240 --> 00:53:57,760 BECAUSE APPROPRIATORS HAVE TO BE 1528 00:53:57,760 --> 00:53:59,160 PRAGMATIC, THEY HAVE TO GET A 1529 00:53:59,160 --> 00:54:01,280 BILL DONE EVERY YEAR AND THEY 1530 00:54:01,280 --> 00:54:02,880 HAVE TO COMPROMISE TO GET IT 1531 00:54:02,880 --> 00:54:03,360 DONE. 1532 00:54:03,360 --> 00:54:09,680 FOR OTHER BILLS INTRODUCED 1533 00:54:09,680 --> 00:54:11,240 AUTHORIZING BILLS. 1534 00:54:11,240 --> 00:54:12,320 THREE-7% OF THOSE BECOME LAW AND 1535 00:54:12,320 --> 00:54:13,960 NOT THAT MANY GO THROUGH THE 1536 00:54:13,960 --> 00:54:15,360 PROCESS OF COMMITTEE HEARINGINGS 1537 00:54:15,360 --> 00:54:16,680 AND MARK UMKCS BUT 1538 00:54:16,680 --> 00:54:18,440 AAPPROPRIATORS HAVE TO GET A 1539 00:54:18,440 --> 00:54:18,880 BILL DONE EVERY YEAR. 1540 00:54:18,880 --> 00:54:21,040 THEY HAVE TO GET IT THROUGH THE 1541 00:54:21,040 --> 00:54:21,920 SUBCOMMITTEE, COMMITTEE, FLOOR 1542 00:54:21,920 --> 00:54:23,240 VOTE, CONFERENCE IT AND THEN 1543 00:54:23,240 --> 00:54:24,520 SEND IT TO THE PRESIDENT'S DESK 1544 00:54:24,520 --> 00:54:27,800 AND IF THEY DON'T DO THAT, THE 1545 00:54:27,800 --> 00:54:28,280 GOVERNMENT SHUTS DOWN. 1546 00:54:28,280 --> 00:54:31,240 SO YOU KNOW THAT IS PROBABLY WHY 1547 00:54:31,240 --> 00:54:32,680 APPROPRIATORS ARE VIEWED A 1548 00:54:32,680 --> 00:54:34,320 LITTLE DEFINITELY. 1549 00:54:34,320 --> 00:54:36,200 THEY TEND TO BE VERY PRAGMATIC 1550 00:54:36,200 --> 00:54:37,720 AND SOMETIMES LESS PARTISAN BUT 1551 00:54:37,720 --> 00:54:40,480 EVEN FOR THIS TEAM, THE OVERALL 1552 00:54:40,480 --> 00:54:41,320 XRNGAL CLIMATE WE'RE SEEING 1553 00:54:41,320 --> 00:54:44,000 RIGHT NOW WILL BE AN ENORMOUS 1554 00:54:44,000 --> 00:54:44,240 CHALLENGE. 1555 00:54:44,240 --> 00:54:45,240 THERE WILL NEED TO BE 1556 00:54:45,240 --> 00:54:46,600 COMPROMISES AND YOU KNOW NO 1'S 1557 00:54:46,600 --> 00:54:47,760 GOING TO GET EVERYTHING THAT 1558 00:54:47,760 --> 00:54:49,360 THEY WANT AND THE FACT THAT 1559 00:54:49,360 --> 00:54:50,760 THERE'S A NEW HOUSE MAJORITY 1560 00:54:50,760 --> 00:54:53,920 WILL BE IMPORTANT HERE. 1561 00:54:53,920 --> 00:54:55,320 THAT THE HOUSE APPROPRIATIONS 1562 00:54:55,320 --> 00:54:56,600 COMMITTEE HAD THEIR FIRST 1563 00:54:56,600 --> 00:54:58,120 MEETING YESTERDAY AND CHAIR 1564 00:54:58,120 --> 00:54:59,280 GRANGER ACKNOWLEDGED THAT THE 1565 00:54:59,280 --> 00:55:00,000 ODDS WERE STACKED AGAINST THEM 1566 00:55:00,000 --> 00:55:01,760 BUT THEY ARE GOING TO DO THEIR 1567 00:55:01,760 --> 00:55:03,560 BEST. 1568 00:55:03,560 --> 00:55:04,080 NEXT SLIDE, PLEASE. 1569 00:55:04,080 --> 00:55:05,720 I WANT TO SHOW YOU THE NEW 1570 00:55:05,720 --> 00:55:09,680 MEMBERS OF THE HOUSE LABOR HHS 1571 00:55:09,680 --> 00:55:11,000 APPROPRIATES SUBCOMMITTEE. 1572 00:55:11,000 --> 00:55:15,960 WE HAVE NEW LEADERSHIP ON THE 1573 00:55:15,960 --> 00:55:18,600 REPUBLICAN SIDE. 1574 00:55:18,600 --> 00:55:19,760 TOM COLE FROM OKLAHOMA HAD BEEN 1575 00:55:19,760 --> 00:55:22,600 THE LONG TIME TOP REPUBLICAN ON 1576 00:55:22,600 --> 00:55:23,760 THIS SUBCOMMITTEE, REALLY GREAT 1577 00:55:23,760 --> 00:55:24,600 ADVOCATE FOR CANCER RESEARCH AND 1578 00:55:24,600 --> 00:55:27,520 HE WAS VERY WELL INFORMED ABOUT 1579 00:55:27,520 --> 00:55:29,960 NIH AND IN, CI, HE USED TO BRING 1580 00:55:29,960 --> 00:55:31,920 THE BIPARTISAN GROUP EVERY YEAR 1581 00:55:31,920 --> 00:55:33,800 TO COME VISIT ON CAMPUS AND HERE 1582 00:55:33,800 --> 00:55:35,880 FROM SEVERAL IC DIRECTORS AND 1583 00:55:35,880 --> 00:55:36,800 CONGRESSMAN DELORA RODRIGUEZ O 1584 00:55:36,800 --> 00:55:38,560 WHEN SHE WAS CHAIR HAS BEEN VERY 1585 00:55:38,560 --> 00:55:41,680 ENGAGED AND IS VERY WELL 1586 00:55:41,680 --> 00:55:45,200 ACQUAINTED WITH NIH AND OUR 1587 00:55:45,200 --> 00:55:45,480 PROGRAMS. 1588 00:55:45,480 --> 00:55:46,520 UNFORT FATALLY CHAIRMAN COLE WAS 1589 00:55:46,520 --> 00:55:48,400 NOT GIVEN A WAIVER TO MAINTAIN 1590 00:55:48,400 --> 00:55:50,600 THE SUBCOMMITTEE SO HE IS NOW 1591 00:55:50,600 --> 00:55:51,560 CHAIRING THE TRANSPORTATION 1592 00:55:51,560 --> 00:55:52,320 SUBCOMMITTEE. 1593 00:55:52,320 --> 00:55:53,960 HE'S ALSO THE VIETION CHAIR OF 1594 00:55:53,960 --> 00:55:54,880 THE FULL APPROPRIATIONS 1595 00:55:54,880 --> 00:55:56,240 COMMITTEE SO HE WILL STILL BE 1596 00:55:56,240 --> 00:55:59,800 INVOLVED IN SOME WAY, LETTING 1597 00:55:59,800 --> 00:56:03,120 THE REPUBLICANS FOR THE 1598 00:56:03,120 --> 00:56:05,520 SUBCOMMITTEE IS CONGRESSMAN 1599 00:56:05,520 --> 00:56:09,440 ROBERT ODERHOALT, HE'S RUN THE 1600 00:56:09,440 --> 00:56:10,160 APPROPRIATIONS SUBCOMMITTEE 1601 00:56:10,160 --> 00:56:10,880 AGRICULTURE AND OTHERS IN THE 1602 00:56:10,880 --> 00:56:14,080 PAST HE'S BEEN A LONG TIME 1603 00:56:14,080 --> 00:56:15,600 APPROPRIATOR AND CONGRESSWOMAN 1604 00:56:15,600 --> 00:56:16,880 DELAURO KNOWS HIM WELL AND 1605 00:56:16,880 --> 00:56:17,960 THEY'VE BEEN ON AG TOGETHER AND 1606 00:56:17,960 --> 00:56:19,120 WE THINK THIS COMMITTEE WILL 1607 00:56:19,120 --> 00:56:19,520 WORK WELL. 1608 00:56:19,520 --> 00:56:22,280 THERE A LOT OF EXPERTISE ON THE 1609 00:56:22,280 --> 00:56:23,440 COMMITTEE, MIKE SIMPSON FROM 1610 00:56:23,440 --> 00:56:24,760 IDAHO WHO HAS BEEN ON THE 1611 00:56:24,760 --> 00:56:25,920 COMMITTEE IN YEARS PAST IS 1612 00:56:25,920 --> 00:56:34,480 RETURNING TO THE COMMITTEE AND 1613 00:56:34,480 --> 00:56:36,920 STENY HOYER, HE WAS ON THE 1614 00:56:36,920 --> 00:56:37,960 PROARGZS COMMITTEE, HE IS GOING 1615 00:56:37,960 --> 00:56:40,520 TO BE JOINING THE DEMS ON THEIR 1616 00:56:40,520 --> 00:56:40,840 SUBCOMMITTEE. 1617 00:56:40,840 --> 00:56:42,560 SO THE NEW MEMBERS HERE ARE 1618 00:56:42,560 --> 00:56:43,200 NOTED IN BLUE. 1619 00:56:43,200 --> 00:56:44,760 AND WE DON'T KNOW SOME OF THESE 1620 00:56:44,760 --> 00:56:47,160 NEW MEMBERS SO WE WILL BECOME 1621 00:56:47,160 --> 00:56:48,320 ACQUAINTED WITH THEM THROUGHOUT 1622 00:56:48,320 --> 00:56:53,080 THE PROCESS, CAN I GET THE NEXT 1623 00:56:53,080 --> 00:56:53,440 SLIDE, PLEASE. 1624 00:56:53,440 --> 00:56:55,760 IN THE SENATE WE'RE GOING OUT ON 1625 00:56:55,760 --> 00:56:57,680 A LIMB HERE, WE KNOW SENATOR 1626 00:56:57,680 --> 00:57:00,000 MURRAY IS THE TOP--SHE'S THE 1627 00:57:00,000 --> 00:57:03,560 CHAIR OF THE FULL PROARGZS 1628 00:57:03,560 --> 00:57:04,880 COMMITTEE, PATRICK LAHEY WAS IN 1629 00:57:04,880 --> 00:57:06,880 THIS POSITION UNTIL HE RETIRED. 1630 00:57:06,880 --> 00:57:09,760 SUSAN COLLINS IS TAKING THE 1631 00:57:09,760 --> 00:57:10,680 MEMBER SLOT. 1632 00:57:10,680 --> 00:57:12,720 HE ALSO RETIRED IN THE LAST 1633 00:57:12,720 --> 00:57:14,560 117th CONGRESS AND SO, THIS IS 1634 00:57:14,560 --> 00:57:17,880 REPORTED, IT IS NOT OFFICIAL OR 1635 00:57:17,880 --> 00:57:19,960 CONFIRMED IN AN PROARGZS 1636 00:57:19,960 --> 00:57:21,360 COMMITTEE,A NOUNSMENT BUT OUR 1637 00:57:21,360 --> 00:57:22,680 UNDERSTANDING IS, AND WE FEEL 1638 00:57:22,680 --> 00:57:24,240 PRETTY CONFIDENT OF THIS, OF THE 1639 00:57:24,240 --> 00:57:26,520 SOURCES WE HEARD THAT SENATOR 1640 00:57:26,520 --> 00:57:27,720 TAMMY BALD WIN OF WISCONSIN WILL 1641 00:57:27,720 --> 00:57:31,400 BE THE CHAIR OF THE LABOR HHS 1642 00:57:31,400 --> 00:57:37,080 SUBCOMMITTEE AND SENATOR SHELLY 1643 00:57:37,080 --> 00:57:38,520 MOORE CAPITO, WILL BE THE 1644 00:57:38,520 --> 00:57:39,640 RANKING MEMBER. 1645 00:57:39,640 --> 00:57:41,360 BO BOTH OF THESE SENATORS ARE 1646 00:57:41,360 --> 00:57:44,040 VERY FAMILIAR WITH NIH AND NCI, 1647 00:57:44,040 --> 00:57:45,840 THEY BOTH VISITED SPECIFICALLY 1648 00:57:45,840 --> 00:57:48,800 VISITED NCI ON CAMPUS AND SO, 1649 00:57:48,800 --> 00:57:51,200 THAT--WE EVEN HAVE MORE OF WOMEN 1650 00:57:51,200 --> 00:57:52,520 IN CONGRESS WORKING AS 1651 00:57:52,520 --> 00:57:54,840 APPROPRIATORS FOR THE LABOR HHS 1652 00:57:54,840 --> 00:57:58,080 BILL. 1653 00:57:58,080 --> 00:57:58,640 NEXT SLIDE, PLEASE. 1654 00:57:58,640 --> 00:58:00,400 SO IT IS REALLY HARD TO MAKE 1655 00:58:00,400 --> 00:58:01,280 PREDICTIONS ABOUT HOW THINGS 1656 00:58:01,280 --> 00:58:03,320 WILL PLAY OUT AND THAT IS TRUE 1657 00:58:03,320 --> 00:58:07,720 IN ANY YEAR BUT THIS YEAR, 1658 00:58:07,720 --> 00:58:10,160 BECAUSE OF THE AGREEMENTS AND 1659 00:58:10,160 --> 00:58:11,320 THE STRONGLY STATED POSITION OF 1660 00:58:11,320 --> 00:58:13,880 THE HOUSE GOP THAT THEY WANT TO 1661 00:58:13,880 --> 00:58:16,040 RETURN TO FY22 FUNDING LEVELS. 1662 00:58:16,040 --> 00:58:17,320 IT IS EVEN HARDER THIS YEAR TO 1663 00:58:17,320 --> 00:58:18,440 TRY TO FIGURE OUT HOW THEY'RE 1664 00:58:18,440 --> 00:58:21,280 GOING TO GET TO SOME COMPROMISE 1665 00:58:21,280 --> 00:58:24,000 AND GET A GOVERNMENT FUNDING 1666 00:58:24,000 --> 00:58:25,840 BILL IN PREP FOR FY24. 1667 00:58:25,840 --> 00:58:27,760 WE'RE VERY USED TO CONTINUING 1668 00:58:27,760 --> 00:58:28,960 RESOLUTIONS BECAUSE THERE'S AN 1669 00:58:28,960 --> 00:58:31,000 AVERAGE OF 5 OR SO A YEAR, SOME 1670 00:58:31,000 --> 00:58:32,520 ARE VERY SHORT, SOME AS YOU CAN 1671 00:58:32,520 --> 00:58:36,560 SEE IN THIS CHART HERE IN 2007 1672 00:58:36,560 --> 00:58:38,880 AND IN 2011, AND 2013, THESE ARE 1673 00:58:38,880 --> 00:58:41,680 FISCAL YEARS WE HAD FULL YEAR 1674 00:58:41,680 --> 00:58:42,360 CONTINUING RESOLUTIONS. 1675 00:58:42,360 --> 00:58:44,440 IT'S INTERESTING TO NOTE THOUGH 1676 00:58:44,440 --> 00:58:46,360 THAT THE DEFENSE APPROPRIATIONS 1677 00:58:46,360 --> 00:58:47,160 BILL, THEY'RE INDIVIDUAL BILL 1678 00:58:47,160 --> 00:58:49,360 HAS NEVER BEEN PART OF A FULL 1679 00:58:49,360 --> 00:58:50,920 YEAR C. R. 1680 00:58:50,920 --> 00:58:52,360 THERE HAVE BEEN ADJUSTMENTS TO 1681 00:58:52,360 --> 00:58:54,120 THEIR BILL THAT WOULD ALLOW THEM 1682 00:58:54,120 --> 00:58:56,320 TO HAVE INCREASED FUNDING. 1683 00:58:56,320 --> 00:58:57,760 SO WE DON'T KNOW WHAT'S GOING TO 1684 00:58:57,760 --> 00:59:00,920 HAPPEN IN TERMS OF FULL YEAR C. 1685 00:59:00,920 --> 00:59:03,960 R. OR THERE'S ALL SORTS OF 1686 00:59:03,960 --> 00:59:04,200 OUTCOMES. 1687 00:59:04,200 --> 00:59:06,000 THE APPROPRIATORS COULD PASS THE 1688 00:59:06,000 --> 00:59:11,440 BILL THAT NEEDS THE OVERALL FY22 1689 00:59:11,440 --> 00:59:12,840 FUNDING LEVEL BUT THERE ARE 1690 00:59:12,840 --> 00:59:14,040 CERTAINLY GOING TO BE WINNERS 1691 00:59:14,040 --> 00:59:15,680 AND LOSERS IN THAT. 1692 00:59:15,680 --> 00:59:16,480 AGENCIES CAN'T REALLY ASSUME 1693 00:59:16,480 --> 00:59:19,960 THAT WHAT WE RECEIVED IN FY22 IS 1694 00:59:19,960 --> 00:59:22,840 WHERE WE'RE STARTING FOR THIS 1695 00:59:22,840 --> 00:59:23,960 PROCESS WITH FY24. 1696 00:59:23,960 --> 00:59:25,960 BECAUSE THE FY22 GOAL IS AN 1697 00:59:25,960 --> 00:59:29,960 OVERALL GOAL, THAT'S ACROSS ALL 1698 00:59:29,960 --> 00:59:31,680 12 SUBCOMMITTEES. 1699 00:59:31,680 --> 00:59:33,760 SO, IT IS NOT--IT'S SOMEWHAT 1700 00:59:33,760 --> 00:59:35,240 OBVIOUS THAT THEY ARE NOT GOING 1701 00:59:35,240 --> 00:59:38,360 TO BE AN ACROSS THE BOARD 1702 00:59:38,360 --> 00:59:38,600 REDUCTION. 1703 00:59:38,600 --> 00:59:40,960 DEFENSE IS GOING TO BE TREATED 1704 00:59:40,960 --> 00:59:41,920 DIFFERENTLY IF THERE WERE THAT 1705 00:59:41,920 --> 00:59:44,680 SORT OF CUT TO DEFENSE, IT WOULD 1706 00:59:44,680 --> 00:59:46,520 REALLY DIVIDE THE REPUBLICAN 1707 00:59:46,520 --> 00:59:48,200 CAUCUS, THERE WON'T BE BE THE 1708 00:59:48,200 --> 00:59:49,960 SORTS OF CUTS TO VETERANS 1709 00:59:49,960 --> 00:59:51,360 ACCOUNTS AND SOME OF THE 1710 00:59:51,360 --> 00:59:53,840 VETERANS PROGRAMS HAVE ADVANCED 1711 00:59:53,840 --> 00:59:55,400 PROARGZS ANYWAY SO THOSE ARE 1712 00:59:55,400 --> 00:59:57,480 REALLY ALREADY OUT THE DOOR. 1713 00:59:57,480 --> 01:00:00,360 WE REALLY JUST DON'T KNOW HOW 1714 01:00:00,360 --> 01:00:01,040 THIS WILL HAPPEN. 1715 01:00:01,040 --> 01:00:03,360 THERE COULD BE A BILL THAT HAS 1716 01:00:03,360 --> 01:00:03,840 STRATEGIC CUTS. 1717 01:00:03,840 --> 01:00:05,000 ONE THING THE APPROPRIATORS 1718 01:00:05,000 --> 01:00:08,000 MIGHT LOOK AT IS LOOK AT FUNDS 1719 01:00:08,000 --> 01:00:09,400 THAT BEEN APPROPRIATED BUT ARE 1720 01:00:09,400 --> 01:00:11,960 NOT SPENT AND THEY MAY RESCIND 1721 01:00:11,960 --> 01:00:13,560 THOSE FUNDS IN ORDER TO WRITE 1722 01:00:13,560 --> 01:00:14,200 THESE BILLS. 1723 01:00:14,200 --> 01:00:16,400 THAT WOULD BE THINGS LIKE 1724 01:00:16,400 --> 01:00:18,760 UNSPENT COVID FUNDS, POTENTIALLY 1725 01:00:18,760 --> 01:00:21,760 FUNDS THAT HAVE BEEN AUTHORIZED 1726 01:00:21,760 --> 01:00:22,880 FOR INSTRAY JECTORY STRUCTURE 1727 01:00:22,880 --> 01:00:25,080 PROGRAMS FOR SOME OF THE BIG 1728 01:00:25,080 --> 01:00:25,680 LEGISLATIVE PROGRAMS THAT 1729 01:00:25,680 --> 01:00:26,960 HAPPENED IN THE LAB AT CONGRESS. 1730 01:00:26,960 --> 01:00:28,040 WE DON'T KNOW HOW THIS IS GOING 1731 01:00:28,040 --> 01:00:30,080 TO PLAY OUT BUT THERE'S A COUPLE 1732 01:00:30,080 --> 01:00:31,320 WAYS THESE APPROPRIATORS AND 1733 01:00:31,320 --> 01:00:33,120 THESE VERY EXPERIENCED SKILLED 1734 01:00:33,120 --> 01:00:33,920 GROUP OF APPROPRIATORS COULD 1735 01:00:33,920 --> 01:00:37,680 FIGURE OUT HOW TO GET TO MARK UP 1736 01:00:37,680 --> 01:00:41,560 A BILL AT A LEVEL THAT WOULD BE 1737 01:00:41,560 --> 01:00:42,800 MEETING WHATEVER BUDGET DEAL 1738 01:00:42,800 --> 01:00:44,240 THEY END UP COMING UP WITH TO 1739 01:00:44,240 --> 01:00:46,000 GET A DEBT INCREASE BUT ALSO 1740 01:00:46,000 --> 01:00:46,920 PRESERVING ACCOUNTS THAT ARE 1741 01:00:46,920 --> 01:00:48,200 VERY POPULAR THAT HAVE A LOT OF 1742 01:00:48,200 --> 01:00:49,680 MEMBER SUPPORT AND WE CERTAINLY 1743 01:00:49,680 --> 01:00:50,840 HOPE THAT CANCER RESEARCH WOULD 1744 01:00:50,840 --> 01:00:53,680 BE FALLING INTO THE THAT 1745 01:00:53,680 --> 01:00:55,000 CATEGORY. 1746 01:00:55,000 --> 01:00:56,360 AND THEN THERE'S ALWAYS, NO 1 1747 01:00:56,360 --> 01:00:57,800 KNOWS IF WE'RE GOING TO HAVE, 1748 01:00:57,800 --> 01:00:59,240 THIS WILL BE COMPLETED BY THE 1749 01:00:59,240 --> 01:01:00,840 TIME THE FISCAL YEAR STARTS SO 1750 01:01:00,840 --> 01:01:03,080 THERE SEEMS TO BE QUITE A BIT OF 1751 01:01:03,080 --> 01:01:06,440 PESSIMISM ABOUT THE LIKELIHOOD 1752 01:01:06,440 --> 01:01:09,360 OF A SHUT DOWN AND A SHUT DOWN, 1753 01:01:09,360 --> 01:01:10,640 SOMETIMES THAT'S A VEHICLE FOR A 1754 01:01:10,640 --> 01:01:12,280 CATALYST TO GET THINGS MOVING, 1755 01:01:12,280 --> 01:01:13,800 THERE ARE SHORT SHUT DOWNS WE 1756 01:01:13,800 --> 01:01:15,920 HAD SHUT DOWNS THAT LASTED IN 1757 01:01:15,920 --> 01:01:17,560 LESS THAN A DAY IN THE PAST 1758 01:01:17,560 --> 01:01:18,840 RECENT YEARS BUT WE REALLY DON'T 1759 01:01:18,840 --> 01:01:20,280 KNOW HOW THIS IS GOING TO PLAY 1760 01:01:20,280 --> 01:01:20,480 OUT. 1761 01:01:20,480 --> 01:01:22,160 ONCE THERE'S A SHUT DOWN, THERE 1762 01:01:22,160 --> 01:01:24,040 NEEDS TO BE A SOLUTION SOLUTION 1763 01:01:24,040 --> 01:01:25,440 TO REOPEN SO AT THE END OF THE 1764 01:01:25,440 --> 01:01:27,120 DAY THERE NEEDS TO BE A DEAL. 1765 01:01:27,120 --> 01:01:28,600 WE ARE HOPEFUL IT WON'T COME TO 1766 01:01:28,600 --> 01:01:30,920 THAT BUT WE'RE GOING TO BE 1767 01:01:30,920 --> 01:01:33,760 WATCHING AS THE APPROPRIATORS 1768 01:01:33,760 --> 01:01:35,640 START MACKING UP, WHEN THEY COME 1769 01:01:35,640 --> 01:01:40,240 UP WITH ALLOCATIONS FOR EACH OF 1770 01:01:40,240 --> 01:01:41,400 THE SUBCOMMITTEES THEN WE WILL 1771 01:01:41,400 --> 01:01:42,800 GET A SENSE OF WHERE THEY'RE 1772 01:01:42,800 --> 01:01:44,120 TRYING TO PROTECT THE CURRENT 1773 01:01:44,120 --> 01:01:46,000 FUNDING LEVELS INCREASES FOR 1774 01:01:46,000 --> 01:01:46,800 SPECIFIC ACCOUNTS AND PROGRAMS 1775 01:01:46,800 --> 01:01:50,040 AND WHICH 1S ARE TARGETED FOR 1776 01:01:50,040 --> 01:01:50,880 MORE SEVERE REDUCTIONS AND AT 1777 01:01:50,880 --> 01:01:52,400 LEAST A PLAN THAT WILL BE PUT 1778 01:01:52,400 --> 01:01:52,680 FORWARD. 1779 01:01:52,680 --> 01:01:53,600 NEXT SLIDE, PLEASE. 1780 01:01:53,600 --> 01:01:54,840 SO BEFORE WE TALK ANYMORE ABOUT 1781 01:01:54,840 --> 01:01:58,280 THAT, I JUST WANTED TO REMIND 1782 01:01:58,280 --> 01:02:01,800 EVERYONE OF WHERE WE ENDED UP 1783 01:02:01,800 --> 01:02:04,120 FOR FY23, HOW THAT COMPARED TO 1784 01:02:04,120 --> 01:02:12,200 FY22 APPROPRIATION AND THEN AS 1785 01:02:12,200 --> 01:02:12,760 DR. BERGTONOLLI, STATED, THE 1786 01:02:12,760 --> 01:02:14,640 RELEASE WILL BE ON MARCH 9th. 1787 01:02:14,640 --> 01:02:16,960 IT'S LATER THAN NORMAL, USUALLY 1788 01:02:16,960 --> 01:02:17,480 IT'S THE FIRST MONDAY IN 1789 01:02:17,480 --> 01:02:18,640 FEBRUARY BUT THAT WILL BE THE 1790 01:02:18,640 --> 01:02:20,080 OFFICIAL START OF THE 1791 01:02:20,080 --> 01:02:21,360 APPROPRIATIONS PROCESS WHERE THE 1792 01:02:21,360 --> 01:02:23,640 PRESIDENT PUTS FORTH HIS REQUEST 1793 01:02:23,640 --> 01:02:31,240 FOR FY24 FUNDING FOR ALL 1794 01:02:31,240 --> 01:02:35,320 GOVERNMENT AGENCIES. 1795 01:02:35,320 --> 01:02:36,000 NEXT SLIDE, PLEASE. 1796 01:02:36,000 --> 01:02:37,480 SO 1 OF THE THINGS I THINK IS 1797 01:02:37,480 --> 01:02:39,760 WORTH NOTING WHEN WE TALK ABOUT 1798 01:02:39,760 --> 01:02:41,080 THE CONCESSIONS THAT SPEAKER 1799 01:02:41,080 --> 01:02:42,920 MCCARTHY MADE TO GET THE VOTES 1800 01:02:42,920 --> 01:02:47,120 HE NEEDED, WAS THAT HE--HE 1801 01:02:47,120 --> 01:02:50,280 AGREED TO NO MORE BIG OMNIBUS 1802 01:02:50,280 --> 01:02:51,400 SPENDING BILLINGS. 1803 01:02:51,400 --> 01:02:57,720 AND UNFORTUNATELY, YOU KNOW, THE 1804 01:02:57,720 --> 01:02:59,800 IDEA OF DOING 12 INDIVIDUAL 1805 01:02:59,800 --> 01:03:01,520 SPENDING BILLS AND HAVE THEM 1806 01:03:01,520 --> 01:03:03,040 ENACTED INTO LAW INDIVIDUALLY, 1807 01:03:03,040 --> 01:03:05,000 WHICH USED TO BE STABBED ARD, 1808 01:03:05,000 --> 01:03:07,440 THE LAST TIME WAS 2002, THERE 1809 01:03:07,440 --> 01:03:10,200 WAS A STRETCH OF MID80S TO 90S 1810 01:03:10,200 --> 01:03:13,760 WHERE IT HAPPENED FOR EACH BILL, 1811 01:03:13,760 --> 01:03:16,160 EACH 1 WAS A SEPARATE LAW AND 1812 01:03:16,160 --> 01:03:18,720 ENACTED AS A SEPARATE LAW BUT 1813 01:03:18,720 --> 01:03:20,120 MANY TIMES PACKAGES WHERE 1814 01:03:20,120 --> 01:03:21,440 THERE'S A COUPLE BUNDLED 1815 01:03:21,440 --> 01:03:23,480 TOGETHER, THOSE THAT HAVE THE 1816 01:03:23,480 --> 01:03:24,600 MOST SUPPORT AND LEAST 1817 01:03:24,600 --> 01:03:27,000 CONTROVERSIAL WHICH WILL NEVER 1818 01:03:27,000 --> 01:03:28,560 INCLUDE THE HHS BILL 1819 01:03:28,560 --> 01:03:30,360 UNFORTUNATELY, BUT THAT HAS 1820 01:03:30,360 --> 01:03:32,680 BECOME REALLY COMMON AND IT WAS 1821 01:03:32,680 --> 01:03:35,200 HAPPENING IN THE 1970S AND IT'S 1822 01:03:35,200 --> 01:03:36,040 BEEN HAPPENING EVER SINCE AND 1823 01:03:36,040 --> 01:03:37,760 IT'S HARD TO IMAGINE THAT IT'S 1824 01:03:37,760 --> 01:03:39,960 POSSIBLE FOR 12 SPENDING BILLS 1825 01:03:39,960 --> 01:03:41,760 TO GET DONE AND THERE MAY NOT 1826 01:03:41,760 --> 01:03:44,680 EVEN BE 12 BILLS PASSED OUT OF 1827 01:03:44,680 --> 01:03:45,640 THE HOUSE AND SENATE 1828 01:03:45,640 --> 01:03:46,360 APPROPRIATIONS COMMITTEE AND 1829 01:03:46,360 --> 01:03:48,920 ACHIEVING VOTES ON THE FLOOR. 1830 01:03:48,920 --> 01:03:51,440 THE BOTTOM LINE, I THINK AND MY 1831 01:03:51,440 --> 01:03:55,360 MAIN MESSAGE TO ALL OF THE--OUR 1832 01:03:55,360 --> 01:03:58,160 LEADERSHIP AND THE RESEARCH 1833 01:03:58,160 --> 01:03:59,200 COMMUNITY IS WE SHOULD EXPECT TO 1834 01:03:59,200 --> 01:04:01,440 SEE AS THE PROCESS PLAYS OUT 1835 01:04:01,440 --> 01:04:03,000 SOME DISAPPOINTING AND PERHAPS 1836 01:04:03,000 --> 01:04:04,400 ALARMING NUMBERS WHEN THE 1837 01:04:04,400 --> 01:04:05,920 SUBCOMMITTEES CAN ONLY WORK WITH 1838 01:04:05,920 --> 01:04:08,400 THE ALLOCATIONS THEY'RE GIVEN. 1839 01:04:08,400 --> 01:04:09,760 MY MESSAGE IS NOT TO PANIC 1840 01:04:09,760 --> 01:04:12,040 BECAUSE THERE IS A LONG ROAD TO 1841 01:04:12,040 --> 01:04:14,560 GO BEFORE WE HAVE FINAL FUNDING, 1842 01:04:14,560 --> 01:04:16,200 BEFORE DECISIONS ARE COMPLETED 1843 01:04:16,200 --> 01:04:17,880 AND THINGS MAY LOOK WORSE BEFORE 1844 01:04:17,880 --> 01:04:19,360 THEY LOOK BETTER, I THINK WE'RE 1845 01:04:19,360 --> 01:04:23,040 ALL WELL AWARE OF THE--IN 1846 01:04:23,040 --> 01:04:24,880 ADDITION TO THE STRONG 1847 01:04:24,880 --> 01:04:25,600 BIPARTISAN SUPPORT FOR CANCER 1848 01:04:25,600 --> 01:04:27,680 RESEARCH, YOU KNOW THE PRESIDENT 1849 01:04:27,680 --> 01:04:29,800 HAS BEEN VERY CLEAR ON HIS 1850 01:04:29,800 --> 01:04:30,440 COMMITMENT TO CANCER RESEARCH 1851 01:04:30,440 --> 01:04:33,520 AND SOME OF THE THINGS THAT BEEN 1852 01:04:33,520 --> 01:04:34,360 DISCUSSED IN THIS MEETING 1853 01:04:34,360 --> 01:04:38,000 ALREADY, THAT IS SOMETHING THAT 1854 01:04:38,000 --> 01:04:39,200 HE IS REITERATED SO THIS WILL BE 1855 01:04:39,200 --> 01:04:43,080 A PRIORITY AND IT'S A SHARED 1856 01:04:43,080 --> 01:04:43,520 PRIORITY. 1857 01:04:43,520 --> 01:04:44,840 AND THERE MAY BE DIFFERENT VIEW 1858 01:04:44,840 --> 01:04:46,480 POINTS AS TO WHAT LEVELS ARE 1859 01:04:46,480 --> 01:04:47,640 NEEDED AND PROGRAMS SHOULD BE 1860 01:04:47,640 --> 01:04:48,800 PROMOTED BUT IT IS A SHARED 1861 01:04:48,800 --> 01:04:50,200 PRIORITY AND WE ARE VERY HOPEFUL 1862 01:04:50,200 --> 01:04:52,840 THAT THAT WILL CONTINUE TO BE 1863 01:04:52,840 --> 01:04:54,000 SOMETHING WHERE, YOU KNOW IN THE 1864 01:04:54,000 --> 01:04:57,920 END WE WILL END UP IN A GOOD 1865 01:04:57,920 --> 01:04:58,480 PLACE FOR FY24. 1866 01:04:58,480 --> 01:05:03,560 AND A GOOD PLACE MAY BE STAYING 1867 01:05:03,560 --> 01:05:04,920 WHOLE, IT MAY BE SLIGHT 1868 01:05:04,920 --> 01:05:05,840 INCREASES, I DON'T THINK THIS IS 1869 01:05:05,840 --> 01:05:10,320 A YEAR WHERE WE CAN EXPECT 1870 01:05:10,320 --> 01:05:11,000 DRAMATIC INCREASES, BUT WE WILL 1871 01:05:11,000 --> 01:05:12,640 HAVE TO SEE WHAT HAPPENS, WE 1872 01:05:12,640 --> 01:05:13,960 DON'T KNOW WHAT'S IN THE 1873 01:05:13,960 --> 01:05:14,680 PRESIDENT'S BUDGET REQUEST AND 1874 01:05:14,680 --> 01:05:18,040 WE DON'T KNOW HOW HE HAS 1875 01:05:18,040 --> 01:05:18,880 PRIORITIZED HIS REQUESTS. 1876 01:05:18,880 --> 01:05:21,840 OVERSIGHT WILL BE A REALLY MAJOR 1877 01:05:21,840 --> 01:05:23,360 PART OF THIS ENTIRE CONGRESS AND 1878 01:05:23,360 --> 01:05:26,720 WE'VE ALREADY SEEN IT START, 1879 01:05:26,720 --> 01:05:28,760 THESE ARE JUST SOME TITLES OF 1880 01:05:28,760 --> 01:05:29,920 HEARINGS THAT HAVE BEEN HELD IN 1881 01:05:29,920 --> 01:05:31,080 THE PAST WEEK. 1882 01:05:31,080 --> 01:05:32,920 THERE WAS A COVID HEARING IN THE 1883 01:05:32,920 --> 01:05:35,000 HOUSE OVERSIGHT COMMITTEE ABOUT 1884 01:05:35,000 --> 01:05:37,720 SOME OF THE PAYCHECK PROTECTION 1885 01:05:37,720 --> 01:05:39,360 ACT FUNDING AND WHERE THINGS 1886 01:05:39,360 --> 01:05:40,720 WENT TOO. 1887 01:05:40,720 --> 01:05:42,760 THERE'S BEEN REAL CONCERNS ABOUT 1888 01:05:42,760 --> 01:05:44,000 OVERSIGHT AND FRAUDULENT 1889 01:05:44,000 --> 01:05:46,320 OBTAINING OF THESE LOANS. 1890 01:05:46,320 --> 01:05:49,440 THERE WAS A HEARING YESTERDAY IN 1891 01:05:49,440 --> 01:05:52,000 THE ENERGY AND HOUSING COMMITTEE 1892 01:05:52,000 --> 01:05:55,040 WHICH IS THE COMMITTEE UNDER 1893 01:05:55,040 --> 01:05:58,520 WHICH NIH FALLS, THIS INCLUDED 1894 01:05:58,520 --> 01:06:00,680 THE CDC DIRECTOR, NIH, AND 1895 01:06:00,680 --> 01:06:01,960 DR. TABAK WHO IS IN THE ACTING 1896 01:06:01,960 --> 01:06:04,320 ROLE FOR THE NIH IS TITLE IS NOW 1897 01:06:04,320 --> 01:06:05,400 PERFORMING THE OFFICIAL DUTIES 1898 01:06:05,400 --> 01:06:06,800 OF THE NIH DIRECTOR BECAUSE HE 1899 01:06:06,800 --> 01:06:08,480 WAS IN AN ACTING ROLE FOR LONGER 1900 01:06:08,480 --> 01:06:10,560 THAN THE TIME WE'RE ALLOWED TO 1901 01:06:10,560 --> 01:06:13,600 BE IN THAT STATUS. 1902 01:06:13,600 --> 01:06:15,840 BUT THIS HEARING WAS A LOT ABOUT 1903 01:06:15,840 --> 01:06:18,840 THE DIFFERENT AGENCIES RESPONSES 1904 01:06:18,840 --> 01:06:22,720 TO COVID AND THE DIFFERENT ROLES 1905 01:06:22,720 --> 01:06:28,840 THAT EACH AGENCY HAD, THERE'S A 1906 01:06:28,840 --> 01:06:30,240 LOT DISAGREEMENT ABOUT GUIDANCE 1907 01:06:30,240 --> 01:06:31,280 AND OPINIONS ABOUT DECISIONS 1908 01:06:31,280 --> 01:06:33,000 THAT WERE MADE ABOUT THE 1909 01:06:33,000 --> 01:06:34,400 DIFFERENT AGENCIES AND SO IT WAS 1910 01:06:34,400 --> 01:06:35,800 A FAIRLY DIFFICULT HEARING, I 1911 01:06:35,800 --> 01:06:37,000 THINK IT'S WHAT WAS EXPECTED BUT 1912 01:06:37,000 --> 01:06:39,440 WE'RE GOING TO SEE MANY MORE OF 1913 01:06:39,440 --> 01:06:41,560 THESE HEARINGS DURING THE COURSE 1914 01:06:41,560 --> 01:06:44,560 OF THIS CONGRESS AND THE 1915 01:06:44,560 --> 01:06:46,320 PROARGZS ARE IN SOME WAYS ALSO 1916 01:06:46,320 --> 01:06:47,040 AN OPPORTUNITY FOR OVERSIGHT AND 1917 01:06:47,040 --> 01:06:48,360 WITH A LOT OF NEW MEMBERS I 1918 01:06:48,360 --> 01:06:49,880 THINK WE WILL SEE A LOT OF 1919 01:06:49,880 --> 01:06:51,160 DIFFERENT SORTS OF QUESTIONS 1920 01:06:51,160 --> 01:06:58,800 THAN WE HAVE BEEN SEEING IN THE 1921 01:06:58,800 --> 01:07:00,520 PAST 6-7 YEARS EMPLOY SO I 1922 01:07:00,520 --> 01:07:01,680 THINK, STAY TUNED AND DON'T 1923 01:07:01,680 --> 01:07:02,560 PANIC ABOUT LAWEDDER DALE YOU 1924 01:07:02,560 --> 01:07:04,560 SEE, THE SPRING IS GOING TO 1925 01:07:04,560 --> 01:07:07,000 BE--IT'S A FRENETIC PACE FOR THE 1926 01:07:07,000 --> 01:07:08,480 APPROPRIATORS, TELL BE DIFFICULT 1927 01:07:08,480 --> 01:07:13,480 AND THE DEBT LIMIT DRIVING THE 1928 01:07:13,480 --> 01:07:14,560 URGENCY IS GOING TO AFFECT THE 1929 01:07:14,560 --> 01:07:17,120 PACE OF THINGINGS AND TRY TO 1930 01:07:17,120 --> 01:07:17,600 JUST RESERVE JUDGMENT. 1931 01:07:17,600 --> 01:07:19,640 SEPTEMBER IS A LONG WAY AWAY. 1932 01:07:19,640 --> 01:07:20,280 THANK YOU. 1933 01:07:20,280 --> 01:07:23,120 I WILL BE HAPPY TO TAKE 1934 01:07:23,120 --> 01:07:26,400 QUESTIONS HERE IF DR. CARPTEN 1935 01:07:26,400 --> 01:07:28,120 SAYS WE HAVE TIME AND IF NOT, 1936 01:07:28,120 --> 01:07:30,080 GET IN TOUCH WITH ME AT YOUR 1937 01:07:30,080 --> 01:07:31,200 CONVENIENCE, I WILL BE HAPPY TO 1938 01:07:31,200 --> 01:07:32,520 TALK WITH YOU. 1939 01:07:32,520 --> 01:07:33,240 >>THAT'S GREAT. 1940 01:07:33,240 --> 01:07:35,360 THANK YOU SO MUCH M. K. 1941 01:07:35,360 --> 01:07:37,200 IF THERE AREN'T ANY BURNING 1942 01:07:37,200 --> 01:07:38,360 QUESTIONS, WE COULD ENTERTAIN 1, 1943 01:07:38,360 --> 01:07:44,640 BUT I THINK WE DO NEED TO 1944 01:07:44,640 --> 01:07:45,320 ADVANCE THE AGENDA. 1945 01:07:45,320 --> 01:07:46,720 SO THANKS M. K. AND AGAIN, IF 1946 01:07:46,720 --> 01:07:51,080 THERE ARE ANY QUESTIONS, WE CAN 1947 01:07:51,080 --> 01:07:52,480 PROVIDE THEM TO PAULET AND SHE 1948 01:07:52,480 --> 01:07:55,360 CAN INTERFACE WITH YOU TO GET 1949 01:07:55,360 --> 01:07:56,080 RESPONSES FOR THOSE. 1950 01:07:56,080 --> 01:07:58,000 THANK YOU SO MUCH. 1951 01:07:58,000 --> 01:08:01,600 NEXT UP ON OUR AGENDA WILL BE 1952 01:08:01,600 --> 01:08:03,080 THE ANNUAL DELEGATIONS OF 1953 01:08:03,080 --> 01:08:04,040 AUTHORITY AND THEY WILL BE 1954 01:08:04,040 --> 01:08:08,040 BROUGHT TO US BY DR. GRAY. 1955 01:08:08,040 --> 01:08:10,760 >>OKAY, SO, I WILL BE THE 1956 01:08:10,760 --> 01:08:13,560 BORING 1 TODAY BUT AS YOU KNOW, 1957 01:08:13,560 --> 01:08:16,640 I ROLL THROUGH THIS QUICKLY TO 1958 01:08:16,640 --> 01:08:22,760 GET US BACK ON TIME TARGET. 1959 01:08:22,760 --> 01:08:24,800 ANNUALLY AT THE FIRST NCAB 1960 01:08:24,800 --> 01:08:27,880 MEETING THE BOARD MUST APPROVE 1961 01:08:27,880 --> 01:08:28,640 SPECIFIC DELEGATIONS OF 1962 01:08:28,640 --> 01:08:31,800 AUTHORITIES SO THAT THE DIRECTOR 1963 01:08:31,800 --> 01:08:34,160 AND NCI STAFF CAN FUNCTION 1964 01:08:34,160 --> 01:08:37,880 WITHOUT HAVING TO COME YOU AS 1965 01:08:37,880 --> 01:08:42,920 NCAB MEMBERS FOR CERTAIN 1966 01:08:42,920 --> 01:08:43,320 ACTIONS. 1967 01:08:43,320 --> 01:08:44,880 SPECIFICALLY DELEGATION A STATES 1968 01:08:44,880 --> 01:08:47,440 THAT THE NCAB DELEGATES TO THE 1969 01:08:47,440 --> 01:08:51,280 DIRECTOR OF THE NATIONAL CANCER 1970 01:08:51,280 --> 01:08:53,200 INSTITUTE PERMISSION TO OBTAIN 1971 01:08:53,200 --> 01:08:56,760 AS STATED IN SECTION 413 B, 5 OF 1972 01:08:56,760 --> 01:09:00,360 THE PUBLIC SERVICE ACT, AND IN 1973 01:09:00,360 --> 01:09:03,640 ACCORDANCE WITH SECTION 3, 109 1974 01:09:03,640 --> 01:09:06,360 OF TITLE 5, UNITED STATES CODE, 1975 01:09:06,360 --> 01:09:07,760 THE OPPORTUNITY TO REQUEST THE 1976 01:09:07,760 --> 01:09:12,320 SERVICES OF NOT MORE THAN 151 1977 01:09:12,320 --> 01:09:15,840 SPECIAL EXPERTS OR CONSULTANTS 1978 01:09:15,840 --> 01:09:18,520 WHO HAVE SCIENTIFIC OR 1979 01:09:18,520 --> 01:09:20,800 PROFESSIONAL QUALIFICATIONS TO 1980 01:09:20,800 --> 01:09:21,440 ASSESS AND ACCOMPLISHING 1981 01:09:21,440 --> 01:09:25,280 SOLUTION 1982 01:09:25,280 --> 01:09:27,760 ACCOMPLISHING--MISSION OF THE 1983 01:09:27,760 --> 01:09:28,480 INSTITUTE. 1984 01:09:28,480 --> 01:09:30,200 DELEGATION B, THE NCAB DELEGATES 1985 01:09:30,200 --> 01:09:33,160 TO THE DIRECTOR NCI PERMISSION 1986 01:09:33,160 --> 01:09:36,480 TO EXERCISE AUTHORITY AS STATED 1987 01:09:36,480 --> 01:09:41,080 IN SECTION 413 B-7 OF THE PUBLIC 1988 01:09:41,080 --> 01:09:43,000 HEALTH SERVICE ACT, THE 1989 01:09:43,000 --> 01:09:46,080 OPPORTUNITY TO ESTABLISH 1 OR 1990 01:09:46,080 --> 01:09:48,000 MORE ADVISORY COMMITTEES 1991 01:09:48,000 --> 01:09:50,800 COMPOSED OF PRIVATE CITIZEN AND 1992 01:09:50,800 --> 01:09:54,400 OFFICIALS OF FEDERAL, STATE AND 1993 01:09:54,400 --> 01:09:55,440 LOCAL GOVERNMENTS TO ADVISE HIM 1994 01:09:55,440 --> 01:10:00,920 OR HER WITH RESPECT TO HIS OR 1995 01:10:00,920 --> 01:10:01,280 HER FUNCTIONS. 1996 01:10:01,280 --> 01:10:03,280 NEXT IS THE STATEMENT OF 1997 01:10:03,280 --> 01:10:04,920 UNDERSTANDING OF WHAT THE NCI 1998 01:10:04,920 --> 01:10:08,160 STAFF WILL OPERATE IN PRINCIPLES 1999 01:10:08,160 --> 01:10:09,920 IN MAKING EXTRAMURAL AWARDS 2000 01:10:09,920 --> 01:10:12,280 WITHIN ACCORDANCE WITH 2001 01:10:12,280 --> 01:10:13,600 MANAGEMENT AND REVIEW PROCEDURES 2002 01:10:13,600 --> 01:10:21,120 SET FORTH IN THE NIH MANUEL 2003 01:10:21,120 --> 01:10:22,640 ISSUANCE 4513. 2004 01:10:22,640 --> 01:10:24,360 NCAB CONCURRENT WITH 2005 01:10:24,360 --> 01:10:25,600 RECOMMENDITIONAS OF INITIAL 2006 01:10:25,600 --> 01:10:26,640 RECRUITMENTS WILL BE REQUIRED 2007 01:10:26,640 --> 01:10:29,080 FOR ALL GRANTS, THAT IS EXCEPT 2008 01:10:29,080 --> 01:10:32,560 FOR TRAINING GRANTS, FELLING 2009 01:10:32,560 --> 01:10:35,000 OSHIPS AND OTHER NONRESEARCH 2010 01:10:35,000 --> 01:10:35,440 GRANT APPLICATIONS. 2011 01:10:35,440 --> 01:10:40,160 THESE GRANTS MAY BE AWARD TD BY 2012 01:10:40,160 --> 01:10:43,400 NCI WITHOUT PRESENTATION TO THE 2013 01:10:43,400 --> 01:10:48,360 NCAB THAT IS WITH EXCEPTION OF 2014 01:10:48,360 --> 01:10:54,200 THE [INDISCERNIBLE] NATIONAL 2015 01:10:54,200 --> 01:10:54,680 RESEARCH SERVICE AWARDS. 2016 01:10:54,680 --> 01:10:56,080 APPLICATIONS MRI KAIGDZS OVER 2017 01:10:56,080 --> 01:10:57,480 THE 20th PERCENTILE WILL NOT 2018 01:10:57,480 --> 01:10:58,520 HAVE SUMMARY STATEMENTS 2019 01:10:58,520 --> 01:11:00,840 PRESENTED TO THE NCAB UNLESS THE 2020 01:11:00,840 --> 01:11:03,800 INTUITY IS CONSIDERING THE AWARD 2021 01:11:03,800 --> 01:11:06,640 OF SUCH AN APPLICATION OR FOR 2022 01:11:06,640 --> 01:11:08,000 SPECIAL CONSIDERATION BY AN 2023 01:11:08,000 --> 01:11:15,000 APPOINTED NUMBER OF THE BOARD. 2024 01:11:15,000 --> 01:11:15,760 APPLICATIONS ASSIGNED BOTH 2025 01:11:15,760 --> 01:11:17,080 SCORES THAT ARE NOT PERCENTILE, 2026 01:11:17,080 --> 01:11:20,640 THE CUT OFF WILL BE AN IMPACT 2027 01:11:20,640 --> 01:11:26,120 SCORE OF 45 FOR ALL MECHANISMS 2028 01:11:26,120 --> 01:11:28,120 EXCEPT R41S, 42S, 43s AND 2029 01:11:28,120 --> 01:11:30,880 44s, FOR THE LATTER AWARDS ALL 2030 01:11:30,880 --> 01:11:33,160 SCORED APPLICATIONS WILL BE 2031 01:11:33,160 --> 01:11:37,960 INCLUDED IN THE [INDISCERNIBLE]. 2032 01:11:37,960 --> 01:11:39,120 EXPEDITED CONCURRENCE WILL BE 2033 01:11:39,120 --> 01:11:44,480 USED FOR RO-1 AND R21 2034 01:11:44,480 --> 01:11:47,120 APPLICATIONS, EXCLUDING THOSE 2035 01:11:47,120 --> 01:11:51,240 FROM FOREIGN ORGANIZATIONS. 2036 01:11:51,240 --> 01:11:52,520 THOSE APPLICATIONS PERCENTILE OR 2037 01:11:52,520 --> 01:11:54,120 GROWTH SCORES MUST FALL WITHIN 2038 01:11:54,120 --> 01:11:57,440 THE NCI PAY LINES AND THAT HAVE 2039 01:11:57,440 --> 01:12:00,520 NO CONCERNS NOTED THAT WOULD 2040 01:12:00,520 --> 01:12:05,000 REPRESENT AN ADMINISTRATIVE BAR 2041 01:12:05,000 --> 01:12:06,400 TO AWARD. 2042 01:12:06,400 --> 01:12:09,960 BARS TO AWARD WOULD INCLUDE HEAL 2043 01:12:09,960 --> 01:12:13,200 SUBJEBS, ANIMAL WELFARE, 2044 01:12:13,200 --> 01:12:14,600 BIOHAZARDS OR INCLUSION OF 2045 01:12:14,600 --> 01:12:17,200 WOMEN, CHILDREN, AND APPROPRIATE 2046 01:12:17,200 --> 01:12:18,760 MINORITY DISTRIBUTION. 2047 01:12:18,760 --> 01:12:19,720 EXPEDITED CONCURRENCE WILL BE 2048 01:12:19,720 --> 01:12:22,040 DELEGATED BY THE CHAIR TO 2049 01:12:22,040 --> 01:12:24,040 SPECIFICALLY DESIGNATED MEMBERS 2050 01:12:24,040 --> 01:12:25,680 OF THE BOARD ACTIVE ON BEHALF OF 2051 01:12:25,680 --> 01:12:29,160 THE BOARD AS A WHOLE. 2052 01:12:29,160 --> 01:12:31,360 THE REVIEWERS WILL CONSIST OF 2053 01:12:31,360 --> 01:12:34,680 THE CHAIR, OF THE SUBCOMMITTEE 2054 01:12:34,680 --> 01:12:36,600 ON SPECIAL ACTIONS AND 3 ARK 2055 01:12:36,600 --> 01:12:38,200 DITIONAL NCAB MEMBERS AS 2056 01:12:38,200 --> 01:12:40,160 APPOINTED BY THE CHAIR OF THE 2057 01:12:40,160 --> 01:12:40,520 NCAB. 2058 01:12:40,520 --> 01:12:42,160 IN PACES OF EMERGING NEED AS 2059 01:12:42,160 --> 01:12:45,840 DETERMINED BY THE DIRECTOR NCI, 2060 01:12:45,840 --> 01:12:48,720 WITH THEIR CONCURRENCE OF THE 2061 01:12:48,720 --> 01:12:49,680 NCAB CHAIR, EXPEDITED 2062 01:12:49,680 --> 01:12:53,560 CONCURRENCE MAY BE UTILIZED FOR 2063 01:12:53,560 --> 01:12:57,400 SINGLE CASE DEVIATIONS. 2064 01:12:57,400 --> 01:12:58,440 EXPEDITED [INDISCERNIBLE] OF 2065 01:12:58,440 --> 01:13:00,280 ENOUGH FOLKS FOR FINAL ACTION 2066 01:13:00,280 --> 01:13:02,200 WILL BE PRESENTED TO THE FULL 2067 01:13:02,200 --> 01:13:05,880 NCAB AT ITS REGULAR MEETING. 2068 01:13:05,880 --> 01:13:09,040 IN TERMS OF ADMINISTRATIVE 2069 01:13:09,040 --> 01:13:11,480 ADJUSTMENTS, THE NCAB DELEGATES 2070 01:13:11,480 --> 01:13:13,880 TO THE DIRECTOR NCI PERMISSION 2071 01:13:13,880 --> 01:13:16,440 TO OUR STAFF TO NEGOTIATE 2072 01:13:16,440 --> 01:13:17,120 APPROPRIATE ADJUSTMENTS IN 2073 01:13:17,120 --> 01:13:19,960 DOLLARS OR OTHER TERMS AND 2074 01:13:19,960 --> 01:13:22,600 CONDITIONS OF GRANT AND 2075 01:13:22,600 --> 01:13:23,400 COOPERATIVE AGREEMENT AWARDS 2076 01:13:23,400 --> 01:13:24,720 RECOMMENDED BY THE BOARD. 2077 01:13:24,720 --> 01:13:27,280 IN DOING SO, THIS ALLOWS THE 2078 01:13:27,280 --> 01:13:29,440 INSTITUTE TO MAINTAIN A SMOOTH 2079 01:13:29,440 --> 01:13:32,000 AND EFFECTIVE OPERATION OF THE 2080 01:13:32,000 --> 01:13:34,920 ADMINISTRATION OF RANKS BY 2081 01:13:34,920 --> 01:13:35,200 INSTITUTE. 2082 01:13:35,200 --> 01:13:37,360 STAFF WILL NEGOTIATE APPROPRIATE 2083 01:13:37,360 --> 01:13:38,840 ADJUSTMENTS AND WHEN APPLICABLE 2084 01:13:38,840 --> 01:13:43,240 WILL MAKE ADJUSTMENTS TO 2085 01:13:43,240 --> 01:13:46,000 RECONCILE INCONSISTENCIES 2086 01:13:46,000 --> 01:13:47,280 BETWEEN RECOMMENDED BUDGET AND 2087 01:13:47,280 --> 01:13:50,160 RECOMMENDED AIMS AND ACTIVITIES. 2088 01:13:50,160 --> 01:13:50,960 ADMINISTRATIVE REQUESTS FOR 2089 01:13:50,960 --> 01:13:51,920 INCREASES IN DIRECT COSTS WHICH 2090 01:13:51,920 --> 01:13:56,000 ARE THE RESULT OF MARKED 2091 01:13:56,000 --> 01:13:57,160 EXPANSION OR SIGNIFICANT CHANGE 2092 01:13:57,160 --> 01:13:59,640 AND SCIENTIFIC CONTENT OF A 2093 01:13:59,640 --> 01:14:00,720 PROGRAM, AFTER FORMAL PEER 2094 01:14:00,720 --> 01:14:02,680 REVIEW WILL BE REFERRED TO THE 2095 01:14:02,680 --> 01:14:04,640 BOARD BY ADVICE THROUGH 2096 01:14:04,640 --> 01:14:05,000 RECOMMENDATION. 2097 01:14:05,000 --> 01:14:06,600 IF THERE'S AN ISSUE THAT IS 2098 01:14:06,600 --> 01:14:10,320 TERMS OF SCOPE AND URGENCY, THE 2099 01:14:10,320 --> 01:14:13,040 DIRECTOR NCI WILL CONSULT WITH 2100 01:14:13,040 --> 01:14:16,120 THE NCAB CHAIR PRIOR TO A FINAL 2101 01:14:16,120 --> 01:14:17,960 DETERMINE NATION. 2102 01:14:17,960 --> 01:14:19,160 THE NCAB CHAIR WILL ACT ON 2103 01:14:19,160 --> 01:14:21,240 BEHALF OF THE BOARD AS A WHOLE. 2104 01:14:21,240 --> 01:14:24,680 IN TERMS OF ACTIONS NOT 2105 01:14:24,680 --> 01:14:28,440 [INDISCERNIBLE] REVIEW OR 2106 01:14:28,440 --> 01:14:29,960 ADVICE, THOSE INCLUDE ACTIONS 2107 01:14:29,960 --> 01:14:32,360 SUCH AS CHANGE OF INSTITUTION, 2108 01:14:32,360 --> 01:14:34,840 CHANGE OF PRINCIPLE 2109 01:14:34,840 --> 01:14:35,640 INVESTIGATOR, PHASE OUT OR 2110 01:14:35,640 --> 01:14:40,000 INTERIM SUPPORT OR ADDITIONAL 2111 01:14:40,000 --> 01:14:42,160 SUPPORT, THE OPPORTUNITY OF 2112 01:14:42,160 --> 01:14:44,200 INCREASED COSTS MAINTAINED AT A 2113 01:14:44,200 --> 01:14:46,160 LEVEL OR RESEARCH PREVIOUSLY 2114 01:14:46,160 --> 01:14:50,000 RECOMMENDED OR TO ACCOMMODATE 2115 01:14:50,000 --> 01:14:51,680 ACTIVITIES JUDGED BY STAFF TO BE 2116 01:14:51,680 --> 01:14:53,880 WITHIN THE SCOPE OF THE THE PEER 2117 01:14:53,880 --> 01:14:54,680 REVIEW RESEARCH. 2118 01:14:54,680 --> 01:14:56,080 THESE ACTIONS WILL NOT BE 2119 01:14:56,080 --> 01:14:58,920 REPORTED TO THE BOARD. 2120 01:14:58,920 --> 01:15:01,560 IN ADDITION STAFF MAY RESTORE 2121 01:15:01,560 --> 01:15:02,960 REQUESTED TIME AND SUPPORT WHICH 2122 01:15:02,960 --> 01:15:05,160 WERE DELETED BY THE INITIAL 2123 01:15:05,160 --> 01:15:08,120 REVIEW GROUP WHICH THE PRINCIPLE 2124 01:15:08,120 --> 01:15:09,240 INVESTIGATOR HAS PROVIDED 2125 01:15:09,240 --> 01:15:11,000 JUSTIFICATION IN AN APPEAL 2126 01:15:11,000 --> 01:15:12,400 LETTER, THE RESTORATION IS IN 2127 01:15:12,400 --> 01:15:14,480 THE BEST INTEREST OF THE NCI, 2128 01:15:14,480 --> 01:15:19,880 AND THE PROJECT IS OF HIGH NCI 2129 01:15:19,880 --> 01:15:22,080 PROGRAMMATIC RELEVANCE. 2130 01:15:22,080 --> 01:15:23,720 DIRECTOR OF NCI AFTER 2131 01:15:23,720 --> 01:15:25,480 CONSULTATION WITH THE NCAB CHAIR 2132 01:15:25,480 --> 01:15:29,080 MAY MAKE EXCEPTIONS TO THESE 2133 01:15:29,080 --> 01:15:29,400 GUIDELINES. 2134 01:15:29,400 --> 01:15:31,800 FINALLY, THERE'S A SPECIAL 2135 01:15:31,800 --> 01:15:33,360 CANCER REVIEW WHICH IS SCR AND 2136 01:15:33,360 --> 01:15:39,760 ALL OF YOU ARE AWARE OF IT, A 2137 01:15:39,760 --> 01:15:40,440 PRINCIPAL INVESTIGATORS WITH 2138 01:15:40,440 --> 01:15:42,920 2 MILLION TOTAL COSTS OR MORE IN 2139 01:15:42,920 --> 01:15:43,440 RPG AWARDS. 2140 01:15:43,440 --> 01:15:45,320 IN AN EFFORT TO CONDITION 2141 01:15:45,320 --> 01:15:46,640 RESPONSIBLE STEWARDSHIP OF 2142 01:15:46,640 --> 01:15:51,840 PUBLIC FUNDS AND TO SUPPORT 2143 01:15:51,840 --> 01:15:53,040 MERITORIOUS AND INNOVATIVE 2144 01:15:53,040 --> 01:15:55,120 RESEARCH, NIH HAS INSTITUTED 2145 01:15:55,120 --> 01:15:56,480 POLICIES OF SPECIAL CANCER 2146 01:15:56,480 --> 01:16:01,200 REVIEW OF THE APPLICATIONS FROM 2147 01:16:01,200 --> 01:16:03,000 WELL FUNDED INVESTIGATORS. 2148 01:16:03,000 --> 01:16:04,720 PENDING GRANTS, GOING TO THE 2149 01:16:04,720 --> 01:16:06,240 BOARD FOR PRINCIPAL 2150 01:16:06,240 --> 01:16:07,760 INVESTIGATORS, THEY HAVE MORE 2151 01:16:07,760 --> 01:16:11,040 THAN 2 MILLION OR MORE IN DIRECT 2152 01:16:11,040 --> 01:16:14,800 COSTS FROM ACTIVE NCI RESEARCH 2153 01:16:14,800 --> 01:16:19,160 PROJECT GRANTS, MUST BE GIVEN AN 2154 01:16:19,160 --> 01:16:19,680 ADDITIONAL CONSIDERATION. 2155 01:16:19,680 --> 01:16:21,480 IT IS IMPORTANT TO RECOGNIZE 2156 01:16:21,480 --> 01:16:25,240 THAT THIS IS A THRESHOLD ONLY. 2157 01:16:25,240 --> 01:16:27,480 INVESTIGATORS WHO HAVE MORE 2158 01:16:27,480 --> 01:16:30,560 RESEARCH SUPPORT MAY STILL 2159 01:16:30,560 --> 01:16:33,480 RECEIVE ADDITIONAL AWARDS AS 2160 01:16:33,480 --> 01:16:35,080 WARRANTED. 2161 01:16:35,080 --> 01:16:37,440 ARE THERE QUESTIONS OR IS 2162 01:16:37,440 --> 01:16:38,320 FURTHER CLARIFICATION NEEDED? 2163 01:16:38,320 --> 01:16:40,920 IF NOT THEN JOHN WILL CALL FOR A 2164 01:16:40,920 --> 01:16:44,120 VOTE FOR APPROVAL, DISAPPROVAL 2165 01:16:44,120 --> 01:16:45,360 OR ABSTENTION, OR ABSTENTION OF 2166 01:16:45,360 --> 01:16:49,160 THE DELEGATIONS OF AUTHORITY. 2167 01:16:49,160 --> 01:16:49,400 JOHN? 2168 01:16:49,400 --> 01:16:54,280 DID I GO FAST ENOUGH? 2169 01:16:54,280 --> 01:16:54,640 >>[LAUGHTER] 2170 01:16:54,640 --> 01:16:55,960 THANK YOU, P A ULETTE. 2171 01:16:55,960 --> 01:16:58,440 ARE THERE ANY QUESTIONS FOR 2172 01:16:58,440 --> 01:16:58,640 PAULET? 2173 01:16:58,640 --> 01:17:02,640 IF NOT, WE NEED TO CALL A MOTION 2174 01:17:02,640 --> 01:17:03,000 TO APPROVE. 2175 01:17:03,000 --> 01:17:10,160 IS THERE A MOTION? 2176 01:17:10,160 --> 01:17:10,800 >>MOTION. 2177 01:17:10,800 --> 01:17:11,320 >>SECOND? 2178 01:17:11,320 --> 01:17:11,640 >>SECOND. 2179 01:17:11,640 --> 01:17:14,280 >>WE CAN PROBABLY MOVE MOVED 2180 01:17:14,280 --> 01:17:16,400 AND SECOND. 2181 01:17:16,400 --> 01:17:16,720 DISCUSSION? 2182 01:17:16,720 --> 01:17:20,880 SO WE CAN NOW PROCEED TO VOTE TO 2183 01:17:20,880 --> 01:17:21,880 ACCEPT. 2184 01:17:21,880 --> 01:17:28,120 AND ARE THERE ANY NAYS? 2185 01:17:28,120 --> 01:17:32,240 ANY ABSTENTIONS? 2186 01:17:32,240 --> 01:17:35,960 NO, SO P A ULETTE, IT'S 2187 01:17:35,960 --> 01:17:36,240 UNANIMOUS. 2188 01:17:36,240 --> 01:17:36,880 >>IT'S UNANIMOUS. 2189 01:17:36,880 --> 01:17:37,360 >>OKAY, GREAT. 2190 01:17:37,360 --> 01:17:42,240 THANK YOU ALL SO MUCH, THANK YOU 2191 01:17:42,240 --> 01:17:43,960 P A ULETTE, OUR FINAL 2192 01:17:43,960 --> 01:17:45,720 PRESENTATION WILL BE BROUGHT TO 2193 01:17:45,720 --> 01:17:50,200 TO US BY JIM DOROSHOW, HE IS 2194 01:17:50,200 --> 01:17:52,040 DEPUTY CLINICAL DIRECTOR FOR 2195 01:17:52,040 --> 01:17:52,760 RESEARCH AND CLINICAL CANCER 2196 01:17:52,760 --> 01:17:53,600 TREATMENT AND DIAGNOSIS AND AT 2197 01:17:53,600 --> 01:17:55,160 THE IN, CI AND HE WILL PRESENT 2198 01:17:55,160 --> 01:17:57,400 WHICH IS FASNAILTING ADAPTING 2199 01:17:57,400 --> 01:17:59,040 NCIA CLINICAL TRIALS SYSTEM TO A 2200 01:17:59,040 --> 01:18:02,120 CHANGED CLINICAL RESEARCH 2201 01:18:02,120 --> 01:18:02,600 ENVIRONMENT. 2202 01:18:02,600 --> 01:18:02,760 JIM? 2203 01:18:02,760 --> 01:18:03,720 >>THANKS JOHN AND THANKS TO 2204 01:18:03,720 --> 01:18:05,800 EVERYONE FOR THE CHANCE TO 2205 01:18:05,800 --> 01:18:08,360 REVIEW WITH YOU THE IMPACT OF 2206 01:18:08,360 --> 01:18:12,240 THE EVENTS OF THE LAST 3 YEARS 2207 01:18:12,240 --> 01:18:15,680 ON THE NCIA CLINICAL TRIALS 2208 01:18:15,680 --> 01:18:15,880 SYSTEMS. 2209 01:18:15,880 --> 01:18:16,680 NEXT SLIDE. 2210 01:18:16,680 --> 01:18:17,960 SO MY TALK WILL FIRST PROVIDE 2211 01:18:17,960 --> 01:18:19,720 DATA ON THE INITIAL AND ONGOING 2212 01:18:19,720 --> 01:18:21,240 EFFECTS OF THE PANDEMIC 2213 01:18:21,240 --> 01:18:22,880 ENVIRONMENT ON CLINICAL TRIALS. 2214 01:18:22,880 --> 01:18:24,520 TALK A LITTLE BIT ABOUT SOME OF 2215 01:18:24,520 --> 01:18:26,480 THE MAJOR FEATURES OF OUR 2216 01:18:26,480 --> 01:18:27,760 STRATEGIC VISION, FOR CLINICAL 2217 01:18:27,760 --> 01:18:29,080 TRIALS THAT WERE DEVELOPED 2218 01:18:29,080 --> 01:18:30,680 DURING THE PANDEMIC AND THEN 2219 01:18:30,680 --> 01:18:32,000 ACTIVITIES THAT WE ARE 2220 01:18:32,000 --> 01:18:35,400 UNDERTAKING TO TRY TO AMELIORATE 2221 01:18:35,400 --> 01:18:36,320 THE CLINICAL RESEARCH WORKFORCE 2222 01:18:36,320 --> 01:18:37,480 PROBLEMS THAT ALL OF YOU ARE 2223 01:18:37,480 --> 01:18:39,800 FAMILIAR WITH. 2224 01:18:39,800 --> 01:18:40,240 NEXT SLIDE. 2225 01:18:40,240 --> 01:18:42,360 SO LET ME JUST REVIEW THINGS 2226 01:18:42,360 --> 01:18:44,400 THAT I THINK ARE FAMILIAR TO 2227 01:18:44,400 --> 01:18:44,680 EVERYONE. 2228 01:18:44,680 --> 01:18:47,120 WE KNOW ABOUT THE ROAD BLOCKS 2229 01:18:47,120 --> 01:18:50,080 THAT BEGAN JUST ALMOST EXACTLY 3 2230 01:18:50,080 --> 01:18:52,080 YEARS AGO TO CLINICAL TRIAL 2231 01:18:52,080 --> 01:18:52,320 ACCRUAL. 2232 01:18:52,320 --> 01:18:53,920 AND WE WERE FACED WITH A 2233 01:18:53,920 --> 01:18:56,200 SITUATION IN WHICH, IN-PERSON 2234 01:18:56,200 --> 01:18:58,960 ACTIVITIES, GETTING INKORMED 2235 01:18:58,960 --> 01:19:00,360 CONSENTS RECEIVING 2236 01:19:00,360 --> 01:19:02,520 INVESTIGATIONAL DRUGS AT 2237 01:19:02,520 --> 01:19:04,000 HOSPITALS, ASSESS THES, FOR 2238 01:19:04,000 --> 01:19:05,800 PATIENT SAFETY AND ADHERENCE 2239 01:19:05,800 --> 01:19:06,920 WERE ALL ADVERSELY IMPACTED 2240 01:19:06,920 --> 01:19:09,920 BECAUSE OF THE DIFFICULTIES OF 2241 01:19:09,920 --> 01:19:11,440 PROVIDING SAFE WAY FOR PATIENTS 2242 01:19:11,440 --> 01:19:13,680 TO RECEIVE THOSE KINDS OF 2243 01:19:13,680 --> 01:19:14,000 TREATMENTS. 2244 01:19:14,000 --> 01:19:17,080 WE ARE ALL FAMILIAR WITH THE 2245 01:19:17,080 --> 01:19:19,160 PROBLEMS NECESSARY THAT WERE 2246 01:19:19,160 --> 01:19:20,480 NECESSITATED BECAUSE OUR 2247 01:19:20,480 --> 01:19:21,920 CLINICAL PROTOCOLS REQUIRED 2248 01:19:21,920 --> 01:19:25,120 PATIENT IT IS TO COME FOR 2249 01:19:25,120 --> 01:19:26,640 IMAGING ACTIVITIES, FOR 2250 01:19:26,640 --> 01:19:31,120 LABORATORY AND DIAGNOSTIC TESTS 2251 01:19:31,120 --> 01:19:32,360 TO CENTRAL FACILITIES. 2252 01:19:32,360 --> 01:19:34,440 I THINK, MANY, NOT ALL OF YOU 2253 01:19:34,440 --> 01:19:37,200 PERHAPS UNDERSTAND HOW ALL OF 2254 01:19:37,200 --> 01:19:39,760 OUR TRIALS COLLECTED ENORMOUS 2255 01:19:39,760 --> 01:19:41,600 AMOUNTS EVER DATA ON HIGH GRADE 2256 01:19:41,600 --> 01:19:43,600 AND LOW GRADE ADVERSE EVENTS OF 2257 01:19:43,600 --> 01:19:45,240 PERHAPS MINIMAL RELEVANCE TO THE 2258 01:19:45,240 --> 01:19:46,640 END POINTS OF THE STUDIES BUT 2259 01:19:46,640 --> 01:19:48,200 ALSO REQUIRED PATIENTS TO COME 2260 01:19:48,200 --> 01:19:50,840 TO CENTRAL FACILITIES AND ALL OF 2261 01:19:50,840 --> 01:19:53,000 THAT WAS ADVERSELY AFFECTED BY 2262 01:19:53,000 --> 01:19:54,640 THE FACT THAT THERE WERE GREAT 2263 01:19:54,640 --> 01:19:56,040 DIFFICULTIES IN TERMS OF MAKING 2264 01:19:56,040 --> 01:20:00,160 AND HAVING THE PERSONNEL AND THE 2265 01:20:00,160 --> 01:20:00,720 FACILITIES AVAILABLE FOR 2266 01:20:00,720 --> 01:20:02,160 PATIENTS TO COME TO BECAUSE OF 2267 01:20:02,160 --> 01:20:05,000 THE COVID PANDEMIC AND THE 2268 01:20:05,000 --> 01:20:05,560 REPROGRAMMING OF CLINICAL 2269 01:20:05,560 --> 01:20:06,160 RESEARCH NURSES FOR CARE. 2270 01:20:06,160 --> 01:20:07,400 BUT WHAT I WOULD LIKE TO 2271 01:20:07,400 --> 01:20:09,880 EMPHASIZE IS THAT ALL OF THOSE 2272 01:20:09,880 --> 01:20:10,600 THINGS HAVE--WE'VE ADAPTED TO 2273 01:20:10,600 --> 01:20:12,240 MANY, IF NOT ALL OF THOSE 2274 01:20:12,240 --> 01:20:15,600 ISSUES, BUT THERE ARE CONTINUING 2275 01:20:15,600 --> 01:20:16,600 MAJOR ONGOING ISSUES. 2276 01:20:16,600 --> 01:20:18,720 AS ANYONE WHO RUNS A CLINICAL 2277 01:20:18,720 --> 01:20:20,800 TRIALS OFFICE OR EVERY CLINICAL 2278 01:20:20,800 --> 01:20:22,920 INVESTIGATOR ACROSS OUR CANCER 2279 01:20:22,920 --> 01:20:23,480 CENTERS UNDERSTANDING THERE 2280 01:20:23,480 --> 01:20:25,120 CONTINUE TO BE CRITICAL 2281 01:20:25,120 --> 01:20:27,400 SHORTAGES OF RESEARCH NURSES, 2282 01:20:27,400 --> 01:20:29,080 CRAs, REGULATORY STAFF AS WELL 2283 01:20:29,080 --> 01:20:31,280 AS ESSENTIAL HEALTH WORKERS, 2284 01:20:31,280 --> 01:20:34,320 PATHOLOGY AND RADIOLOGY 2285 01:20:34,320 --> 01:20:34,640 FACILITIES. 2286 01:20:34,640 --> 01:20:36,280 WE HAVE--WE LACK THE APPROPRIATE 2287 01:20:36,280 --> 01:20:38,480 STAFFING IN OUR IRBs AND IN 2288 01:20:38,480 --> 01:20:39,800 OUR LEGAL AND CONTRACTING 2289 01:20:39,800 --> 01:20:41,880 OFFICES AND ALL OF THOSE THINGS 2290 01:20:41,880 --> 01:20:43,560 HAVE DECREASED THE AVAILABILITY 2291 01:20:43,560 --> 01:20:45,280 OF CLINICAL TRIALS, HAVE HAD AN 2292 01:20:45,280 --> 01:20:47,280 ADVERSE EFFECT ON A CLINICAL 2293 01:20:47,280 --> 01:20:49,200 TRIAL ACCRUAL AND I WANT TO 2294 01:20:49,200 --> 01:20:51,080 EMPHASIZE HAS LED TO SUBSTANTIVE 2295 01:20:51,080 --> 01:20:53,080 DELAYS AND RESULT IN REPORTING 2296 01:20:53,080 --> 01:20:54,480 THAT ALSO HAVE LONG-TERM 2297 01:20:54,480 --> 01:20:55,840 NEGATIVE IMPACTS ON OUR CLINICAL 2298 01:20:55,840 --> 01:20:58,680 TRIAL SYSTEM. 2299 01:20:58,680 --> 01:20:59,960 NEXT SLIDE. 2300 01:20:59,960 --> 01:21:01,400 HOW DO WE RESPOND? 2301 01:21:01,400 --> 01:21:03,240 SO FIRST, HATS OFF TO ALL OF YOU 2302 01:21:03,240 --> 01:21:06,920 AND ALL OF YOUR INSTITUTIONS AS 2303 01:21:06,920 --> 01:21:13,160 WELL TO MY COLLEAGUES DR. MOONY 2304 01:21:13,160 --> 01:21:14,600 AND DR. STEPHENS FOR VERY RAPID 2305 01:21:14,600 --> 01:21:17,960 LOAMACYY AFTER THE ONSET OF THE 2306 01:21:17,960 --> 01:21:19,600 PANDEMIC MAKING MAJOR CHANGES TO 2307 01:21:19,600 --> 01:21:22,440 OUR SYSTEMS, WE MADE THE USES TO 2308 01:21:22,440 --> 01:21:24,120 ELECTRONIC CONSEBTING, WE 2309 01:21:24,120 --> 01:21:26,160 PROVIDED ORAL MEDS TO ALL 2310 01:21:26,160 --> 01:21:26,440 PATIENTS. 2311 01:21:26,440 --> 01:21:29,840 WE ISSUED ELECTRONIC RATHER THAN 2312 01:21:29,840 --> 01:21:31,800 IN-PERSON STUDY AUGHTITS. 2313 01:21:31,800 --> 01:21:33,080 WE FACILITATED TELEMEDICINE FOR 2314 01:21:33,080 --> 01:21:33,320 VISITS. 2315 01:21:33,320 --> 01:21:36,000 WE TOOK A POSITIVE VIEW OF HOW 2316 01:21:36,000 --> 01:21:38,000 TO LIMIT THE IMPACT OF MINOR 2317 01:21:38,000 --> 01:21:40,480 STUDY DEVIATIONS ON THE OVERALL 2318 01:21:40,480 --> 01:21:42,760 EVALUATION OF CLINICAL TRIAL 2319 01:21:42,760 --> 01:21:43,000 CONDUCT. 2320 01:21:43,000 --> 01:21:45,440 WE IMPLEMENTED VERY IMPORTANTLY 2321 01:21:45,440 --> 01:21:46,600 DECENTRALIZED TESTING REQUIRED 2322 01:21:46,600 --> 01:21:50,520 LAB AND IMAGING STUDIES AND 2323 01:21:50,520 --> 01:21:51,840 PERHAPS AS IMPORTANT AS ANY OF 2324 01:21:51,840 --> 01:21:53,160 THESE THINGS, DURING THE 2325 01:21:53,160 --> 01:21:59,760 PANDEMIC ITSELF, WE QUEPED A NEW 2326 01:21:59,760 --> 01:22:00,600 -DEVELOPED A NEW STRATEGIC 2327 01:22:00,600 --> 01:22:02,240 PLAN SOME OF WHICH WE HAVE NOW 2328 01:22:02,240 --> 01:22:03,080 IMPLEMENTED AND I WILL SHARE 2329 01:22:03,080 --> 01:22:03,800 WITH YOU. 2330 01:22:03,800 --> 01:22:04,160 NEXT SLIDE. 2331 01:22:04,160 --> 01:22:06,600 I WOULD LIKE TO SPEND THE NEXT 2332 01:22:06,600 --> 01:22:07,440 COUPLE MINUTES GOING OVER DATA 2333 01:22:07,440 --> 01:22:11,640 AND THIS IS UP TO DATE DATA 2334 01:22:11,640 --> 01:22:15,240 BEGINNING WITH JANUARY 2020 AND 2335 01:22:15,240 --> 01:22:16,320 CURRENT THROUGH DECEMBER OF 2336 01:22:16,320 --> 01:22:16,520 2022. 2337 01:22:16,520 --> 01:22:19,360 AND WHAT IT SHOWS IS THE ACCRUAL 2338 01:22:19,360 --> 01:22:21,520 TO EVERYTHING BUT OUR INDUSTRIAL 2339 01:22:21,520 --> 01:22:23,640 TRIALS AT THE NCI'S CANCER 2340 01:22:23,640 --> 01:22:24,960 CENTERS, ALL THE CANCER CENTERS 2341 01:22:24,960 --> 01:22:26,680 THAT DO CLINICAL TRIALS AND SO 2342 01:22:26,680 --> 01:22:28,440 ALL OF YOU ARE VERY FAMILIAR 2343 01:22:28,440 --> 01:22:30,360 WITH WHAT I CALL THE GRAND 2344 01:22:30,360 --> 01:22:32,800 CANYON EFFECT IN MARCH, APRIL 2345 01:22:32,800 --> 01:22:35,200 APRIL, MAY, JUNE OF 2020 WHERE 2346 01:22:35,200 --> 01:22:37,960 EVERY TYPE OF CLINICAL TRIAL WE 2347 01:22:37,960 --> 01:22:41,200 WERE CONDUCTING CHIBTED A MOIJOR 2348 01:22:41,200 --> 01:22:41,880 REDUCTION IN ACCRUAL. 2349 01:22:41,880 --> 01:22:44,200 BUT WHAT IS PERHAPS NOT SO WELL 2350 01:22:44,200 --> 01:22:46,840 KNOWN IS THAT AS CAN YOU SEE IN 2351 01:22:46,840 --> 01:22:50,520 GRAY, IT WAS A TREMENDOUS AND 2352 01:22:50,520 --> 01:22:52,840 WONDERFUL REBOUND AND ACCRUAL TO 2353 01:22:52,840 --> 01:22:54,560 OUR NCTN TRIALS THAT HAS 2354 01:22:54,560 --> 01:22:55,680 CONTINUED THROUGHOUT THE LAST 2 2355 01:22:55,680 --> 01:22:56,800 AND HALF 3 YEARS BUT I DON'T 2356 01:22:56,800 --> 01:22:58,800 THINK IT IS AS WELL APPRECIATED 2357 01:22:58,800 --> 01:23:02,120 THAT IF YOU LOOK IN BLUE OR IN 2358 01:23:02,120 --> 01:23:06,240 ORANGE, IF YOU LOOK AT ACCRUAL 2359 01:23:06,240 --> 01:23:08,920 TO INVESTIGATOR INITIATED TRIALS 2360 01:23:08,920 --> 01:23:10,960 OR EXTERNAL PERPERRY VIEW 2361 01:23:10,960 --> 01:23:13,320 TRIALS, SORE BY RO-1S OR R21S, 2362 01:23:13,320 --> 01:23:14,920 THOSE HAVE IN FACT NEVER 2363 01:23:14,920 --> 01:23:16,680 RECOVERED OVER 3 YEARS AND STILL 2364 01:23:16,680 --> 01:23:20,920 ARE AT ABOUT A 20-25% DECREASE 2365 01:23:20,920 --> 01:23:23,200 IN OVERALL CLINICAL TRIAL 2366 01:23:23,200 --> 01:23:25,360 ACCRUAL FOR THIS ENTIRE LAST 3 2367 01:23:25,360 --> 01:23:25,560 YEARS. 2368 01:23:25,560 --> 01:23:28,920 THE NEXT SLIDE WILL SHOW YOU 2369 01:23:28,920 --> 01:23:29,880 EVEN MORE DETAIL ABOUT EXACTLY 2370 01:23:29,880 --> 01:23:31,480 WHERE THE ISSUE IS. 2371 01:23:31,480 --> 01:23:33,800 SO CAN YOU SEE 2019 WITH ACCRUAL 2372 01:23:33,800 --> 01:23:37,200 IN THE RANGE OF ABOUT 50,000 2373 01:23:37,200 --> 01:23:39,040 PATIENTS A YEAR TO TREATMENT 2374 01:23:39,040 --> 01:23:41,120 TRIALS NOW AT NCI DESIGNATED 2375 01:23:41,120 --> 01:23:42,200 CANCER CENTERS, BUT WHAT I WOULD 2376 01:23:42,200 --> 01:23:43,960 LIKE TO POINT OUT IS THAT NOT 2377 01:23:43,960 --> 01:23:45,960 WHAT YOU ALL KNOW THERE WAS THIS 2378 01:23:45,960 --> 01:23:47,320 ENORMOUS DECREASE IN ACCRUAL IN 2379 01:23:47,320 --> 01:23:47,640 2020. 2380 01:23:47,640 --> 01:23:50,520 BUT LAWEDDER DALE'S HAPPENED IN 2381 01:23:50,520 --> 01:23:51,160 2021 AND 2022? 2382 01:23:51,160 --> 01:23:53,120 AND I THINK THAT THE FIRST THING 2383 01:23:53,120 --> 01:23:54,240 THAT'S PRETTY CLEAR IS THAT IF 2384 01:23:54,240 --> 01:23:58,440 YOU LOOK AT THE BOTTOM, IN BLUE, 2385 01:23:58,440 --> 01:24:00,920 HAPPILY OUR ACCRUAL TO THE NCTN 2386 01:24:00,920 --> 01:24:02,560 TRIALS HAS REMAINED STUDY AND 2387 01:24:02,560 --> 01:24:03,840 THAT'S A GREAT TRIBUTE TO THE 2388 01:24:03,840 --> 01:24:14,200 MEMBERS OF ALL OF OUR CLINICAL 2389 01:24:14,200 --> 01:24:14,840 TRIAL GROUPS. 2390 01:24:14,840 --> 01:24:16,600 WHAT YOU CAN TELL IN THE ACCRUAL 2391 01:24:16,600 --> 01:24:19,080 IN 2020 THAT HAS REBOUNDED AS 2392 01:24:19,080 --> 01:24:19,640 WELL. 2393 01:24:19,640 --> 01:24:22,520 BUT WHAT HAS NOT HAPPENED AS I 2394 01:24:22,520 --> 01:24:24,640 POINTED OUT IN THE MONTH TO 2395 01:24:24,640 --> 01:24:25,800 MONTH REVIEW IS THAT HERE YOU 2396 01:24:25,800 --> 01:24:27,880 CAN ACTUALLY SEE THE NUMBERS IN 2397 01:24:27,880 --> 01:24:29,760 LIGHT BLUE, KIND OF A TEAL 2398 01:24:29,760 --> 01:24:35,760 COLOR, THERE'S BEEN A 4-5000 2399 01:24:35,760 --> 01:24:37,400 PATIENT DECKRAMENT AT CANCER 2400 01:24:37,400 --> 01:24:39,040 CENTERS TO ACCRUAL INVESTIGATOR 2401 01:24:39,040 --> 01:24:40,000 INITIATED TRIALS. 2402 01:24:40,000 --> 01:24:41,840 THESE ARE THE TRIALS THAT ALL OF 2403 01:24:41,840 --> 01:24:42,800 OUR INVESTIGATORS RELY UPON TO 2404 01:24:42,800 --> 01:24:45,200 BRING IN NEW IDEAS AND GET 2405 01:24:45,200 --> 01:24:46,960 TENURE AND THIS HAS NOT 2406 01:24:46,960 --> 01:24:47,240 REBOUNDED. 2407 01:24:47,240 --> 01:24:49,640 AND THE SAME IS TRUE FOR 2408 01:24:49,640 --> 01:24:51,480 EXTERNAL PEER REVIEW TRIALS, 2409 01:24:51,480 --> 01:24:52,880 TRIALS FUNDED BY GRANTS. 2410 01:24:52,880 --> 01:24:55,000 THERE'S ABOUT A 20-30% DECREASE 2411 01:24:55,000 --> 01:24:57,160 THAT HAS NOT REBOUNDED IF YOU 2412 01:24:57,160 --> 01:25:00,600 TAKE UP TO THE FULL CALENT ARD 2413 01:25:00,600 --> 01:25:02,640 2022, THIS IS PERHAPS A MAJOR, 2414 01:25:02,640 --> 01:25:04,080 MAJOR IMPACT ON WHAT'S AVAILABLE 2415 01:25:04,080 --> 01:25:08,320 TO OUR PATIENTS. 2416 01:25:08,320 --> 01:25:11,120 NEXT SLIDE. 2417 01:25:11,120 --> 01:25:12,600 WE BASICALLY THOUGHT AND HEARD 2418 01:25:12,600 --> 01:25:13,680 FROM SO MANY PEOPLE THAT A LOT 2419 01:25:13,680 --> 01:25:15,120 OF THIS WAS DUE TO WORKFORCE 2420 01:25:15,120 --> 01:25:16,560 ISSUES THAT WE CONDUCTED A 2421 01:25:16,560 --> 01:25:18,520 SURVEY OF THE NCI DESIGNATED 2422 01:25:18,520 --> 01:25:20,040 CANCER CENTERS TO FIND OUT 2423 01:25:20,040 --> 01:25:21,360 REALLY WHAT WERE SOME OF THE 2424 01:25:21,360 --> 01:25:24,320 DETAILS ABOUT THE WORKFORCE 2425 01:25:24,320 --> 01:25:26,280 ISSUES THAT AT LEAST IN PART, 2426 01:25:26,280 --> 01:25:28,600 PERHAPS IN MAJOR PART WERE 2427 01:25:28,600 --> 01:25:30,440 RELATED TO THE DECK RAMENT AND 2428 01:25:30,440 --> 01:25:30,840 FILE ACCRUAL. 2429 01:25:30,840 --> 01:25:33,840 AND I THINK IT'S A TESTAMENT 2430 01:25:33,840 --> 01:25:35,280 THAT WE HAVE A HUNDRED PERCENT 2431 01:25:35,280 --> 01:25:36,680 RESPONSE RATE FOR ALL OF THE 2432 01:25:36,680 --> 01:25:39,440 CANCER CENTERS TO THESE 2433 01:25:39,440 --> 01:25:39,720 QUESTIONS. 2434 01:25:39,720 --> 01:25:40,240 NEXT SLIDE. 2435 01:25:40,240 --> 01:25:42,080 SO AGAIN, PROBABLY NOT A 2436 01:25:42,080 --> 01:25:44,400 SURPRISE TO ANYBODY WHO'S 2437 01:25:44,400 --> 01:25:46,320 INVOLVED IN THIS ON THE 2438 01:25:46,320 --> 01:25:47,720 DAY-TO-DAY BUT IF YOU FOCUS ON 2439 01:25:47,720 --> 01:25:49,400 WHAT IS IN DARK BLUE AND IN 2440 01:25:49,400 --> 01:25:50,440 ORANGE, WHAT YOU SEE VERY 2441 01:25:50,440 --> 01:25:53,560 CLEARLY IS THAT THE MAJOR ISSUES 2442 01:25:53,560 --> 01:25:55,520 THAT AFFECTED CLINICAL TRIAL 2443 01:25:55,520 --> 01:25:59,480 CAPACITY, ARE THE LACK OF STAFF. 2444 01:25:59,480 --> 01:26:00,960 SO THIS AFFECTED NOT ONLY THE 2445 01:26:00,960 --> 01:26:03,520 NUMBER OF TRIALS THAT COULD BE 2446 01:26:03,520 --> 01:26:05,680 OPENED, BUT ALSO IF YOU SEE ON 2447 01:26:05,680 --> 01:26:07,640 THE FAR RIGHT OF THE SLIDE, AND 2448 01:26:07,640 --> 01:26:10,000 LIMIT THE ABILITY OF OUR 2449 01:26:10,000 --> 01:26:11,960 RESEARCH STAFF TO ACCRUE 2450 01:26:11,960 --> 01:26:12,240 PATIENTS. 2451 01:26:12,240 --> 01:26:14,360 ACTUALLY MANY TRIALS WERE PUT ON 2452 01:26:14,360 --> 01:26:15,000 HOLD. 2453 01:26:15,000 --> 01:26:18,720 SO THE ISSUE IS NOT SO MUCH, 2454 01:26:18,720 --> 01:26:19,640 WHERE PATIENTS NOT AVAILABLE FOR 2455 01:26:19,640 --> 01:26:22,040 TRIAL BUT WE SIMPLY DIDN'T HAVE 2456 01:26:22,040 --> 01:26:24,880 THE WORKFORCE TO ANNUL THOSE 2457 01:26:24,880 --> 01:26:26,280 PATIENTS OR STUDIES AND THERE 2458 01:26:26,280 --> 01:26:28,200 WERE MANY OTHER ISSUES IN 2459 01:26:28,200 --> 01:26:29,600 HEALTHCARE FACILITIES THAT 2460 01:26:29,600 --> 01:26:30,760 ADVERSELY EFFECTED OUR ABILITY 2461 01:26:30,760 --> 01:26:33,040 TO CONDUCT OUR CLINICAL 2462 01:26:33,040 --> 01:26:33,400 INVESTIGATIONS. 2463 01:26:33,400 --> 01:26:34,880 NEXT SLIDE. 2464 01:26:34,880 --> 01:26:36,840 IF YOU LOOK AT REALLY WHY WAS 2465 01:26:36,840 --> 01:26:38,640 THERE THIS STAFF ATTRITION? 2466 01:26:38,640 --> 01:26:41,200 WELL, AGAIN, PROBABLY NOT A 2467 01:26:41,200 --> 01:26:43,080 SURPRISE TO ANYBODY WHO'S 2468 01:26:43,080 --> 01:26:45,360 INVOLVED IN THIS BUT WHAT YOU 2469 01:26:45,360 --> 01:26:48,960 CAN SEE IS THAT MANY, MANY OF 2470 01:26:48,960 --> 01:26:51,600 OUR CLINICAL RESEARCH STAFF HAD 2471 01:26:51,600 --> 01:26:54,520 THE ABILITY TO FIND OTHER WORK 2472 01:26:54,520 --> 01:26:56,400 AT HIGHER PAY AND THEY ALSO HAD 2473 01:26:56,400 --> 01:26:58,360 THE ABILITY TO FIND OTHER TYPES 2474 01:26:58,360 --> 01:27:01,200 OF WORK THAT ALLOW THEM TO WORK 2475 01:27:01,200 --> 01:27:01,440 REMOTELY. 2476 01:27:01,440 --> 01:27:04,120 AND ON TOP OF THAT, THERE WAS A 2477 01:27:04,120 --> 01:27:07,560 SIGNIFICANT AMOUNT OF BURN OUT 2478 01:27:07,560 --> 01:27:08,680 IN TERMS OF THE--REALLY THE LACK 2479 01:27:08,680 --> 01:27:10,920 OF STAFFING AND THE DIFFICULTY 2480 01:27:10,920 --> 01:27:14,280 IN CONDUCTING THEIR JOBS, 2481 01:27:14,280 --> 01:27:14,720 DAY-TO-DAY. 2482 01:27:14,720 --> 01:27:15,080 NEXT SLIDE. 2483 01:27:15,080 --> 01:27:16,440 FINALLY, IF YOU LOOK WHAT 2484 01:27:16,440 --> 01:27:18,360 HAPPENED, WHAT HAPPENED TO THOSE 2485 01:27:18,360 --> 01:27:21,240 INDIVIDUALS WHO LEFT OUR 2486 01:27:21,240 --> 01:27:22,200 ACADEMIC CANCER CENTERS. 2487 01:27:22,200 --> 01:27:25,680 AGAIN, NOT A SURPRISE THAT 2488 01:27:25,680 --> 01:27:26,680 ROUGHLY, 60% OF THE ATTRITION 2489 01:27:26,680 --> 01:27:29,000 THAT WAS DUE TO RECRUITMENT, 2490 01:27:29,000 --> 01:27:31,080 AWAY FROM ACADEMIC MEDICAL 2491 01:27:31,080 --> 01:27:34,600 CENTERS, INTO PHARMA AND CROs 2492 01:27:34,600 --> 01:27:36,320 AND THERE IS ALSO APPROXIMATELY 2493 01:27:36,320 --> 01:27:39,080 10% OF THE WORKFORCE, ACTUALLY 2494 01:27:39,080 --> 01:27:40,880 LEFT ACTIVE EMPLOYMENT DURING 2495 01:27:40,880 --> 01:27:43,720 THE PANDEMIC. 2496 01:27:43,720 --> 01:27:44,440 NEXT SLIDE. 2497 01:27:44,440 --> 01:27:45,520 WE ALSO HEARD NOT ONLY IN THE 2498 01:27:45,520 --> 01:27:46,560 ANSWER TO THESE QUESTIONS BUT 2499 01:27:46,560 --> 01:27:48,960 OTHER THINGS THAT I THINK ARE 2500 01:27:48,960 --> 01:27:49,720 IMPORTANT IN TERMS OF 2501 01:27:49,720 --> 01:27:50,600 UNDERSTANDING WHAT'S HAPPENED IN 2502 01:27:50,600 --> 01:27:52,080 THE LAST 3 YEARS. 2503 01:27:52,080 --> 01:27:54,840 WE HEARD FROM MANY CENTERS, THAT 2504 01:27:54,840 --> 01:27:57,560 IT WASN'T JUST A LOSS OF JUNIOR 2505 01:27:57,560 --> 01:27:59,640 STAFF BUT BOTH SENIOR AND 2506 01:27:59,640 --> 01:28:01,360 RECENTLY TRAINED STAFF, SO 2507 01:28:01,360 --> 01:28:02,600 EVERYONE LEFT CLINICAL TRIALS 2508 01:28:02,600 --> 01:28:07,680 OFFICES AND THAT MEANT THAT IT 2509 01:28:07,680 --> 01:28:10,680 WAS A POOL OFA QUALIFIED 2510 01:28:10,680 --> 01:28:12,200 CANDIDATES WERE DIFFICULT TO 2511 01:28:12,200 --> 01:28:13,280 FIND AND IN RESPONSE TO THE 2512 01:28:13,280 --> 01:28:14,240 SURVEY, THERE ARE INSTITUTIONS 2513 01:28:14,240 --> 01:28:17,520 AND IT'S MORE THAN 1, THAT LOST 2514 01:28:17,520 --> 01:28:19,640 UPWARDS OF 50% OF THEIR ENTIRE 2515 01:28:19,640 --> 01:28:21,080 STAFFING FOR THE CLINICAL TRIALS 2516 01:28:21,080 --> 01:28:21,440 OFFICE. 2517 01:28:21,440 --> 01:28:23,760 SO THIS REALLY MADE THEIR WHOLE 2518 01:28:23,760 --> 01:28:26,000 CLINICAL TRIALS OPERATION VERY 2519 01:28:26,000 --> 01:28:28,200 DIFFICULT TO SUSTAIN; NOT ONLY 2520 01:28:28,200 --> 01:28:29,480 FROM A WORKFORCE PERSPECTIVE BUT 2521 01:28:29,480 --> 01:28:30,440 ALSO THESE ARE IMPORTANT INCOME 2522 01:28:30,440 --> 01:28:32,280 STREAMS THAT ARE NECESSARY TO 2523 01:28:32,280 --> 01:28:33,080 SUPPORT THESE ACTIVITIES ACROSS 2524 01:28:33,080 --> 01:28:34,800 THE BOARD THAT HAVE MADE IT 2525 01:28:34,800 --> 01:28:38,360 DIFFICULT FOR MANY, MANY OF OUR 2526 01:28:38,360 --> 01:28:40,040 CANCER CENTERS TO CONDUCT THEIR 2527 01:28:40,040 --> 01:28:41,000 CLINICAL RESEARCH PROGRAMS. 2528 01:28:41,000 --> 01:28:42,200 NEXT SLIDE. 2529 01:28:42,200 --> 01:28:45,960 SO DURING THIS WHOLE PANDEMIC 2530 01:28:45,960 --> 01:28:48,880 THAT REALLY BROUGHT US REALLY 2531 01:28:48,880 --> 01:28:51,360 HAD THIS ADVERSE EFFECT ON OUR 2532 01:28:51,360 --> 01:28:52,840 CLINICAL TRIALS OPERATIONS, THE 2533 01:28:52,840 --> 01:28:55,520 NCIA CLINICAL TRIALS AND 2534 01:28:55,520 --> 01:28:56,880 RESEARCH ADVISORY COMMITTEE 2535 01:28:56,880 --> 01:28:59,200 BEGAN AS THE PANDEMIC BEGAN TO 2536 01:28:59,200 --> 01:29:00,800 WORK ON A NEW STRATEGIC VISION 2537 01:29:00,800 --> 01:29:03,240 AND I CAN TELL YOU THAT THAT 2538 01:29:03,240 --> 01:29:06,080 EFFORT OVER 2020 REALLY HAS 2539 01:29:06,080 --> 01:29:07,760 RESULTED IN MANY IMPORTANT 2540 01:29:07,760 --> 01:29:10,800 RECOMMENDATIONS THAT AND ALL OF 2541 01:29:10,800 --> 01:29:12,840 THOSE RECOMMENDATIONS HAVE BEEN 2542 01:29:12,840 --> 01:29:14,160 TEMPERED BY WHAT WE'VE ALL 2543 01:29:14,160 --> 01:29:16,240 EXPERIENCED DURING THE PANDEMIC. 2544 01:29:16,240 --> 01:29:16,520 NEXT SLIDE? 2545 01:29:16,520 --> 01:29:19,480 SO HERE ARE THE MAJOR THEMES, 2546 01:29:19,480 --> 01:29:21,480 AGAIN, NO SURPRISE, BUT WE 2547 01:29:21,480 --> 01:29:22,840 LITERALLY WANT TO REASSESS IN 2548 01:29:22,840 --> 01:29:23,840 THE CONTEXT OF WHAT'S HAPPENED 2549 01:29:23,840 --> 01:29:26,680 OVER THE LAST COUPLE YEARS HOW 2550 01:29:26,680 --> 01:29:29,120 WE COULD REDUCE TRIAL COMPLEXITY 2551 01:29:29,120 --> 01:29:29,440 AND COST. 2552 01:29:29,440 --> 01:29:33,040 HOW WE CAN DO THINGS BETTER FROM 2553 01:29:33,040 --> 01:29:33,760 A DECENTRALIZED PERSPECTIVE. 2554 01:29:33,760 --> 01:29:36,280 HOW WE COULD PROMOTE ACCRUAL. 2555 01:29:36,280 --> 01:29:37,800 HOW WE COULD APPROACH DATA 2556 01:29:37,800 --> 01:29:39,280 COLLECTION DIFFERENTLY. 2557 01:29:39,280 --> 01:29:41,000 WHAT ARE WERE THE OPERATIONAL 2558 01:29:41,000 --> 01:29:42,800 BURDENS TO BE DEALT WITH AND 2559 01:29:42,800 --> 01:29:44,240 REALLY HOW DO WE DEAL WITH THE 2560 01:29:44,240 --> 01:29:45,760 WORKFORCE ISSUES AND TRAINING 2561 01:29:45,760 --> 01:29:47,360 ISSUES THAT HAVE LED TO MANY OF 2562 01:29:47,360 --> 01:29:57,640 THESE PROBLEMS. 2563 01:29:57,640 --> 01:29:58,200 NEXT SLIDE. 2564 01:29:58,200 --> 01:30:00,640 SO IF I TAKE THE ENTIRE 2565 01:30:00,640 --> 01:30:01,320 RECOMMENDATION, IT'S ONLINE AND 2566 01:30:01,320 --> 01:30:02,520 HAPPY TO GET YOU A COPY. 2567 01:30:02,520 --> 01:30:03,760 THE IDEA FROM THIS REPORT IS 2568 01:30:03,760 --> 01:30:05,600 THAT WE HAD A GREAT NEED AT THE 2569 01:30:05,600 --> 01:30:10,080 NKRIRKS I TO DEVELOP FLEXIBLE 2570 01:30:10,080 --> 01:30:11,880 FASTER SIMPLER LESS EXPENSIVE 2571 01:30:11,880 --> 01:30:13,200 HIGH IMPACT TRIALS THAT 2572 01:30:13,200 --> 01:30:13,880 INTEGRATE WITH CLINICAL PRACTICE 2573 01:30:13,880 --> 01:30:16,880 AND TO DO THAT WE NEED TO 2574 01:30:16,880 --> 01:30:18,880 STREAMLINE OUR CLINICAL TRIAL 2575 01:30:18,880 --> 01:30:20,640 DESIGN PROCESSES, AND ESSENTIAL 2576 01:30:20,640 --> 01:30:23,200 POINTS AND DECREASE REGULATORY 2577 01:30:23,200 --> 01:30:24,280 HURDLES AND INCREASE EFFICIENCY 2578 01:30:24,280 --> 01:30:25,400 OF DATA COLLECTION. 2579 01:30:25,400 --> 01:30:25,680 NEXT SLIDE. 2580 01:30:25,680 --> 01:30:29,200 SO I'M GOING TO FOCUS REALLY 2581 01:30:29,200 --> 01:30:31,320 ONLY ON 1 MODEST--IT'S VERY 2582 01:30:31,320 --> 01:30:32,840 IMPORTANT BUT IT'S ONLY A PART 2583 01:30:32,840 --> 01:30:34,920 OF THE SERIES OF RECOMMENDATIONS 2584 01:30:34,920 --> 01:30:36,400 THAT ARE STRATEGIC PLANNING 2585 01:30:36,400 --> 01:30:37,560 GROUP BROUGHT FORWARD AND I'M 2586 01:30:37,560 --> 01:30:38,760 GOING TO FOCUS ON A COUPLE 2587 01:30:38,760 --> 01:30:40,960 THINGS THAT WE'RE DOING IN THE 2588 01:30:40,960 --> 01:30:41,760 AREA OF STREAMLINING CLINICAL 2589 01:30:41,760 --> 01:30:45,000 TRIALS AND I THINK WILL BE OF 2590 01:30:45,000 --> 01:30:45,240 INTEREST. 2591 01:30:45,240 --> 01:30:48,360 WE HAD A WONDERFUL WORKING GROUP 2592 01:30:48,360 --> 01:30:50,960 THAT ADDRESSED THE ISSUE OF HOW 2593 01:30:50,960 --> 01:30:52,840 DO WE STREAMLINE OUR TRIALS AND 2594 01:30:52,840 --> 01:30:54,520 WACAN WE DO NOW. 2595 01:30:54,520 --> 01:30:56,680 AND THIS EXPERT GROUP ANALYZED A 2596 01:30:56,680 --> 01:31:00,400 LARGE NUMBER OF RECENT NCTN 2597 01:31:00,400 --> 01:31:03,840 PHASE 3 TRIALS. 2598 01:31:03,840 --> 01:31:05,280 TRY TO UNDERSTAND WHAT DATA ARE 2599 01:31:05,280 --> 01:31:07,320 WE COLLECTING AND WHAT DATA DO 2600 01:31:07,320 --> 01:31:08,400 WE NODE NEED TO COLLECT AND I 2601 01:31:08,400 --> 01:31:10,080 WILL GO INTO THAT IN A MINUTE. 2602 01:31:10,080 --> 01:31:11,720 WE ALSO HAD A GROUP THAT TRIED 2603 01:31:11,720 --> 01:31:14,600 TO LOOK AT THE ISSUE OF THERE 2604 01:31:14,600 --> 01:31:17,600 ARE 2 ENORMOUS ISSUES RELATED TO 2605 01:31:17,600 --> 01:31:18,800 ELECTRONIC HEALTH RECORDS, 2606 01:31:18,800 --> 01:31:19,600 DR. BURREDON TALKED ABOUT 1 2607 01:31:19,600 --> 01:31:20,680 EARLIER, I WILL TALK ABOUT THE 2608 01:31:20,680 --> 01:31:22,880 ISSUE THAT IT GETS LESS IF YOU 2609 01:31:22,880 --> 01:31:25,000 WILL PLAY AND THAT IS, WE TRY TO 2610 01:31:25,000 --> 01:31:28,440 GET DATA OUT OF ELECTRONIC 2611 01:31:28,440 --> 01:31:29,760 HEALTH RECORDS FOR OUR GET THEM 2612 01:31:29,760 --> 01:31:31,480 OUT OF CLINICAL TRIALS TO GET 2613 01:31:31,480 --> 01:31:32,680 THEM IN CASE REPORTS. 2614 01:31:32,680 --> 01:31:34,520 BUT WE ALSO HAVE TO GET THEM 2615 01:31:34,520 --> 01:31:35,480 INTO ELECTRONIC HEGHT DATA 2616 01:31:35,480 --> 01:31:36,800 RECORDS IN TERMS OF TREATMENT 2617 01:31:36,800 --> 01:31:40,480 PLANS FOR THE STUDIES AND WHAT 2618 01:31:40,480 --> 01:31:41,960 DOES THAT INVOLVE? 2619 01:31:41,960 --> 01:31:43,480 AND WHAT IS INVOLVED WITH IT AND 2620 01:31:43,480 --> 01:31:46,760 HOW DO WE MAKE THAT ACTIVITY 2621 01:31:46,760 --> 01:31:47,400 THAT MUCH MORE STREAMLINED. 2622 01:31:47,400 --> 01:31:49,680 NEXT SLIDE. 2623 01:31:49,680 --> 01:31:51,120 SO WHAT ABOUT THE VALUE OF ALL 2624 01:31:51,120 --> 01:31:54,200 THE DATA WE COLLECT? 2625 01:31:54,200 --> 01:31:54,760 NEXT SLIDE. 2626 01:31:54,760 --> 01:31:56,720 WELL, I CAN TELL THAT YOU IN MY 2627 01:31:56,720 --> 01:31:58,200 CAREER, IT'S BEEN A RELATIVELY 2628 01:31:58,200 --> 01:32:00,080 LONG CAREER IN DOING CLINICAL 2629 01:32:00,080 --> 01:32:01,560 TRIALS. 2630 01:32:01,560 --> 01:32:03,000 I DON'T EVER RECOLLECT AN 2631 01:32:03,000 --> 01:32:05,280 INCREMENT OF TIME WHEN WE 2632 01:32:05,280 --> 01:32:06,280 DECIDED TO COLLECT LESS DAILY 2633 01:32:06,280 --> 01:32:07,560 BASIS THEA. 2634 01:32:07,560 --> 01:32:10,200 IT'S ALWAYS MORE DATA AND EVERY 2635 01:32:10,200 --> 01:32:12,200 ITEM, EVERY PIECE OF DATA THAT 2636 01:32:12,200 --> 01:32:15,800 YOU COLLECT COSTS MONEY. 2637 01:32:15,800 --> 01:32:17,680 AND SO, WE WANTED TO THINK ABOUT 2638 01:32:17,680 --> 01:32:18,680 AND TAKE AN APPROACH THAT WILL 2639 01:32:18,680 --> 01:32:20,840 ALLOW US TO MAKE RECOMMENDATIONS 2640 01:32:20,840 --> 01:32:25,160 THAT WERE IMMEDIATELY APPLICABLE 2641 01:32:25,160 --> 01:32:25,880 TO BASICALLY CHANGING. 2642 01:32:25,880 --> 01:32:32,160 AND SO WE DECIDED TO LOOK AT 2643 01:32:32,160 --> 01:32:33,560 NCI, CTEP SPONSORED TRIALS AND 2644 01:32:33,560 --> 01:32:35,240 LATE PHASE TRIALS THAT WERE 2645 01:32:35,240 --> 01:32:35,920 INTERVENTIONAL, FOCUSED ON 2646 01:32:35,920 --> 01:32:40,080 TREATMENT AND IN ADULTS BUT 2647 01:32:40,080 --> 01:32:41,080 IMPORTANTLY WERE IND-EXEMPT 2648 01:32:41,080 --> 01:32:42,400 TRIALS, TRIALS THAT DID NOT 2649 01:32:42,400 --> 01:32:43,920 INVOLVE THE APPLICATION OF AN 2650 01:32:43,920 --> 01:32:46,600 IND TO THE FDA AND THAT MIGHT BE 2651 01:32:46,600 --> 01:32:48,560 OF NEWS TO YOU THAT IT'S A VERY 2652 01:32:48,560 --> 01:32:52,360 LARGE PERCENTAGE OF THE NCTN 2653 01:32:52,360 --> 01:32:53,600 TRIALS AND ACCRUAL DOES NOT 2654 01:32:53,600 --> 01:32:56,160 INVOLVE THE SUBMISSION OF AN FDA 2655 01:32:56,160 --> 01:32:58,600 IND, AND IT'S SOMETHING THAT WE 2656 01:32:58,600 --> 01:33:00,800 COULD PERHAPS MAKE CHANGES IN, 2657 01:33:00,800 --> 01:33:03,520 MORE QUICKLY, NEXT SLIDE. 2658 01:33:03,520 --> 01:33:05,640 SO THESE ARE THE CATEGORIES THAT 2659 01:33:05,640 --> 01:33:06,720 WE LOOKED AT. 2660 01:33:06,720 --> 01:33:09,000 BASICALLY ALL THE MAJOR EFFORTS 2661 01:33:09,000 --> 01:33:12,000 THAT GO ON TO COLLECT ADVERSE 2662 01:33:12,000 --> 01:33:13,080 EVENTS, ISSUES RELATED TO WHAT 2663 01:33:13,080 --> 01:33:16,960 PARTS OF THE MEDICAL HISTORY ARE 2664 01:33:16,960 --> 01:33:17,640 IMPORTANT, CONCOMITANT 2665 01:33:17,640 --> 01:33:19,280 MEDICATIONS, PARTS OF THE 2666 01:33:19,280 --> 01:33:21,400 PHYSICAL EXAM, LAB RATOORY 2667 01:33:21,400 --> 01:33:23,040 TESTING, IMAGES AND PROCEDURES 2668 01:33:23,040 --> 01:33:25,440 AND PATIENT REPORTED DATA. 2669 01:33:25,440 --> 01:33:27,760 AND AS I SAY, THESE WERE LOOKED 2670 01:33:27,760 --> 01:33:29,960 AT ACROSS A SERIOUS OF CTN 2671 01:33:29,960 --> 01:33:31,000 TRIALS AND WHAT DID WE COLLECT 2672 01:33:31,000 --> 01:33:41,240 AND WHAT COULD WE NOT COLLECT? 2673 01:33:41,240 --> 01:33:41,800 NEXT SLIDE. 2674 01:33:41,800 --> 01:33:44,680 THIS IS JUST A SAMPLING, A LOT 2675 01:33:44,680 --> 01:33:45,960 OF DISCUSSION IN WHAT ARE WE 2676 01:33:45,960 --> 01:33:48,480 DOING IN COLLECTION OF ADVERSE 2677 01:33:48,480 --> 01:33:51,240 EVENTS, WE COLLECT GREAT 1 AND 2 2678 01:33:51,240 --> 01:33:53,440 ADVERSE EVENTS FOR IN THE LATE 2679 01:33:53,440 --> 01:33:54,800 STAGE TRIALS THAT INVOLVE DRUGS 2680 01:33:54,800 --> 01:33:57,480 THAT HAVE BEEN AROUND FOR YEARS, 2681 01:33:57,480 --> 01:33:59,480 WHERE THE TOXICITY PROFILES ARE 2682 01:33:59,480 --> 01:34:02,760 EXTREMELY WELL KNOWN, FOR NO 2683 01:34:02,760 --> 01:34:05,280 APPARENT PURPOSE. 2684 01:34:05,280 --> 01:34:08,120 EVEN WORSE, WE INFLECT THE 2685 01:34:08,120 --> 01:34:09,360 REQUIREMENT FOR THE ATTRIBUTION 2686 01:34:09,360 --> 01:34:10,680 OF THOSE ADVERSE EVENTS AND WHEN 2687 01:34:10,680 --> 01:34:13,240 THEY START AND WHEN THEY STOP 2688 01:34:13,240 --> 01:34:16,440 WITHOUT EVER ROUTINELY USING 2689 01:34:16,440 --> 01:34:17,480 THAT DATA IN RECORDING THE 2690 01:34:17,480 --> 01:34:22,880 OUTCOME EVER THESE TRIALS. 2691 01:34:22,880 --> 01:34:24,840 ESPECIALLY IF THIS IS 2692 01:34:24,840 --> 01:34:27,240 PROBLEMATIC FOR A SPECIFIC 2693 01:34:27,240 --> 01:34:28,400 TOXICITY TRIAL FOR A DRUG OR 2694 01:34:28,400 --> 01:34:29,520 TREATMENT IS WELL CHARACTER IDZ 2695 01:34:29,520 --> 01:34:31,360 FOR A GIVEN POPULATION. 2696 01:34:31,360 --> 01:34:33,320 PERHAPS EVEN WORSE, WE COLLECT 2697 01:34:33,320 --> 01:34:34,480 LABORATORY DATA BEYOND THE 2698 01:34:34,480 --> 01:34:36,680 STANDARD OF CARE THAT MAY BE 2699 01:34:36,680 --> 01:34:38,320 UNRELATED TO THE END POINTS OF 2700 01:34:38,320 --> 01:34:40,640 THE STUDY OR SAFETY MONITORING 2701 01:34:40,640 --> 01:34:44,440 AND IS FREQUENTLY UNFORTUNATELY 2702 01:34:44,440 --> 01:34:46,480 VERY UNFREQUENTLY UNUSED BUT YET 2703 01:34:46,480 --> 01:34:48,600 THAT DATA IS COLLECTED, PUT INTO 2704 01:34:48,600 --> 01:34:50,160 ELECTRONIC CASE REPORT FORMS AND 2705 01:34:50,160 --> 01:34:51,080 TAKES TIME. 2706 01:34:51,080 --> 01:34:52,240 WE COLLECT IMAGES DATA THAT 2707 01:34:52,240 --> 01:34:54,240 DOESN'T GET USED OR WE ASK FOR 2708 01:34:54,240 --> 01:34:57,320 DATA FOR IMAGING TO BE DONE 2709 01:34:57,320 --> 01:34:58,600 PERHAPS BEYOND THE STANDARD OF 2710 01:34:58,600 --> 01:35:00,880 CARE THAT MAY OR MAY NOT AFFECT 2711 01:35:00,880 --> 01:35:02,720 THE END POINT OF A LATE STAGE 2712 01:35:02,720 --> 01:35:05,920 CLINICAL TRIAL. 2713 01:35:05,920 --> 01:35:06,960 NEXT SLIDE. 2714 01:35:06,960 --> 01:35:09,160 HISTORY AND PHYSICAL 2715 01:35:09,160 --> 01:35:09,720 EXAMINATIONS ARE IMPORTANT. 2716 01:35:09,720 --> 01:35:11,000 HOW MUCH OF THAT INFORMATION IS 2717 01:35:11,000 --> 01:35:13,080 ACTUALLY IMPORTANT TO THE 2718 01:35:13,080 --> 01:35:17,040 CLINICAL TRIAL IS ABSOLUTELY 2719 01:35:17,040 --> 01:35:18,200 UNCLEAR. 2720 01:35:18,200 --> 01:35:19,200 WE ASK FOR CONCOMITANT 2721 01:35:19,200 --> 01:35:20,440 MEDICATIONS THAT ARE UNRELATED 2722 01:35:20,440 --> 01:35:22,640 TO THE OUTCOME OF THE TRIAL. 2723 01:35:22,640 --> 01:35:25,600 THE START DATES, THE STOP DATES 2724 01:35:25,600 --> 01:35:27,040 OF THESE CONCOMITANT 2725 01:35:27,040 --> 01:35:27,680 MEDICATIONS, PARTS OF HISTORY 2726 01:35:27,680 --> 01:35:29,600 THAT ARE NOT NECESSARY, VITAL 2727 01:35:29,600 --> 01:35:30,920 SIGNS THAT ARE TICKEN THAT ARE 2728 01:35:30,920 --> 01:35:31,960 NOT NECESSARY. 2729 01:35:31,960 --> 01:35:33,160 IT'S REALLY EXTRAORDINARY HOW 2730 01:35:33,160 --> 01:35:35,240 MUCH INFORMATION THAT WE COLLECT 2731 01:35:35,240 --> 01:35:36,280 THAT UNFORTUNATELY WHEN THE 2732 01:35:36,280 --> 01:35:38,760 TRIALS GET WRITTEN UP AND 2733 01:35:38,760 --> 01:35:39,960 REPORTED HAVE NO EFFECT ON 2734 01:35:39,960 --> 01:35:41,920 OUTCOME AND ARE REALLY UNUSED 2735 01:35:41,920 --> 01:35:44,080 AND UNNECESSARY. 2736 01:35:44,080 --> 01:35:44,400 NEXT SLIDE. 2737 01:35:44,400 --> 01:35:47,520 SO THE GOALS OF THIS ACTIVITY, 2738 01:35:47,520 --> 01:35:48,800 WE'VE IDENTIFIED MANY OF THESE 2739 01:35:48,800 --> 01:35:52,840 AREAS AND NOW, WE ARE BASICALLY 2740 01:35:52,840 --> 01:35:55,040 BRINGING TOGETHER A GROUP FROM 2741 01:35:55,040 --> 01:35:58,360 THE NCTN GROUPS AND OTHER 2742 01:35:58,360 --> 01:35:58,800 EXPERIENCE CLINICAL 2743 01:35:58,800 --> 01:36:01,280 INVESTIGATORS TO HELP US 2744 01:36:01,280 --> 01:36:02,280 OPERATIONALIZE STANDARDS OF 2745 01:36:02,280 --> 01:36:05,080 PRACTICE THAT WILL IN THE 2746 01:36:05,080 --> 01:36:08,480 CONTEXT OF IND-EXEMPT TRIALS 2747 01:36:08,480 --> 01:36:10,560 ALLOW US TO REDUCE OPERATIONAL 2748 01:36:10,560 --> 01:36:12,560 BURDEN OF THESE CLINICAL TRIALS 2749 01:36:12,560 --> 01:36:13,880 ACTUALLY MAKING IT STANDARD OF 2750 01:36:13,880 --> 01:36:15,160 PRACTICE NOT TO COLLECT A LOT OF 2751 01:36:15,160 --> 01:36:17,280 THIS DATA AND WE THINK THAT THIS 2752 01:36:17,280 --> 01:36:19,120 PROCESS WHICH I'M QUITE SURE 2753 01:36:19,120 --> 01:36:20,840 WILL BE SUCCESSFUL WILL PROVIDE 2754 01:36:20,840 --> 01:36:21,600 IMPORTANT INVITES THAT WILL 2755 01:36:21,600 --> 01:36:23,560 ALLOW US TO GO THROUGH THE SAME 2756 01:36:23,560 --> 01:36:25,320 PROCESS, TO SEE WHAT WE CAN DO 2757 01:36:25,320 --> 01:36:27,400 IN TERMS OF DECREASING THE DATA 2758 01:36:27,400 --> 01:36:31,200 THAT NEED TO BE COLLECTED FOR 2759 01:36:31,200 --> 01:36:33,520 LATE PHASE IND-SPECIFIC TRIAL 2760 01:36:33,520 --> 01:36:36,080 PEDIATRIC TRIALS BUT THIS ALL 2761 01:36:36,080 --> 01:36:37,200 REQUIRES BROAD STAKEHOLDER 2762 01:36:37,200 --> 01:36:38,880 ENGAGEMENT WHICH WE ARE INVOLVED 2763 01:36:38,880 --> 01:36:41,160 IN AT THE PRESENT TIME. 2764 01:36:41,160 --> 01:36:44,760 NEXT SLIDE. 2765 01:36:44,760 --> 01:36:46,240 >>AS DR. BURREDON POINTED OUT, 2766 01:36:46,240 --> 01:36:49,160 I WOULD LIKE TO MAKE A FEW 2767 01:36:49,160 --> 01:36:50,400 POINTS ABOUT PRAGMATICCA, YOU 2768 01:36:50,400 --> 01:36:51,480 MAY THINK EVERYTHING I SAID 2769 01:36:51,480 --> 01:36:52,440 WELL, THAT SOUNDS GOOD BUT ARE 2770 01:36:52,440 --> 01:36:54,880 THEY GOING TO DO ANY OF THIS? 2771 01:36:54,880 --> 01:36:56,400 WILL IT HAVE IMPACT IN MY 2772 01:36:56,400 --> 01:36:56,800 CENTER? 2773 01:36:56,800 --> 01:36:59,640 WELL THIS SHOWS YOU THAT THIS 2774 01:36:59,640 --> 01:37:01,120 TRIAL WHICH IS THE OUTGROWTH 2775 01:37:01,120 --> 01:37:03,280 FROM A LUNG MAP, RANDOMIZED 2776 01:37:03,280 --> 01:37:05,960 PHASE 2 TRIAL WITH 136 PATIENTS, 2777 01:37:05,960 --> 01:37:08,280 THAT SHOWED AN OVERALL SURVIVAL 2778 01:37:08,280 --> 01:37:09,880 ADVANTAGE OR GIVING THE 2779 01:37:09,880 --> 01:37:11,520 COMBINATION OF THE 2780 01:37:11,520 --> 01:37:12,920 [INDISCERNIBLE] THE PATIENTS 2781 01:37:12,920 --> 01:37:15,440 ALREADY PROGRESSED ON 2782 01:37:15,440 --> 01:37:18,040 IMMUNOTHERAPY, THAT WE COULD--WE 2783 01:37:18,040 --> 01:37:19,720 COULD DEVELOP A TRIAL THAT WILL 2784 01:37:19,720 --> 01:37:21,760 OPEN ALMOST CERTAINLY IN THE 2785 01:37:21,760 --> 01:37:27,000 NEXT 4-6 WEEKS THAT HAS A 2786 01:37:27,000 --> 01:37:27,840 SURVIVAL OUTPUT, SURVIVAL END 2787 01:37:27,840 --> 01:37:29,920 POINT WILL BE DONE WITH THE 2788 01:37:29,920 --> 01:37:31,840 COLLECTION OF ESSENTIALLY NO 2789 01:37:31,840 --> 01:37:33,240 ADVERSE EVENTS EXCEPT 2790 01:37:33,240 --> 01:37:35,160 HOSPITALIZATION, WHICH WILL 2791 01:37:35,160 --> 01:37:37,080 REQUIRE NO STUDY LAB DATA TO BE 2792 01:37:37,080 --> 01:37:38,520 COLLECTED OTHER THAN STANDARD OF 2793 01:37:38,520 --> 01:37:40,880 CARE, IMAGING TO BE PERFORMED 2794 01:37:40,880 --> 01:37:44,520 ORGT THAN STANDARD OF CARE, AND 2795 01:37:44,520 --> 01:37:46,200 WILL INVOLVE EITHER THE 2796 01:37:46,200 --> 01:37:50,120 INVESTIGATION ARMS, ARM OR THE 2797 01:37:50,120 --> 01:37:51,640 [INDISCERNIBLE] CHOICE WILL BE 2798 01:37:51,640 --> 01:38:00,000 POWERED TO HAVE A POOL OF 800 2799 01:38:00,000 --> 01:38:02,440 PATIENTS AND IF THE FDA SAYS 2800 01:38:02,440 --> 01:38:05,320 THERE'S A SIGNIFICANT SURVIVAL 2801 01:38:05,320 --> 01:38:06,680 PERCENTAGE, IT WILL LEAD TO A 2802 01:38:06,680 --> 01:38:08,640 STUDY IN THE PATIENT POPULATION. 2803 01:38:08,640 --> 01:38:11,080 THIS WILL HAVE THE SMALLEST 2804 01:38:11,080 --> 01:38:12,600 STUDY CALENDAR THAT ANY OF THE 2805 01:38:12,600 --> 01:38:14,400 CLINICAL INVESTIGATORS IN THE 2806 01:38:14,400 --> 01:38:16,400 NCAB HAVE EVER SEEN AND I THINK 2807 01:38:16,400 --> 01:38:17,920 IT'S REALLY REMARKABLE, IT'S 2808 01:38:17,920 --> 01:38:19,120 SOMETHING WE CAN DO AND IT'S 2809 01:38:19,120 --> 01:38:20,240 SOMETHING WE CAN TAKE SERIOUSLY 2810 01:38:20,240 --> 01:38:21,640 WITH RESPECT TO ALL THE TRIALS 2811 01:38:21,640 --> 01:38:23,000 SO WE CONDUCT BECAUSE THIS IS 2812 01:38:23,000 --> 01:38:24,960 THE KIND OF TRIAL THAT WILL 2813 01:38:24,960 --> 01:38:28,000 REQUIRE LESS PERSONNEL, IN AN 2814 01:38:28,000 --> 01:38:29,080 ENVIRONMENT WHERE HIRING AND 2815 01:38:29,080 --> 01:38:30,560 TRAINING THE INDIVIDUAL WHO IS 2816 01:38:30,560 --> 01:38:31,560 NEED CLINICAL TRIALS IS BECOMING 2817 01:38:31,560 --> 01:38:34,600 MORE AND MORE DIFFICULT. 2818 01:38:34,600 --> 01:38:35,040 NEXT SLIDE. 2819 01:38:35,040 --> 01:38:37,000 WE NEED TO SAY A WORD TO EACH OF 2820 01:38:37,000 --> 01:38:38,160 OUR STUDY BILLS, NEXT SLIDE, 2821 01:38:38,160 --> 01:38:39,320 BECAUSE AGAIN, THIS MAY BE 2822 01:38:39,320 --> 01:38:40,920 SOMETHING THAT'S SOME OF YOU ARE 2823 01:38:40,920 --> 01:38:43,880 VERY WELL FAMILIAR WITH AND SOME 2824 01:38:43,880 --> 01:38:45,520 PERHAPS NOT. 2825 01:38:45,520 --> 01:38:48,040 BUT, THE EXTENT OF THE CHALLENGE 2826 01:38:48,040 --> 01:38:49,160 OF ELECTRONIC HEALTH RECORD 2827 01:38:49,160 --> 01:38:52,720 SYSTEM NOT SIMPLY 1 IN WHICH 2828 01:38:52,720 --> 01:38:54,680 THERE WERE EXPENSIVE TO 2829 01:38:54,680 --> 01:38:55,440 SUBSTANTIATE AT INSTITUTIONS BUT 2830 01:38:55,440 --> 01:38:57,600 THE FACT IS THAT FOR EVERY CLIN 2831 01:38:57,600 --> 01:38:59,240 CLINICAL TRIAL AND EVERY ARM OF 2832 01:38:59,240 --> 01:39:00,280 EVERY CLINICAL TRIAL, THERE 2833 01:39:00,280 --> 01:39:02,480 NEEDS TO BE AN EXTENSIVE AMOUNT 2834 01:39:02,480 --> 01:39:05,800 OF WORK DONE TO PUT THESE THE 2835 01:39:05,800 --> 01:39:08,200 DRUG TESTING OR THE DRUG 2836 01:39:08,200 --> 01:39:09,600 ADMINISTRATION AND TESTING 2837 01:39:09,600 --> 01:39:11,440 SCHEDULES INTO THE ELECTRONIC 2838 01:39:11,440 --> 01:39:12,240 HEALTH RECORD. 2839 01:39:12,240 --> 01:39:13,560 THIS MAY SEEM VERY STRAIGHT 2840 01:39:13,560 --> 01:39:15,040 FORWARD, HOW MANY DRUGS COULD 2841 01:39:15,040 --> 01:39:16,360 THERE BE, HOW DIFFICULT COULD 2842 01:39:16,360 --> 01:39:18,640 THIS BE, I'M HERE TO TELL YOU 2843 01:39:18,640 --> 01:39:24,240 THAT THERE ARE OVER 80 DIFFERENT 2844 01:39:24,240 --> 01:39:26,720 POSSIBLE DATA ENTRY PATTERNS FOR 2845 01:39:26,720 --> 01:39:30,000 A SINGLE ADMINISTRATION OF A 2846 01:39:30,000 --> 01:39:32,440 SINGLE DOSE OF SIS PLATNIN. 2847 01:39:32,440 --> 01:39:34,040 AND WHAT THIS MEAN SYSTEM THAT 2848 01:39:34,040 --> 01:39:36,560 IF 1 INSTITUTION GIVES THEIR SIS 2849 01:39:36,560 --> 01:39:37,840 PLATIN IN NORMAL SALINE AND 2850 01:39:37,840 --> 01:39:39,800 ANOTHER DID IT IN HALF NORMAL 2851 01:39:39,800 --> 01:39:42,160 SALINE AND 1 INSTITUTION 2852 01:39:42,160 --> 01:39:44,800 REQUIRES 100 CCs OF FLUID AND 2853 01:39:44,800 --> 01:39:47,760 ANOTHER 500 CCs OF FLUID, 2854 01:39:47,760 --> 01:39:49,480 EVERY SINGLE STUDY ARM FOR EVERY 2855 01:39:49,480 --> 01:39:54,000 SINGLE DRUG NEEDS TO BE MODIFIED 2856 01:39:54,000 --> 01:39:58,120 BASED ON THE INDIVIDUALIZED 2857 01:39:58,120 --> 01:39:59,280 FORMULARYS TREATMENT PRACTICES 2858 01:39:59,280 --> 01:40:02,520 AT EVERY INDIVIDUAL 2859 01:40:02,520 --> 01:40:02,880 ORGANIZATION. 2860 01:40:02,880 --> 01:40:04,160 AND THE PROBLEM WITH THAT IS, 2861 01:40:04,160 --> 01:40:05,600 YOU CAN SAY THERE THAT'S REALLY 2862 01:40:05,600 --> 01:40:07,720 DIFFICULT BUT THE PROTOCOLS 2863 01:40:07,720 --> 01:40:08,560 THEMSELVES, THE PROTOCOLS WE 2864 01:40:08,560 --> 01:40:12,400 WRITE THAT MAY BE 80 OR 100 2865 01:40:12,400 --> 01:40:14,160 PAGES LONG, SELDOM IF EVER 2866 01:40:14,160 --> 01:40:16,800 OUTLINE ALL THOSE DETAILS, WHAT 2867 01:40:16,800 --> 01:40:19,640 KIND OF MEDIC TO BE USED, WELL 2868 01:40:19,640 --> 01:40:20,920 THE PROBLEM IS THAT 2869 01:40:20,920 --> 01:40:22,560 [INDISCERNIBLE] MAY BE STANDARD 2870 01:40:22,560 --> 01:40:26,920 PRACTICE AT JOHNS HOPKINS AND B 2871 01:40:26,920 --> 01:40:29,080 MAY BE STANDARD OF PRACTICE AT 2872 01:40:29,080 --> 01:40:30,520 DANA FARBER AND THE PROTOCOLS 2873 01:40:30,520 --> 01:40:32,040 DON'T TELL YOU WHICH TO USE OR 2874 01:40:32,040 --> 01:40:33,760 NOT USE AND THEY MAY CONFLICT 2875 01:40:33,760 --> 01:40:34,720 WITH THE FORMULAS OF THOSE 2876 01:40:34,720 --> 01:40:36,120 INSTITUTIONS AND THIS IS WHERE 2877 01:40:36,120 --> 01:40:39,280 THIS IS AN ENORMOUS BURDEN THAT 2878 01:40:39,280 --> 01:40:40,760 REQUIRES 20-30 HOURS OF EFFORT 2879 01:40:40,760 --> 01:40:43,600 TO BUILD 1 TREATMENT PLAN FOR 1 2880 01:40:43,600 --> 01:40:45,960 SINGLE STUDY ARM IN THE EPIC EHR 2881 01:40:45,960 --> 01:40:49,960 SYSTEM, IF YOU IMAGINE, 100 NEW 2882 01:40:49,960 --> 01:40:51,720 CTEP PROTOCOLS A YEAR, MANY OF 2883 01:40:51,720 --> 01:40:55,160 THEM HAVE MULTIPLE ARMS, BEING 2884 01:40:55,160 --> 01:40:56,640 STANTIATED AT OVER A THOUSAND 2885 01:40:56,640 --> 01:40:59,640 SITES AND EACH SITE HAS ITS OWN 2886 01:40:59,640 --> 01:41:01,480 INSTANCE OF THEIR OWN EHR, THIS 2887 01:41:01,480 --> 01:41:03,240 IS HUNDREDS OF THOUSANDS OF 2888 01:41:03,240 --> 01:41:06,320 HOURS OF TIME TO DO THIS IN A 2889 01:41:06,320 --> 01:41:09,000 WAY THAT EXPANDS ENORMOUS AMOUNT 2890 01:41:09,000 --> 01:41:10,280 OF RESOURCES EVEN FORPROTOCOLS 2891 01:41:10,280 --> 01:41:13,680 THAT MAY NOT ENROLL A SINGLE 2892 01:41:13,680 --> 01:41:13,920 PATIENT. 2893 01:41:13,920 --> 01:41:14,440 NEXT SLIDE. 2894 01:41:14,440 --> 01:41:17,000 SO ABOUT A YEAR AND HALF AGO, WE 2895 01:41:17,000 --> 01:41:20,000 STARTED A PILOT PROJECT WITH 10 2896 01:41:20,000 --> 01:41:22,320 NCI DESIGNATED CANCER CENTERS, 2 2897 01:41:22,320 --> 01:41:24,080 CONSORTIA THAT HAVE NOW BEEN PUT 2898 01:41:24,080 --> 01:41:25,640 TOGETHER INTO 1. 2899 01:41:25,640 --> 01:41:31,960 TRY TO BUILD A WAY TO 2900 01:41:31,960 --> 01:41:33,800 SYSTEMATIZE THESE DATA AND THESE 2901 01:41:33,800 --> 01:41:34,640 TREATMENT PLANS SO THAT THEY CAN 2902 01:41:34,640 --> 01:41:37,520 BE DONE IN A MODEL SYSTEM THAT 2903 01:41:37,520 --> 01:41:39,200 CAN BE DISSEMINATED ACROSS 2904 01:41:39,200 --> 01:41:39,840 CANCER CENTERS. 2905 01:41:39,840 --> 01:41:40,440 NEXT SLIDE. 2906 01:41:40,440 --> 01:41:43,560 OUR GOAL IS TO DEVELOP 2907 01:41:43,560 --> 01:41:44,440 REPRESENTATIONS AND PROTOCOL 2908 01:41:44,440 --> 01:41:46,920 SPECIFIC THERAPIES AND TO HAVE A 2909 01:41:46,920 --> 01:41:50,720 WAY TO PACKAGE ELECTRONICALLY 2910 01:41:50,720 --> 01:41:52,800 THESE RIERPTS, INFORMING THE 2911 01:41:52,800 --> 01:41:54,600 COMMUNITY DIRECTLY FOR EHRs OR 2912 01:41:54,600 --> 01:41:59,840 AT LEAST FACILITATE THE LOCAL 2913 01:41:59,840 --> 01:42:00,760 CUSTOMIZATION FORT TREATMENT ARM 2914 01:42:00,760 --> 01:42:02,200 AND IN THE END OVER A PERIOD OF 2915 01:42:02,200 --> 01:42:03,480 YEARS TO HAVE A LIBRARY OF 2916 01:42:03,480 --> 01:42:05,120 MODULES THAT CAN BE USED AND 2917 01:42:05,120 --> 01:42:07,880 USED OVER AND OVER AGAIN TO MAKE 2918 01:42:07,880 --> 01:42:09,200 THIS PROCESS SIMPLER, AND MAKE 2919 01:42:09,200 --> 01:42:12,080 IT EASIER TO OPEN TRIALS AND 2920 01:42:12,080 --> 01:42:15,480 INSTITUTIONS ACROSS THE COUNTRY. 2921 01:42:15,480 --> 01:42:15,920 NEXT SLIDE. 2922 01:42:15,920 --> 01:42:17,360 SO I WOULD LIKE TO END PRETTY 2923 01:42:17,360 --> 01:42:20,360 MUCH THE WAY I BEGAN AND THAT IS 2924 01:42:20,360 --> 01:42:23,840 TO THINK ABOUT THIS ENORMOUS 2925 01:42:23,840 --> 01:42:25,360 PROBLEM WITH OUR CLINICAL TRIALS 2926 01:42:25,360 --> 01:42:26,800 WORKFORCE AND SO YES, I THINK WE 2927 01:42:26,800 --> 01:42:29,560 CAN HELP THE PROCESS, AND HELP 2928 01:42:29,560 --> 01:42:33,400 THE ACCRUAL AND THE DATA 2929 01:42:33,400 --> 01:42:35,040 DEVELOPMENT AND REPORTING BY 2930 01:42:35,040 --> 01:42:35,840 STREAMLINING WHAT WE REQUIRE AND 2931 01:42:35,840 --> 01:42:39,400 WE'VE TALKED ABOUT THAT. 2932 01:42:39,400 --> 01:42:42,080 BECAUSE WE HAVE TO HAVE, IF WE 2933 01:42:42,080 --> 01:42:43,680 REPORT FEWER DATA, THEN THE 2934 01:42:43,680 --> 01:42:45,080 STAFFS THAT WE HAVE MIGHT BE 2935 01:42:45,080 --> 01:42:46,800 ABLE TO DO THEIR WORK. 2936 01:42:46,800 --> 01:42:48,680 BUT WE'RE GOING TO HAVE TO THINK 2937 01:42:48,680 --> 01:42:51,080 EVEN MORE ABOUT HOW TO MAKE 2938 01:42:51,080 --> 01:42:53,760 THEIR WORK ACTIVITIES MORE 2939 01:42:53,760 --> 01:42:56,160 FLEXIBLE, HOW TO ALIGN WHAT WE 2940 01:42:56,160 --> 01:42:59,520 REQUIRE WITH THE ABILITY TO 2941 01:42:59,520 --> 01:43:01,600 RETAIN STAFF AND WE'RE RIGHT NOW 2942 01:43:01,600 --> 01:43:02,680 THINKING VERY SERIOUSLY ABOUT 2943 01:43:02,680 --> 01:43:06,240 WAYS THAT THE NCI CAN HELP THIS 2944 01:43:06,240 --> 01:43:07,480 SIGNIFICANT PROBLEM. 2945 01:43:07,480 --> 01:43:08,680 THIS 1 IS UNDER CONSIDERATION, 2946 01:43:08,680 --> 01:43:12,720 IT'S A NEW TRAINING GRANT 2947 01:43:12,720 --> 01:43:14,040 PROGRAM TO TRY TO PRIME THE PUMP 2948 01:43:14,040 --> 01:43:16,680 TO HAVE A LARGER WORKFORCE IN 2949 01:43:16,680 --> 01:43:17,960 THIS AREA, TO BASICALLY SUPPORT 2950 01:43:17,960 --> 01:43:20,720 CANCER CENTERS IN THE TRAINING 2951 01:43:20,720 --> 01:43:23,440 OF INDIVIDUALS, MAYBE FOCUSING 2952 01:43:23,440 --> 01:43:24,120 ON POST BACCALAUREATE INDIVIDUAL 2953 01:43:24,120 --> 01:43:26,680 WHO IS WILL COME INTO THE CRA 2954 01:43:26,680 --> 01:43:29,760 FIELD AND THEY MAY OR MAY NOT 2955 01:43:29,760 --> 01:43:31,160 STAY INDEFINITELY IN INDIVIDUAL 2956 01:43:31,160 --> 01:43:32,120 INSTITUTIONS BUT, I THINK WE 2957 01:43:32,120 --> 01:43:34,600 NEED TO INCREASE THE WORKFORCE 2958 01:43:34,600 --> 01:43:35,800 BECAUSE THE REQUIREMENT IS NOT 2959 01:43:35,800 --> 01:43:37,640 GOING AWAY FOR THESE SKILLED 2960 01:43:37,640 --> 01:43:39,960 INDIVIDUALS AND WE NEED TO DEAL 2961 01:43:39,960 --> 01:43:42,280 WITH THE FACT THAT WE JUST D%N'T 2962 01:43:42,280 --> 01:43:44,400 HAVE THE INDIVIDUALS NECESSARY 2963 01:43:44,400 --> 01:43:46,720 TO FOCUS ON THE TRIALS WE WANT 2964 01:43:46,720 --> 01:43:47,320 TO CONDUCT. 2965 01:43:47,320 --> 01:43:49,320 WE ARE ALSO INITIATING A PILOT 2966 01:43:49,320 --> 01:43:50,960 PROJECT TO SEE ABOUT THE 2967 01:43:50,960 --> 01:43:53,960 FEASIBILITY OF CONDUCTING WHAT I 2968 01:43:53,960 --> 01:43:55,480 CALL A DEVELOPING--VIRTUAL 2969 01:43:55,480 --> 01:43:56,280 CLINICAL TRIALS OFFICE. 2970 01:43:56,280 --> 01:43:58,360 CAN WE PROVIDE THE SERVICES 2971 01:43:58,360 --> 01:44:00,440 NECESSARY, SOME OF THE SERVICES 2972 01:44:00,440 --> 01:44:01,440 TO INDIVIDUALS, INDIVIDUAL 2973 01:44:01,440 --> 01:44:03,840 ORGANIZATIONS THAT REALLY ARE 2974 01:44:03,840 --> 01:44:04,680 TREMENDOUSLY BACK LOGGED TODAY 2975 01:44:04,680 --> 01:44:06,640 BECAUSE OF PROBLEMS WITH 2976 01:44:06,640 --> 01:44:08,160 RECRUITMENT, SO WE CAN HELP THEM 2977 01:44:08,160 --> 01:44:10,120 GET THEIR DATA UP TO DATE, AND 2978 01:44:10,120 --> 01:44:12,040 THE TRIALS CAN BE CONCLUDED AND 2979 01:44:12,040 --> 01:44:17,520 THE OUTCOME FOR OUR PATIENTS 2980 01:44:17,520 --> 01:44:18,560 MADE--MADE APPROPRIATELY, AND 2981 01:44:18,560 --> 01:44:20,520 MUCH MORE RAPIDLY IN A PUBLIC 2982 01:44:20,520 --> 01:44:20,760 VENUE. 2983 01:44:20,760 --> 01:44:22,480 SO I APPRECIATE VERY MUCH THE 2984 01:44:22,480 --> 01:44:23,560 TRANCE TO UPDATE YOU AND I AM 2985 01:44:23,560 --> 01:44:32,000 HAPPY TO TAKE QUESTIONS. 2986 01:44:32,000 --> 01:44:33,360 >>THANKS, JIM. 2987 01:44:33,360 --> 01:44:35,280 FASCINATING WE'RE RUNNING A 2988 01:44:35,280 --> 01:44:39,800 LITTLE CLOSE TO THE HOUR BUT 2989 01:44:39,800 --> 01:44:41,360 IF--ARE THERE ANY QUESTIONS FROM 2990 01:44:41,360 --> 01:44:43,000 THE BOARD, I THINK WE CAN TAKE 1 2991 01:44:43,000 --> 01:44:46,240 IF THERE'S A BURNING QUESTION? 2992 01:44:46,240 --> 01:44:48,960 I GUESS FOR ME 1 QUESTION WOULD 2993 01:44:48,960 --> 01:44:55,320 BE, YOU KNOW I KNOW IT'S A 2994 01:44:55,320 --> 01:44:56,000 RECURRING THEME, RIGHT? 2995 01:44:56,000 --> 01:44:57,560 WE TALK ABOUT REPRESENTATION IN 2996 01:44:57,560 --> 01:45:00,680 CLINICAL TRIALS AND I KNOW A LOT 2997 01:45:00,680 --> 01:45:03,640 OF THAT ACTIVITY HAPPENS UNDER 2998 01:45:03,640 --> 01:45:05,000 NCORP, SO IS NCORP INTERFACING 2999 01:45:05,000 --> 01:45:06,120 WITH THIS AT ALL WHEN YOU TALK 3000 01:45:06,120 --> 01:45:07,080 ABOUT THE WORKING GROUP. 3001 01:45:07,080 --> 01:45:08,600 THERE ARE PROBLEMS OR ISSUES, 3002 01:45:08,600 --> 01:45:11,360 THE SAME ISSUES THAT YOU KNOW WE 3003 01:45:11,360 --> 01:45:14,200 SEE AT IN OF THE LARGER CANCER 3004 01:45:14,200 --> 01:45:16,760 CENTERS AND ARE THOSE 2 THINGS 3005 01:45:16,760 --> 01:45:17,440 INTERFACING? 3006 01:45:17,440 --> 01:45:18,840 >>THEY ARE TOTALLY INTEGRATED 3007 01:45:18,840 --> 01:45:23,520 BECAUSE THE EXACT SAME PROBLEMS 3008 01:45:23,520 --> 01:45:26,320 MAY BE EVEN WORSE AT SOME OF OUR 3009 01:45:26,320 --> 01:45:27,720 MAJOR NCORSITES IN TERMS OF 3010 01:45:27,720 --> 01:45:29,840 THEIR ABILITY TO ATTRACT AND 3011 01:45:29,840 --> 01:45:33,120 RETAIN STAFFS ARE CLEAR AND 3012 01:45:33,120 --> 01:45:34,520 THAT'S WHY DR. MCCASKILL 3013 01:45:34,520 --> 01:45:36,240 STEPHENS AND DR. MOONY AND I ARE 3014 01:45:36,240 --> 01:45:38,360 WORKING HAND IN HAND TO ADDRESS 3015 01:45:38,360 --> 01:45:39,240 THESE PROBLEMS. 3016 01:45:39,240 --> 01:45:39,680 >>THAT'S GREAT. 3017 01:45:39,680 --> 01:45:43,640 THAT'S VERY GOOD TO KNOW. 3018 01:45:43,640 --> 01:45:46,000 OH I SEE A CLAP AND A HAND, I'LL 3019 01:45:46,000 --> 01:45:47,040 NOT SURE, IF YOU HAVE 1 3020 01:45:47,040 --> 01:45:48,800 QUESTION, I THINK WE CAN DO THAT 3021 01:45:48,800 --> 01:45:50,640 1 BEFORE WE MOVE TO THE NEXT 3022 01:45:50,640 --> 01:45:52,840 AGENDA DO HAVE YOU A QUESTION 3023 01:45:52,840 --> 01:45:53,360 HOWARD? 3024 01:45:53,360 --> 01:45:54,040 >>YES, I DO. 3025 01:45:54,040 --> 01:45:56,720 JIM IS THERE ANY POSITIVE 3026 01:45:56,720 --> 01:46:00,520 CONSTRUCTIVE MODELS IN TERMS OF 3027 01:46:00,520 --> 01:46:01,200 COLLABORATIONS, CERTAINTY FROM 3028 01:46:01,200 --> 01:46:05,040 INDUSTRY THAT YOU WOULD LIKE TO 3029 01:46:05,040 --> 01:46:05,520 TO EXPRESS? 3030 01:46:05,520 --> 01:46:07,160 I MEAN OVER THE YEARS SOME OF 3031 01:46:07,160 --> 01:46:09,000 THE COMPANIES HAVE DONE? 3032 01:46:09,000 --> 01:46:12,800 VERY NICE THINGS IN TERMS OF YOU 3033 01:46:12,800 --> 01:46:14,360 KNOW ADVANCING TRIALS IN 3034 01:46:14,360 --> 01:46:14,960 UNDERSERVED POPULATIONS, ET 3035 01:46:14,960 --> 01:46:17,360 CETERA BI IN THIS, IT'S A SHARED 3036 01:46:17,360 --> 01:46:19,000 ISSUE WITH INDUSTRY NOW AND DO 3037 01:46:19,000 --> 01:46:24,040 YOU SEE ANY THAT YOU KNOW WHO 3038 01:46:24,040 --> 01:46:27,280 ARE LET'S SAY FORMER NCI 3039 01:46:27,280 --> 01:46:28,560 TRAINEES WHO REALLY DO CARE 3040 01:46:28,560 --> 01:46:30,960 ABOUT THE SUCCESS OF THE NCI 3041 01:46:30,960 --> 01:46:32,880 TRIALS THAT YOU SEE BEING DONE 3042 01:46:32,880 --> 01:46:38,000 OR CAN BE DONE BETTER BY 3043 01:46:38,000 --> 01:46:39,000 INDUSTRY? 3044 01:46:39,000 --> 01:46:41,440 >>SO HOWARD, I THINK WE SET OUT 3045 01:46:41,440 --> 01:46:43,960 ABOUT 10 DAYS AGO NOW, A LETTER 3046 01:46:43,960 --> 01:46:46,360 TO ALL THE NCI DESIGNATED CANCER 3047 01:46:46,360 --> 01:46:46,960 CENTERS TO UNDERSTAND WHETHER 3048 01:46:46,960 --> 01:46:50,000 THEY WOULD BE INTERESTED IN 3049 01:46:50,000 --> 01:46:53,200 MAKING IT, WHETHER IT WOULD BE 3050 01:46:53,200 --> 01:46:55,960 POSSIBLE TO REMOTELY ADDRESS 3051 01:46:55,960 --> 01:46:57,000 THEIR EHRs, TO BASICALLY HELP 3052 01:46:57,000 --> 01:46:59,600 WITH THE DATA MANAGEMENT ISSUES 3053 01:46:59,600 --> 01:47:02,640 INVOLVED AND I THINK THIS 3054 01:47:02,640 --> 01:47:04,640 IS--THIS IS REALLY SOMETHING 3055 01:47:04,640 --> 01:47:06,320 THAT IF WE CAN PUMMEL AT THIS 3056 01:47:06,320 --> 01:47:10,200 AND SHOW IT IS POSSIBLE TO HAVE 3057 01:47:10,200 --> 01:47:11,920 REMOTE VAF HELP WITH THE 3058 01:47:11,920 --> 01:47:14,040 ACQUISITION OF DATA AND NOT 3059 01:47:14,040 --> 01:47:14,840 REQUIRE ONSITE PERSONNEL. 3060 01:47:14,840 --> 01:47:16,640 THIS IS SOMETHING THAT I THINK 3061 01:47:16,640 --> 01:47:19,760 WILL BE OF GREAT INTEREST TO 3062 01:47:19,760 --> 01:47:24,040 INDUSTRY AS WELL AS TO THE NCI. 3063 01:47:24,040 --> 01:47:24,360 >>GREAT. 3064 01:47:24,360 --> 01:47:26,080 YOU KNOW YOU MIGHT CONSIDER 3065 01:47:26,080 --> 01:47:28,000 SENDING THAT OUT TO SOME OF THE 3066 01:47:28,000 --> 01:47:30,400 PATIENT ADVOCACY GROUPS YOU MAY 3067 01:47:30,400 --> 01:47:31,480 REMEMBER THE LEUKEMIA LYMPHOMA 3068 01:47:31,480 --> 01:47:32,840 FOUNDATION HAD A PILOT LIKE 3069 01:47:32,840 --> 01:47:36,960 THIS, I THINK AT CASE WESTERN. 3070 01:47:36,960 --> 01:47:38,640 >>THANK YOU. 3071 01:47:38,640 --> 01:47:39,760 WILL DO. 3072 01:47:39,760 --> 01:47:41,560 >>THANKS, HOWARD. 3073 01:47:41,560 --> 01:47:43,240 THANKS, JIM. 3074 01:47:43,240 --> 01:47:45,440 AND LOOK FORWARD TO UPDATES AND 3075 01:47:45,440 --> 01:47:48,120 ADVANCES IN THIS AREA. 3076 01:47:48,120 --> 01:47:53,240 SO WE'RE GOING TO MOVE ALONG AND 3077 01:47:53,240 --> 01:47:54,320 THANKS EVERYONE FOR REMAINING 3078 01:47:54,320 --> 01:47:56,840 ENGAGED AND FOR YOUR ATTENTION. 3079 01:47:56,840 --> 01:47:59,200 OUR NEXT AGENDA ITEM IS ONGOING 3080 01:47:59,200 --> 01:48:01,120 AND NEW BUSINESS. 3081 01:48:01,120 --> 01:48:03,680 SPECIFICALLY, THERE WERE 2 3082 01:48:03,680 --> 01:48:04,800 SUBCOMMITTEE MEETINGS EARLIER 3083 01:48:04,800 --> 01:48:06,400 TODAY, AND THE REPORT WAS GIVEN 3084 01:48:06,400 --> 01:48:07,920 BY THE SUBCOMMITTEE CHAIRS AND 3085 01:48:07,920 --> 01:48:11,040 AS A BOARD WE'LL NEED TO VOTE TO 3086 01:48:11,040 --> 01:48:11,720 ACCEPT THESE REPORTS. 3087 01:48:11,720 --> 01:48:18,760 THE FIRST WILL BE GIVEN BY DR. P 3088 01:48:18,760 --> 01:48:24,880 A SKETT WHO CHAIRS THE ADHOC 3089 01:48:24,880 --> 01:48:26,960 SUBCOMMITTEE ON POPULATION 3090 01:48:26,960 --> 01:48:27,960 SCIENCE EPIDEMIOLOGY AND 3091 01:48:27,960 --> 01:48:28,440 DISPARITIES. 3092 01:48:28,440 --> 01:48:29,280 >>THANK YOU VERY MUCH. 3093 01:48:29,280 --> 01:48:30,760 WE STARTED TODAY WITH REMINDING 3094 01:48:30,760 --> 01:48:33,040 EVERYBODY OF THE CHARGE OF THE 3095 01:48:33,040 --> 01:48:35,720 SUBCOMMITTEE HAD IS TO ADVISE TD 3096 01:48:35,720 --> 01:48:37,560 NCI AND DIRECTOR ON 3097 01:48:37,560 --> 01:48:40,440 OPPORTUNITIES TO ENHANCE NCI'S 3098 01:48:40,440 --> 01:48:42,640 CONTRIBUTION TO POPULATION 3099 01:48:42,640 --> 01:48:43,800 SCIENCE, EPIDEMIOLOGY AND 3100 01:48:43,800 --> 01:48:44,240 DISPARITIES. 3101 01:48:44,240 --> 01:48:47,600 WE THEN TURNED OUR TASK TO 3102 01:48:47,600 --> 01:48:52,720 DISCUSSING OUR FUTURE PRIORITIES 3103 01:48:52,720 --> 01:48:54,320 AND THESE ARE OUR MARCHING 3104 01:48:54,320 --> 01:48:54,520 ORDERS. 3105 01:48:54,520 --> 01:48:56,760 WE TALKED ABOUT THE 2 REPORTS WE 3106 01:48:56,760 --> 01:48:58,160 HAVE ALREADY CONCLUDED THE FIRST 3107 01:48:58,160 --> 01:48:59,880 BEING THE REPORT ON THE COHORTS, 3108 01:48:59,880 --> 01:49:03,960 CANCER COHORTS AND THE SECOND IT 3109 01:49:03,960 --> 01:49:06,720 WAS PRESENTED IN DECEMBER ON THE 3110 01:49:06,720 --> 01:49:11,480 NUMBER OF GRANTS BEING CONDUCTED 3111 01:49:11,480 --> 01:49:14,040 BY IN MINORITIES AND UNDERSERVED 3112 01:49:14,040 --> 01:49:14,320 POPULATIONS. 3113 01:49:14,320 --> 01:49:17,200 SO THE FIRST THING THAT WAS 3114 01:49:17,200 --> 01:49:21,600 RAISED WAS THAT WE MIGHT EXAMINE 3115 01:49:21,600 --> 01:49:25,440 THE FUNDING FOR TRAINING FOR 3116 01:49:25,440 --> 01:49:27,080 POPULATIONS SCIENTISTS AS THE 3117 01:49:27,080 --> 01:49:33,240 KO7S AND THE R25S WENT AWAY. 3118 01:49:33,240 --> 01:49:35,160 SO REALLY CAN WE REVISIT THIS? 3119 01:49:35,160 --> 01:49:40,200 WHAT IS THE LANDSCAPE AND 3120 01:49:40,200 --> 01:49:41,320 OPPORTUNITIES? 3121 01:49:41,320 --> 01:49:44,000 AND ALSO, WE TALKED ABOUT OTHER 3122 01:49:44,000 --> 01:49:45,800 TRAINEES WHO COULD BE E-MAILED 3123 01:49:45,800 --> 01:49:48,640 INTO THIS AND DR. CASTLE 3124 01:49:48,640 --> 01:49:51,960 MENTIONED THAT HE AND COLLEAGUES 3125 01:49:51,960 --> 01:49:55,440 AT NCR ARE CURRENTLY ANALYZING 3126 01:49:55,440 --> 01:49:56,800 THE LANDSCAPE OF THE 3127 01:49:56,800 --> 01:49:58,640 [INDISCERNIBLE] AS WELL AS 3128 01:49:58,640 --> 01:50:00,760 TRANSLATIONAL SCIENCE CANCER 3129 01:50:00,760 --> 01:50:01,280 PREVENTION WORKFORCE. 3130 01:50:01,280 --> 01:50:04,600 SO WE REALLY LIKED THAT IDEA AND 3131 01:50:04,600 --> 01:50:09,440 WE ARE GOING TO HAVE THIS 3132 01:50:09,440 --> 01:50:13,240 ANALYSIS PRESENTED THAT US IN 3133 01:50:13,240 --> 01:50:16,120 JUNE AT OUR MEETING AND WE ALSO 3134 01:50:16,120 --> 01:50:19,200 SUGGESTED THAT THE ANALYSIS 3135 01:50:19,200 --> 01:50:25,560 INCLUDED GRANT SUPPLEMENTS AS 3136 01:50:25,560 --> 01:50:29,880 WELL AS T32s, AND OTHER AREAS. 3137 01:50:29,880 --> 01:50:32,680 SO, ALSO A NOVEL IDEA OF 3138 01:50:32,680 --> 01:50:34,080 EXPANDING THE NCI CANCER BRANCH 3139 01:50:34,080 --> 01:50:37,240 AND FELLOWSHIP, NOT ONLY AT NCI 3140 01:50:37,240 --> 01:50:40,320 BUT INTO THE EXTRAMURAL 3141 01:50:40,320 --> 01:50:40,560 COMMUNITY. 3142 01:50:40,560 --> 01:50:42,760 SOME OTHER IDEAS THAT WERE ALSO 3143 01:50:42,760 --> 01:50:46,640 BROUGHT UP AND DISCUSSED INCLUDE 3144 01:50:46,640 --> 01:50:49,160 UNIFIED DESCRIPTORS FOR THE 3145 01:50:49,160 --> 01:50:53,200 SOCIAL DETERMINANTS OF HEALTH, 3146 01:50:53,200 --> 01:50:54,120 ENGAGEMENT OF--WITH REGULATORY 3147 01:50:54,120 --> 01:50:57,280 AGENCIES FOR EXAMPLE, TO PROVIDE 3148 01:50:57,280 --> 01:50:59,120 GUIDANCE ON UPTO DATE ANALYTIC 3149 01:50:59,120 --> 01:51:01,640 APPROACHES AND THE USE OF 3150 01:51:01,640 --> 01:51:03,240 REGISTRIES SUCH AS SEER TO HELP 3151 01:51:03,240 --> 01:51:08,080 DO SOME POST MARKETING 3152 01:51:08,080 --> 01:51:08,360 MONITORING. 3153 01:51:08,360 --> 01:51:13,360 THERE WAS A SUGGESTION OF 3154 01:51:13,360 --> 01:51:15,200 LOOKING AT HOW NEW TECHNIQUES 3155 01:51:15,200 --> 01:51:18,680 AND GERM LINE SEQUENCING AND 3156 01:51:18,680 --> 01:51:19,480 EPIGENOMICS HAVE EVOLVED AND 3157 01:51:19,480 --> 01:51:24,400 COULD THEY BE USED IN POPULATION 3158 01:51:24,400 --> 01:51:25,360 EFFORTS ESPECIALLY THOSE THAT 3159 01:51:25,360 --> 01:51:28,440 COULD BE USED TO BENEFIT 3160 01:51:28,440 --> 01:51:29,600 MINORITY AND UNDERSERVED 3161 01:51:29,600 --> 01:51:30,000 POPULATIONS. 3162 01:51:30,000 --> 01:51:33,480 THERE WAS A SUGGESTION TO LOOK 3163 01:51:33,480 --> 01:51:37,920 AT CLINICAL TRIAL ACCRUAL 3164 01:51:37,920 --> 01:51:39,000 INCLUDING SUPPLEMENTS AND ALSO 3165 01:51:39,000 --> 01:51:41,240 THE ACCRUAL THAT GETS CONDUCTED 3166 01:51:41,240 --> 01:51:45,040 AT CANCER CENTERS, NOT JUST 3167 01:51:45,040 --> 01:51:47,000 THROUGH NCORP WHICH LAST TIME WE 3168 01:51:47,000 --> 01:51:51,680 WERE PRESENTED WITH NCORP DATA 3169 01:51:51,680 --> 01:51:55,280 LOOKED LOOKED REALLY GOOD. 3170 01:51:55,280 --> 01:51:59,680 AND SOME SUGGESTIONS OF 3171 01:51:59,680 --> 01:52:02,560 INTEGRATING POP SI WITH OTHER 3172 01:52:02,560 --> 01:52:04,640 DISCIPLINES IN ADDITION 3173 01:52:04,640 --> 01:52:06,400 INCLUDING CANCER DRUG DISCOVERY 3174 01:52:06,400 --> 01:52:07,080 AND CARE. 3175 01:52:07,080 --> 01:52:11,440 SO, WHAT WE DECIDED TO DO IS AS 3176 01:52:11,440 --> 01:52:17,000 I MENTIONED WE'VE ASKED 3177 01:52:17,000 --> 01:52:18,000 DR. CASTLE AND HIS OTHER 3178 01:52:18,000 --> 01:52:20,160 COLLEAGUES TO COME AND PRESENT 3179 01:52:20,160 --> 01:52:24,480 TO US OUR JUNE MEETING ON WHAT 3180 01:52:24,480 --> 01:52:26,440 THEY FOUND ABOUT FROM THEIR 3181 01:52:26,440 --> 01:52:28,400 LANDSCAPE AND PORTFOLIO ANALYSIS 3182 01:52:28,400 --> 01:52:28,680 ON TRAINING. 3183 01:52:28,680 --> 01:52:31,560 AND IN THE MEAN TIME I WILL WORK 3184 01:52:31,560 --> 01:52:38,600 WITH FOLKS AT THE NCI, AS WELL 3185 01:52:38,600 --> 01:52:41,400 AS JOHN CARPTEN WHO KNOWS ALL OF 3186 01:52:41,400 --> 01:52:42,160 OUR SUBCOMMITTEES, DETERMINE THE 3187 01:52:42,160 --> 01:52:44,840 OTHER IERK TEMS THAT WERE 3188 01:52:44,840 --> 01:52:46,360 MENTIONED ARE APPROPRIATE TOPICS 3189 01:52:46,360 --> 01:52:49,120 FOR THE SUBCOMMITTEE TO ADDRESS, 3190 01:52:49,120 --> 01:52:49,680 WHETHER OTHER SUBCOMMITTEES 3191 01:52:49,680 --> 01:52:51,520 MIGHT CONSIDER OR WHETHER 3192 01:52:51,520 --> 01:52:54,440 THEY'RE ALREADY BEING ADDRESSED 3193 01:52:54,440 --> 01:52:56,560 BY THE NCI OR COULD BE ADDRESSED 3194 01:52:56,560 --> 01:52:57,040 BY THE NCI. 3195 01:52:57,040 --> 01:53:00,400 SO THAT IS MY REPORT, HAPPY IF I 3196 01:53:00,400 --> 01:53:02,080 MISSED SOMETHING FOR SOMEBODY TO 3197 01:53:02,080 --> 01:53:02,400 BRING THAT UP. 3198 01:53:02,400 --> 01:53:12,760 THANK YOU VERY MUCH. 3199 01:53:14,920 --> 01:53:15,400 >>THANKS ELECTRA. 3200 01:53:15,400 --> 01:53:19,040 ARE THERE ANY QUESTIONS FOR 3201 01:53:19,040 --> 01:53:20,520 DR. P A SKETT? 3202 01:53:20,520 --> 01:53:22,480 IF FOCUS ON THE WE WILL NEED TO 3203 01:53:22,480 --> 01:53:23,560 VOTE TO ACCEPT THE REPORT. 3204 01:53:23,560 --> 01:53:28,240 IS THERE A MOTION TO ACCEPT THE 3205 01:53:28,240 --> 01:53:28,760 REPORT? 3206 01:53:28,760 --> 01:53:30,200 >>YES, I MOVE. 3207 01:53:30,200 --> 01:53:31,280 >>SECOND? 3208 01:53:31,280 --> 01:53:32,280 >>SECOND. 3209 01:53:32,280 --> 01:53:32,600 >>SECOND. 3210 01:53:32,600 --> 01:53:36,960 >>MOVED AND SECOND. 3211 01:53:36,960 --> 01:53:37,840 ANY DISCUSSION? 3212 01:53:37,840 --> 01:53:42,000 >>OKAY, WE CAN NOW VOTE TO 3213 01:53:42,000 --> 01:53:42,560 ACCEPT THE REPORT. 3214 01:53:42,560 --> 01:53:51,280 ARE THERE ANY NAYS? 3215 01:53:51,280 --> 01:53:52,720 ABSTENTIONS? 3216 01:53:52,720 --> 01:53:56,400 AS THERE ARE NONE, PAULET? 3217 01:53:56,400 --> 01:53:59,080 >>YOU'RE GOOD, IT'S UNANIMOUS. 3218 01:53:59,080 --> 01:53:59,440 >>UNANIMOUS. 3219 01:53:59,440 --> 01:53:59,760 OKAY GREAT. 3220 01:53:59,760 --> 01:54:01,880 NEXT WE WILL HAVE ANN BARKER WHO 3221 01:54:01,880 --> 01:54:03,520 WILL PRESENT THE REPORT FROM THE 3222 01:54:03,520 --> 01:54:08,080 SUBCOMMITTEE ON PLANNING AND 3223 01:54:08,080 --> 01:54:09,680 BUDGET. 3224 01:54:09,680 --> 01:54:09,840 ANN? 3225 01:54:09,840 --> 01:54:10,800 >>THANK YOU VERY MUCH. 3226 01:54:10,800 --> 01:54:13,720 WE HAD A GOT REPRESENTATION OF 3227 01:54:13,720 --> 01:54:14,440 THE SUBCOMMITTEE TODAY AND WE 3228 01:54:14,440 --> 01:54:16,960 HAVE A LOT OF STUFF GOING ON IN 3229 01:54:16,960 --> 01:54:19,400 THIS SPACE RIGHT NOW, AS YOU 3230 01:54:19,400 --> 01:54:23,280 HEARD FROM M. K. AND ALSO FROM 3231 01:54:23,280 --> 01:54:24,520 OUR SUBCOMMITTEE MEETING WHERE 3232 01:54:24,520 --> 01:54:29,000 WE HEARD FROM OUR EXECUTIVE 3233 01:54:29,000 --> 01:54:30,960 SECRETARY PATRICK Mc GARY AND 3234 01:54:30,960 --> 01:54:32,640 HAD THE ANNUAL PLAN PRESENTED TO 3235 01:54:32,640 --> 01:54:37,160 THE SUBCOMMITTEE BY DIANE MARY. 3236 01:54:37,160 --> 01:54:38,960 SO WE OPENED THE SUBCOMMITTEE 3237 01:54:38,960 --> 01:54:40,240 WITH A FEW COMMENTS ON SOME OF 3238 01:54:40,240 --> 01:54:42,360 THESE ISSUES THAT ARE BEFORE US 3239 01:54:42,360 --> 01:54:43,320 RIGHT NOW. 3240 01:54:43,320 --> 01:54:44,960 EVERYTHING FROM THE PRESIDENT'S 3241 01:54:44,960 --> 01:54:47,040 YOU KNOW CHALLENGE TO ALL OF US 3242 01:54:47,040 --> 01:54:50,120 TO REDUCE CANCER BY 50% IN THE 3243 01:54:50,120 --> 01:54:53,080 NEXT 25 YEARS, WHICH SEEMS A 3244 01:54:53,080 --> 01:54:54,640 LONG WAY OFF BUT WE HAVE TO 3245 01:54:54,640 --> 01:54:55,600 START THINKING ABOUT, SHOULD 3246 01:54:55,600 --> 01:54:57,240 HAVE STARTED THINK BEING IT 5 3247 01:54:57,240 --> 01:54:58,160 YEARS AGO OR MORE. 3248 01:54:58,160 --> 01:54:59,520 WE'VE BEEN THINK BEING IT FOR A 3249 01:54:59,520 --> 01:55:04,560 LONG TIME BUT WE DON'T--THE 3250 01:55:04,560 --> 01:55:06,000 OTHER THING I REMINDED US ALL IS 3251 01:55:06,000 --> 01:55:08,360 THAT WE JUST SAW THE DAILY BASIS 3252 01:55:08,360 --> 01:55:10,960 THEA FROM LAST YEAR ON OUR 3253 01:55:10,960 --> 01:55:13,160 MORTALITY RATES AND SAW THAT THE 3254 01:55:13,160 --> 01:55:14,000 CANCER MORTALITY, THANKS TO A 3255 01:55:14,000 --> 01:55:16,560 LOT OF EFFORTS ON THE PART OF 3256 01:55:16,560 --> 01:55:18,400 NCI AND THE ONLY OTHER 3257 01:55:18,400 --> 01:55:20,960 ENTERPRISE THAT IS THE NCI AND 3258 01:55:20,960 --> 01:55:22,720 ITS AFFILIATES AND PARTNERS, 3259 01:55:22,720 --> 01:55:28,360 INCLUDING THE PRIVATE SECTOR IN 3260 01:55:28,360 --> 01:55:32,280 CANCER WE SAW A MORTALITY 3261 01:55:32,280 --> 01:55:33,080 DECREASE OF 33%. 3262 01:55:33,080 --> 01:55:34,880 IT'S NOT EQUALLY DIVIDED AMONGST 3263 01:55:34,880 --> 01:55:36,120 THE CANCERS OBVIOUSLY AND A LOT 3264 01:55:36,120 --> 01:55:39,480 OF THAT 33% COMES FROM SMOKING 3265 01:55:39,480 --> 01:55:42,760 PROGRAMS AND THEY'VE WORKED. 3266 01:55:42,760 --> 01:55:44,160 AND WE'RE BEGINNING TO SEE THE 3267 01:55:44,160 --> 01:55:47,080 RESULTS OF OUR INVESTMENTS IN 3268 01:55:47,080 --> 01:55:48,720 OMICS AND WITH THE OMICS AND 3269 01:55:48,720 --> 01:55:50,680 OTHER AREAS OF BASIC BIOLOGY ARE 3270 01:55:50,680 --> 01:55:53,240 STARTING TO AFFECT SURVIVAL 3271 01:55:53,240 --> 01:55:54,200 ESPECIALLY IN CERTAIN CANCERS, 3272 01:55:54,200 --> 01:55:57,840 BREAST CANCER BEING 1 OF THOSE 3273 01:55:57,840 --> 01:55:59,200 THAT'S VERY SIGNIFICANT. 3274 01:55:59,200 --> 01:56:02,480 WELL, I ALSO POINTED OUT THAT 3275 01:56:02,480 --> 01:56:03,320 SOMETIMES THEY'RE UNTOWARD 3276 01:56:03,320 --> 01:56:04,480 AFFECTS OF THINGS THAT WE MAY 3277 01:56:04,480 --> 01:56:06,880 THINK WE KNOW ABOUT BUT MAYBE WE 3278 01:56:06,880 --> 01:56:08,960 DON'T AND THAT IS WHEN YOU 3279 01:56:08,960 --> 01:56:10,360 CHANGE SCREENING PROTOCOLS AS WE 3280 01:56:10,360 --> 01:56:12,720 DID FOR PROSTATE CANCER ABOUT 3, 3281 01:56:12,720 --> 01:56:14,560 4 YEARS AGO, WHAT HAPPENS IS, IT 3282 01:56:14,560 --> 01:56:16,920 COMES OUT IN SOME OTHER PART 3283 01:56:16,920 --> 01:56:18,080 OBVIOUSLY, VERY HIGHLY CONNECTED 3284 01:56:18,080 --> 01:56:22,040 SYSTEM IN THIS CASE, SEEING A 3285 01:56:22,040 --> 01:56:23,480 LOT OF ADVANCED PROSTATE CANCER 3286 01:56:23,480 --> 01:56:25,920 IN THE LAST 3 YEARS WHICH IS 3287 01:56:25,920 --> 01:56:26,440 IMPACTING MORTALITY. 3288 01:56:26,440 --> 01:56:28,480 SO A LOT OF THINGS ARE GOING ON 3289 01:56:28,480 --> 01:56:31,680 AND LAST BUT NOT LEAST IS THE 3290 01:56:31,680 --> 01:56:34,080 ISSUE OF THE PRESIDENT 3291 01:56:34,080 --> 01:56:35,560 MENTIONING, I THINK 3292 01:56:35,560 --> 01:56:36,600 REAUTHORIZATION OF THE NATIONAL 3293 01:56:36,600 --> 01:56:36,920 CANCER ACT. 3294 01:56:36,920 --> 01:56:38,680 I DON'T KNOW WHAT THAT MEANS BUT 3295 01:56:38,680 --> 01:56:40,920 FROM A FINANCIAL STANDPOINT IT 3296 01:56:40,920 --> 01:56:42,480 REALLY WOULD CHANGE A LOT OF 3297 01:56:42,480 --> 01:56:44,240 THINGS IN TERMS OF OUR ANNUAL 3298 01:56:44,240 --> 01:56:45,160 PLAN. 3299 01:56:45,160 --> 01:56:48,680 SO IN TERMS OF SOME HIGHLIGHTS, 3300 01:56:48,680 --> 01:56:52,040 PATRICK Mc GARY OUR EXECUTIVE 3301 01:56:52,040 --> 01:56:53,960 CHAIRMAN FOR THIS PARTICULAR 3302 01:56:53,960 --> 01:56:55,800 SUBCOMMITTEE PRESENTED A LOT OF 3303 01:56:55,800 --> 01:56:58,960 DATA AND IT WAS ALL PRETTY GOOD 3304 01:56:58,960 --> 01:57:01,640 NEWS FOR THIS YEAR, I THINK, WE 3305 01:57:01,640 --> 01:57:02,440 PROBABLY--YOU KNOW MAYBE HAD 1 3306 01:57:02,440 --> 01:57:04,640 OF THE BEST YEARS WE'RE GOING TO 3307 01:57:04,640 --> 01:57:06,480 SEE HOPEFULLY IT'S NOT THE BEST 3308 01:57:06,480 --> 01:57:09,240 YEAR WE'LL EVER SEE BUT IT'S 3309 01:57:09,240 --> 01:57:10,200 PRETTY GOOD. 3310 01:57:10,200 --> 01:57:12,880 WE AWARDED 7500 NEW GRANTS. 3311 01:57:12,880 --> 01:57:16,240 THAT'S AN AMAZING, AMAZING 3312 01:57:16,240 --> 01:57:18,800 PROBABLY THE BEST 1 WE'VE EVER 3313 01:57:18,800 --> 01:57:21,240 HAD AND IT MEANT THAT WE REACHED 3314 01:57:21,240 --> 01:57:22,440 THE 12th PERCENTILE AND YOU'LL 3315 01:57:22,440 --> 01:57:31,640 RECALL WE DID HAVE A GOAL BACK 3316 01:57:31,640 --> 01:57:34,400 UNDER NED'S LEADERSHIP WHERE WE 3317 01:57:34,400 --> 01:57:35,880 WERE VECTORING TOWARD 15% BY 3318 01:57:35,880 --> 01:57:38,000 2025, YET TO BE SEEN IF WE WILL 3319 01:57:38,000 --> 01:57:39,040 MAKE THAT. 3320 01:57:39,040 --> 01:57:42,600 THAT WILL REQUIRE QUITE A BIT OF 3321 01:57:42,600 --> 01:57:42,840 FUNDING. 3322 01:57:42,840 --> 01:57:44,880 AS WAS POINTED OUT TO US ALL, 3323 01:57:44,880 --> 01:57:46,920 ANYTIME WE APPROVE THIS MANY 3324 01:57:46,920 --> 01:57:50,120 GRANTS WITH 5 OR 7 YEAR 3325 01:57:50,120 --> 01:57:51,080 OUTLOOKS, IT ALL ROLLED THROUGH 3326 01:57:51,080 --> 01:57:52,520 THE SYSTEM FOR THE NEXT 5 YEARS 3327 01:57:52,520 --> 01:57:53,920 SO IT MAKES IT VERY, VERY 3328 01:57:53,920 --> 01:57:55,960 DIFFICULT TO THINK ABOUT HOW WE 3329 01:57:55,960 --> 01:57:57,600 FUND ADDITIONAL IDEAS AND 3330 01:57:57,600 --> 01:57:57,840 GRANTS. 3331 01:57:57,840 --> 01:57:58,800 AND SO SOMETHING WE HAVE TO 3332 01:57:58,800 --> 01:58:02,160 THINK ABOUT IS, AS WE FIGURE OUT 3333 01:58:02,160 --> 01:58:05,120 HOW WE CAN HELP THROUGH THIS 3334 01:58:05,120 --> 01:58:06,720 SUBCOMMITTEE, THE NEW NCI 3335 01:58:06,720 --> 01:58:14,080 DIRECTOR AND THE WHOLE OF THE 3336 01:58:14,080 --> 01:58:14,840 NCI'S BUDGET. 3337 01:58:14,840 --> 01:58:16,480 A COUPLE THINGS CAME UP THAT I 3338 01:58:16,480 --> 01:58:19,840 THOUGHT WERE KIND OF INTERESTING 3339 01:58:19,840 --> 01:58:22,360 HERE AND THAT IS THE ANNUAL PLAN 3340 01:58:22,360 --> 01:58:24,320 WHICH HAS BEEN AROUND SINCE 3341 01:58:24,320 --> 01:58:26,200 1971, WE CALL IT THE BYPASS 3342 01:58:26,200 --> 01:58:29,080 BUDGET FOR MANY YEARS HAS, I 3343 01:58:29,080 --> 01:58:31,160 THINK NOT--IT HAS BT RECEIVED 3344 01:58:31,160 --> 01:58:33,680 MUCH ATTENTION UNTIL I THINK THE 3345 01:58:33,680 --> 01:58:35,080 LAST 3-4 YEARS AND IF YOU LOOK 3346 01:58:35,080 --> 01:58:36,880 AT THIS YEAR'S PLAN, WHICH IS BY 3347 01:58:36,880 --> 01:58:39,160 THE WAY, JUST OUTSTANDING, IT'S 3348 01:58:39,160 --> 01:58:40,840 VERY EASY TO READ, IT'S ONLINE, 3349 01:58:40,840 --> 01:58:43,240 CAN YOU GO SEE IT, YOU SHOULD 3350 01:58:43,240 --> 01:58:44,800 DRIEWBT IT IN YOUR CANCER 3351 01:58:44,800 --> 01:58:45,960 CENTERS OR LABORATORY SO PEOPLE 3352 01:58:45,960 --> 01:58:48,160 ARE ALL IN THE SAME PAGE, BUT 3353 01:58:48,160 --> 01:58:49,520 IT'S 10 BILLION DOLLARS. 3354 01:58:49,520 --> 01:58:51,880 I MEAN THAT'S KIND OF WHAT IT 3355 01:58:51,880 --> 01:58:54,520 WOULD TAKE OPTIMALLY FOR US TO 3356 01:58:54,520 --> 01:58:59,880 MEET THE GOAL WE WANT TO MEET. 3357 01:58:59,880 --> 01:59:01,600 A YEAR FROM NOW OR A LITTLE MORE 3358 01:59:01,600 --> 01:59:03,280 THAN A YEAR FROM NOW, THAT'S NOT 3359 01:59:03,280 --> 01:59:05,720 VERY MUCH MONEY AND IT INVOLVES 3360 01:59:05,720 --> 01:59:07,920 4 SPECIFIC AREAS, CELLULAR 3361 01:59:07,920 --> 01:59:12,240 THERAPIES, TARGETING THE 3362 01:59:12,240 --> 01:59:13,200 UNTARGETTABLE, REALLY PUTTING 3363 01:59:13,200 --> 01:59:15,040 MONEY UNDERNEATH THE KINDS OF 3364 01:59:15,040 --> 01:59:15,800 THINGS THAT ELECTRA'S 3365 01:59:15,800 --> 01:59:18,240 SUBCOMMITTEE TALKS ABOUT AND 3366 01:59:18,240 --> 01:59:19,680 THAT'S REALLY SOLVING THIS, 3367 01:59:19,680 --> 01:59:23,280 LET'S DELIVER TO THE MINORITY 3368 01:59:23,280 --> 01:59:24,480 AND UNDERSERVED COMMUNITIES AND 3369 01:59:24,480 --> 01:59:26,880 THOSE CANCERS WHERE WE DON'T 3370 01:59:26,880 --> 01:59:28,400 HAVE SCREENINGS VERY 3371 01:59:28,400 --> 01:59:28,720 INTERESTING. 3372 01:59:28,720 --> 01:59:31,280 SO THE 4 AREAS, THERE COULD BE 3373 01:59:31,280 --> 01:59:33,160 OTHER 4 AREAS, 5 KREBS CYCLE 3374 01:59:33,160 --> 01:59:35,120 AREAS, 10 AREAS, WHATEVER, THOSE 3375 01:59:35,120 --> 01:59:36,080 ARE 4 HIGHLIGHTED AREAS AND YOU 3376 01:59:36,080 --> 01:59:40,400 COULD THINK OF LOTS MORE, BUT 3377 01:59:40,400 --> 01:59:42,360 THIS IS THE KIND OF THING WE 3378 01:59:42,360 --> 01:59:43,600 SHOULD BE PLANNING MUCH FURTHER 3379 01:59:43,600 --> 01:59:54,080 THAN WHAT YOU HEARD TODAY. 3380 01:59:55,760 --> 01:59:57,000 THE DR. BERTAGNOLLI'S GOING TO 3381 01:59:57,000 --> 01:59:58,520 HELP US IN THAT REGARD. 3382 01:59:58,520 --> 02:00:01,720 IT'S NOT ALWAYS POSSIBLE TO KNOW 3383 02:00:01,720 --> 02:00:03,000 WHAT OUR LINES ARE IN TERMS WHAT 3384 02:00:03,000 --> 02:00:05,320 HAVE WE CAN DO TBH THIS SPACE 3385 02:00:05,320 --> 02:00:13,360 BECAUSE WE'RE ALL SPECIAL 3386 02:00:13,360 --> 02:00:14,840 GOVERNMENT EMPLOYEES. 3387 02:00:14,840 --> 02:00:16,800 WE DON'T PARTICIPATE IN THE 3388 02:00:16,800 --> 02:00:18,400 KINDS OF THING LIKE WHAT PAULET 3389 02:00:18,400 --> 02:00:24,680 JUST READ TO YOU WHEN SHE READ 3390 02:00:24,680 --> 02:00:27,000 HER LONG DESCRIPTION SO HOW CAN 3391 02:00:27,000 --> 02:00:27,680 OUR SUBCOMMITTEE HELP? 3392 02:00:27,680 --> 02:00:30,160 AND WE HEARD FROM MONITORRIC AND 3393 02:00:30,160 --> 02:00:31,360 AND THANK HER VERY MUCH FOR 3394 02:00:31,360 --> 02:00:33,120 JOINING US, SHE WILL BE 3395 02:00:33,120 --> 02:00:34,720 CHALLENGING US TO THINK ABOUT 3396 02:00:34,720 --> 02:00:36,120 WHERE CAN WE REALLY HAVE AN 3397 02:00:36,120 --> 02:00:37,160 IMPACT HERE IN TERMS OF LOOKINGA 3398 02:00:37,160 --> 02:00:39,240 THE SOME OF THESE ISSUES TO HELP 3399 02:00:39,240 --> 02:00:43,520 NCI, TO ASK BETTER QUESTIONS, TO 3400 02:00:43,520 --> 02:00:44,760 ACTUALLY PRIORITIZE, I THINK 3401 02:00:44,760 --> 02:00:46,400 PRIORITIZATION WILL BE CRITICAL 3402 02:00:46,400 --> 02:00:48,160 AND SO A COUPLE OF IDEAS CAME UP 3403 02:00:48,160 --> 02:00:51,800 AND SOME OF YOU HAVE SENT ME 3404 02:00:51,800 --> 02:00:53,840 IDEAS BUT WE REALLY WANT TO 3405 02:00:53,840 --> 02:00:57,280 THINK ABOUT HOW WE FUND SOME OF 3406 02:00:57,280 --> 02:00:57,840 THIS UNDERREPRESENTED 3407 02:00:57,840 --> 02:00:59,400 CONVERSATION THAT WE HAVE ALL 3408 02:00:59,400 --> 02:01:01,560 THE TIME, I MEAN WE REALLY NEED 3409 02:01:01,560 --> 02:01:08,720 TO DO SOMETHING ABOUT DELIVERY 3410 02:01:08,720 --> 02:01:10,480 TO THESE AND THE AFRICAN 3411 02:01:10,480 --> 02:01:12,440 AMERICAN, YOU KNOW ALL OF THOSE 3412 02:01:12,440 --> 02:01:15,160 SUBPOPULATIONS WE KEEP TALKING 3413 02:01:15,160 --> 02:01:17,360 ABOUT, HOW DO WE DO THAT? 3414 02:01:17,360 --> 02:01:23,720 ASK THEN, THE WHOLE ISSUE CANCER 3415 02:01:23,720 --> 02:01:25,520 CENTERS AND INFRASTRUCTURE 3416 02:01:25,520 --> 02:01:30,040 AROUND US AS YOU HEARD FROM 3417 02:01:30,040 --> 02:01:31,080 DR. BERTAGNOLLI, HOW DO WE KEEP 3418 02:01:31,080 --> 02:01:32,800 UP IN THE DATA SCIENCE AREAS, ET 3419 02:01:32,800 --> 02:01:33,040 CETERA. 3420 02:01:33,040 --> 02:01:34,440 SO IT WAS A GOOD MEETING. 3421 02:01:34,440 --> 02:01:36,200 I WANT THANK OUR PRESENTERS 3422 02:01:36,200 --> 02:01:38,040 TODAY WHO WAS REALLY AN 3423 02:01:38,040 --> 02:01:39,000 INFORMATION MEETING GOING FROM 3424 02:01:39,000 --> 02:01:41,280 HERE'S WHERE WE ARE AND TO 3425 02:01:41,280 --> 02:01:43,200 HERE'S WHERE WE REALLY NEED TO 3426 02:01:43,200 --> 02:01:45,440 BE ON AN ANNUAL BASIS IN TERMS 3427 02:01:45,440 --> 02:01:46,960 OF OUR ANNUAL PLAN AND I THOUGHT 3428 02:01:46,960 --> 02:01:48,160 THAT WAS VERY GOOD CONTINUUM TO 3429 02:01:48,160 --> 02:01:49,440 START TO THINK ABOUT HOW DO WE 3430 02:01:49,440 --> 02:01:53,200 GO FROM WHERE WE ARE TO ACHIEVE 3431 02:01:53,200 --> 02:01:54,600 THAT ANNUAL PLAN TO FUND THE 3432 02:01:54,600 --> 02:01:57,440 THINGS WE NEED TO FUND. 3433 02:01:57,440 --> 02:01:59,280 AND IN ADDITION TO THANKING 3434 02:01:59,280 --> 02:02:00,920 DIANE FOR HER EXCELLENT 3435 02:02:00,920 --> 02:02:04,440 PRESENTATION, THANKS TO PATRICK 3436 02:02:04,440 --> 02:02:06,200 WHO IS RETIRING FROM PATRICK 3437 02:02:06,200 --> 02:02:08,600 FROM THE NCI AND FEDERAL SERVICE 3438 02:02:08,600 --> 02:02:10,120 HAVING SPENT 2 DECADES ON TAP 3439 02:02:10,120 --> 02:02:10,960 TOLL-LIKE RECEPTOR HILL, 13 3440 02:02:10,960 --> 02:02:13,840 YEARS AT THE FDA AND 10 YEARS 3441 02:02:13,840 --> 02:02:15,680 ADDED THE NCI AND I WANT THE 3442 02:02:15,680 --> 02:02:17,040 WHOLE BOARD TO THANK YOU 3443 02:02:17,040 --> 02:02:17,280 PATRICK. 3444 02:02:17,280 --> 02:02:18,520 YOU'VE BEEN SUCH A GREAT ASSET 3445 02:02:18,520 --> 02:02:19,800 TO ALL OF US AND WE WISH YOU 3446 02:02:19,800 --> 02:02:21,120 WELL IN YOUR CAREER. 3447 02:02:21,120 --> 02:02:26,280 AND THAT'S MY REPORT. 3448 02:02:26,280 --> 02:02:27,960 >>THANKS, ANN. 3449 02:02:27,960 --> 02:02:31,040 IT'S REALLY, REALLY A CRITICALLY 3450 02:02:31,040 --> 02:02:32,280 IMPORTANT ASPECT OF THIS. 3451 02:02:32,280 --> 02:02:34,000 YOU KNOW WITHOUT A PLAN AND 3452 02:02:34,000 --> 02:02:35,240 WITHOUT BUDGETS, YOU KNOW HOW DO 3453 02:02:35,240 --> 02:02:38,920 YOU GET ANYTHING DONE, RIGHT? 3454 02:02:38,920 --> 02:02:41,680 AND I THINK ELECTRA'S BEEN 3455 02:02:41,680 --> 02:02:43,760 THROWING AROUND THIS WORD, 3456 02:02:43,760 --> 02:02:44,920 DISRUPT, RIGHT? 3457 02:02:44,920 --> 02:02:47,440 IS SEEMS LIKE 1 OF THE HARDER 3458 02:02:47,440 --> 02:02:50,400 AREAS TO DISRUPT, BUT, YOU KNOW 3459 02:02:50,400 --> 02:02:51,200 IT-- 3460 02:02:51,200 --> 02:02:53,160 >>IT'S GOING TO BE DISRUPTED. 3461 02:02:53,160 --> 02:02:55,360 IT'S GOT TO BE DISRUPTED. 3462 02:02:55,360 --> 02:02:55,640 >>YES. 3463 02:02:55,640 --> 02:02:58,360 >>WE NEED TO START WITH THE 3464 02:02:58,360 --> 02:02:59,360 10 MILLION, BECAUSE WHEN YOU 3465 02:02:59,360 --> 02:03:02,120 THINK OF CANCER GOING UP 30% IN 3466 02:03:02,120 --> 02:03:06,520 THIS COUNTRY AND UP TO 75% ON A 3467 02:03:06,520 --> 02:03:07,840 GLOBAL BASIS, WE CAN'T AFFORD 3468 02:03:07,840 --> 02:03:10,440 NOT TO DO IT. 3469 02:03:10,440 --> 02:03:12,280 >>AGREED. 3470 02:03:12,280 --> 02:03:13,400 AGREED. 3471 02:03:13,400 --> 02:03:14,560 OKAY, WELL, THANKS, ANN. 3472 02:03:14,560 --> 02:03:19,080 ARE THERE ANY OTHER QUESTIONS 3473 02:03:19,080 --> 02:03:26,120 FOR ANN REGARDING HER REPORT? 3474 02:03:26,120 --> 02:03:26,640 NO? 3475 02:03:26,640 --> 02:03:27,560 THEIR BEING NONE, WE ALSO NEED 3476 02:03:27,560 --> 02:03:31,160 TO VOTE ON THIS REPORT. 3477 02:03:31,160 --> 02:03:33,840 SO IS THERE A MOTION TO APPROVE 3478 02:03:33,840 --> 02:03:37,280 OR ACCEPT THE REPORT? 3479 02:03:37,280 --> 02:03:41,840 OKAY, IS THERE A SECOND? 3480 02:03:41,840 --> 02:03:42,520 OKAY. 3481 02:03:42,520 --> 02:03:47,600 PROBABLY MOVED AND SECOND. 3482 02:03:47,600 --> 02:03:48,280 ANY DISCUSSION? 3483 02:03:48,280 --> 02:03:50,040 IF THERE IS NONE, WE NEED TO 3484 02:03:50,040 --> 02:03:52,720 THEN VOTE TO ACCEPT THE REPORT. 3485 02:03:52,720 --> 02:04:01,240 I WILL ASK ARE THERE ANY NAYS? 3486 02:04:01,240 --> 02:04:03,040 ABSTENTIONS? 3487 02:04:03,040 --> 02:04:05,800 >>IT'S UNANIMOUS. 3488 02:04:05,800 --> 02:04:07,440 >>THANK YOU PAULET. 3489 02:04:07,440 --> 02:04:13,960 >>AND NOW, WE NEED TO MOVE ON 3490 02:04:13,960 --> 02:04:15,680 TO EVERYONE WAS SENT AND SHOULD 3491 02:04:15,680 --> 02:04:16,520 HAVE RECEIVED A MISSION 3492 02:04:16,520 --> 02:04:19,680 STATEMENT THAT ADDRESS TD THE 3493 02:04:19,680 --> 02:04:21,640 ESTABLISHMENT OF AN AD HOC 3494 02:04:21,640 --> 02:04:23,000 REVIEW GROUP FOR EVALUATION OF 3495 02:04:23,000 --> 02:04:25,080 THE SCIENTIFIC DIRECTOR OF THE 3496 02:04:25,080 --> 02:04:28,440 NCI CENTER FOR CANCER RESEARCH 3497 02:04:28,440 --> 02:04:30,520 SCIENTIFIC DIRECTOR. 3498 02:04:30,520 --> 02:04:35,240 SO, YOU ALL SHOULD HAVE RECEIVED 3499 02:04:35,240 --> 02:04:35,440 THAT-- 3500 02:04:35,440 --> 02:04:35,800 >>EXCUSE ME. 3501 02:04:35,800 --> 02:04:36,400 EXCUSE ME. 3502 02:04:36,400 --> 02:04:40,080 >>IT'S MORE THAN 1. 3503 02:04:40,080 --> 02:04:41,320 >>THE SCIENTIFIC DIRECTORS. 3504 02:04:41,320 --> 02:04:43,000 >>YES, WITH AN S. 3505 02:04:43,000 --> 02:04:43,720 >>RIGHT. 3506 02:04:43,720 --> 02:04:45,000 >>WITH AN S. 3507 02:04:45,000 --> 02:04:49,640 I APOLOGIZE FOR MY DICTION, I 3508 02:04:49,640 --> 02:04:49,880 APOLOGIZE. 3509 02:04:49,880 --> 02:04:51,960 SO YOU SHOULD HAVE ALL RECEIVED, 3510 02:04:51,960 --> 02:04:54,800 I DON'T HAVE TO READ THIS. 3511 02:04:54,800 --> 02:04:57,120 ARE THERE ANY QUESTIONS RELATED 3512 02:04:57,120 --> 02:04:58,320 TO THE MISSION STATEMENT THAT 3513 02:04:58,320 --> 02:05:07,680 YOU ALL SHOULD HAVE RECEIVED? 3514 02:05:07,680 --> 02:05:08,320 YES, MARGARET? 3515 02:05:08,320 --> 02:05:11,160 >>I DON'T RECALL US RECEIVING 3516 02:05:11,160 --> 02:05:13,120 SOMETHING LIKE THIS IS THIS 3517 02:05:13,120 --> 02:05:17,600 SOMETHING NEW OR HAVE I BEEN 3518 02:05:17,600 --> 02:05:19,200 MISSING PREVIOUS MISSION 3519 02:05:19,200 --> 02:05:19,480 STATEMENTS? 3520 02:05:19,480 --> 02:05:20,600 >>NO, IT'S NOT NEW, IF YOU 3521 02:05:20,600 --> 02:05:22,880 RECALL WE DID 1 FOR THE 3522 02:05:22,880 --> 02:05:29,160 SCIENTIFIC DIRECTOR OF THE 3523 02:05:29,160 --> 02:05:32,120 DIVISION OF ACADEMIA 3524 02:05:32,120 --> 02:05:34,760 [INDISCERNIBLE] ABOUT 6 MONTHS, 3525 02:05:34,760 --> 02:05:35,360 12-6 MONTHS AGO. 3526 02:05:35,360 --> 02:05:45,680 AND SO LOOKING AT CCR. 3527 02:05:45,680 --> 02:05:46,080 YES. 3528 02:05:46,080 --> 02:05:46,840 >>OKAY. 3529 02:05:46,840 --> 02:05:52,960 >>YEAH, SO THIS IS INTRAMURAL. 3530 02:05:52,960 --> 02:05:53,280 >>CORRECT. 3531 02:05:53,280 --> 02:05:55,280 >>DID YOU CALL FOR THE VOTE? 3532 02:05:55,280 --> 02:05:56,720 >>SO, YEAH, I'M GOING TO 3533 02:05:56,720 --> 02:06:03,080 NEED--IS THERE A MOTION TO 3534 02:06:03,080 --> 02:06:04,200 APPROVE? 3535 02:06:04,200 --> 02:06:04,520 >>APPROVE. 3536 02:06:04,520 --> 02:06:06,800 >>OKAY, WE HAVE A MOTION FOR 3537 02:06:06,800 --> 02:06:08,200 MARGARET. 3538 02:06:08,200 --> 02:06:12,720 IS THERE A SECOND? 3539 02:06:12,720 --> 02:06:17,040 >>OKAY, THIS IS MOVED AND 3540 02:06:17,040 --> 02:06:17,800 SECOND. 3541 02:06:17,800 --> 02:06:18,120 DISCUSSION? 3542 02:06:18,120 --> 02:06:20,960 IF NOT, WE CAN VOTE TO APPROVE 3543 02:06:20,960 --> 02:06:21,560 THE MISSION STATEMENT. 3544 02:06:21,560 --> 02:06:26,240 I WILL ASK IF THERE ARE ANY 3545 02:06:26,240 --> 02:06:28,400 NAYS? 3546 02:06:28,400 --> 02:06:30,040 ANY ABSTENTIONS? 3547 02:06:30,040 --> 02:06:31,680 THERE BEING NONE. 3548 02:06:31,680 --> 02:06:34,640 >>IT'S UNANIMOUS. 3549 02:06:34,640 --> 02:06:35,080 >>IT'S UNANIMOUS. 3550 02:06:35,080 --> 02:06:35,400 OKAY, GREAT. 3551 02:06:35,400 --> 02:06:38,200 SO PRIOR TO ADJOURNING THE OPEN 3552 02:06:38,200 --> 02:06:40,920 SESSION, I HAVE TO ASK IF THERE 3553 02:06:40,920 --> 02:06:43,680 ARE OTHER ISSUES THAT ANYONE 3554 02:06:43,680 --> 02:06:45,080 MIGHT WANT TO HAVE ADDRESSED 3555 02:06:45,080 --> 02:06:48,960 BEFORE WE,A JOWRN? 3556 02:06:48,960 --> 02:06:49,360 --ADJOURN? 3557 02:06:49,360 --> 02:06:52,040 I JUST WOULD LIKE TO THANK 3558 02:06:52,040 --> 02:06:55,600 EVERYONE FROM THE NCI AND M. K. 3559 02:06:55,600 --> 02:06:58,120 AND AGAIN, VERY INFORMATIVE 3560 02:06:58,120 --> 02:07:02,760 PRESENTATIONS, A LOT OF ACTIVITY 3561 02:07:02,760 --> 02:07:05,680 AND LOOKING FORWARD TO UPCOMING 3562 02:07:05,680 --> 02:07:07,680 PRESENTATIONS COMING OUT OF THE 3563 02:07:07,680 --> 02:07:08,480 NCI. 3564 02:07:08,480 --> 02:07:11,800 IF THERE ARE NO ADDITIONAL 3565 02:07:11,800 --> 02:07:13,720 QUESTIONS OR ARE THERE ANY 3566 02:07:13,720 --> 02:07:19,160 SUGGESTIONS FOR FUTURE AGENDA 3567 02:07:19,160 --> 02:07:19,400 ITEMS? 3568 02:07:19,400 --> 02:07:27,520 SO I HAVE 1, I THINK IT CAME UP 3569 02:07:27,520 --> 02:07:28,360 REGARDING, YOU KNOW, I THINK IT 3570 02:07:28,360 --> 02:07:32,240 WAS PART OF EXPECTATIONS LECT 3571 02:07:32,240 --> 02:07:36,280 RA'S PREVIOUS REPORT ON SORT OF 3572 02:07:36,280 --> 02:07:38,360 GATHERING INFORMATION ON VARIOUS 3573 02:07:38,360 --> 02:07:41,800 FUNDING MECHANISMS THAT GO INTO 3574 02:07:41,800 --> 02:07:44,200 FOR INSTANCE DISPARITIES 3575 02:07:44,200 --> 02:07:45,360 RESEARCH AND SO 1 OF THE THINGS 3576 02:07:45,360 --> 02:07:47,880 THAT WILL BE INTERESTING TO SEE 3577 02:07:47,880 --> 02:07:49,880 IS I THINK 1 WHERE IS THE MONEY 3578 02:07:49,880 --> 02:07:50,320 GOING? 3579 02:07:50,320 --> 02:07:52,200 LIKE, YOU KNOW, IF WE WERE TO 3580 02:07:52,200 --> 02:07:53,720 LOOK ACROSS CANCER CENTERS, 3581 02:07:53,720 --> 02:07:56,360 LOOKING AT FUNDING LEVELS TO 3582 02:07:56,360 --> 02:07:58,320 CANCER CENTERS, AND THEN, WE 3583 02:07:58,320 --> 02:07:59,800 LOOK AT THOSE CANCER CENTERS, 3584 02:07:59,800 --> 02:08:02,920 HOW MUCH OF THE RESEARCH IS 3585 02:08:02,920 --> 02:08:04,920 GOING INTO DISPARITIES TYPE 3586 02:08:04,920 --> 02:08:09,240 RESEARCH AND THAT COULD BE 3587 02:08:09,240 --> 02:08:12,240 ACROSS POPULATION SCIENCE, 3588 02:08:12,240 --> 02:08:12,800 EPIDEMIOLOGY, TRANSLATIONAL 3589 02:08:12,800 --> 02:08:13,520 BASIC SCIENCES OR CLINICAL 3590 02:08:13,520 --> 02:08:16,320 BECAUSE IT WOULD JUST BE 3591 02:08:16,320 --> 02:08:17,880 INTERESTING TO SEE, IF WE LOOKED 3592 02:08:17,880 --> 02:08:19,960 AT FUNDING LEVELS AS A WHOLE 3593 02:08:19,960 --> 02:08:20,920 ACROSS CANCER CENTERS, THEN 3594 02:08:20,920 --> 02:08:22,640 BEGIN TO ASK THE QUESTION, HOW 3595 02:08:22,640 --> 02:08:25,240 MUCH FUNDING ARE GOING INTO 3596 02:08:25,240 --> 02:08:26,040 THOSE CENTERS THAT'S ASSOCIATE 3597 02:08:26,040 --> 02:08:28,800 WIDE THE RESEARCH AND TO 3598 02:08:28,800 --> 02:08:30,480 UNDERREPRESENT MINORITIES CANCER 3599 02:08:30,480 --> 02:08:32,760 DISPARITIES, HEALTH EQUITY. 3600 02:08:32,760 --> 02:08:34,560 YEAH, ELECTRA IN. 3601 02:08:34,560 --> 02:08:38,800 >>YEAH, SO OUR REPORT DID THAT 3602 02:08:38,800 --> 02:08:39,400 ON THE MACROLEVEL. 3603 02:08:39,400 --> 02:08:39,720 >>RIGHT. 3604 02:08:39,720 --> 02:08:41,920 I WANT TO SEE IT ON THE MICRO. 3605 02:08:41,920 --> 02:08:43,640 >>YOU COULD TAKE THOSE THAT 3606 02:08:43,640 --> 02:08:45,920 WERE ALREADY IDENTIFIED AND 3607 02:08:45,920 --> 02:08:49,080 AGAIN, THAT'S FISCAL YEAR 21 AND 3608 02:08:49,080 --> 02:08:50,680 THEN YOU KNOW I'M SURE THEY 3609 02:08:50,680 --> 02:08:52,520 COULD BE ASSIGNED BY CANCER 3610 02:08:52,520 --> 02:08:52,720 CENTER. 3611 02:08:52,720 --> 02:08:55,160 IS THAT SORT OF WHAT YOU'RE 3612 02:08:55,160 --> 02:08:56,080 THINKING ABOUT. 3613 02:08:56,080 --> 02:08:56,440 >>YEAH, YEAH. 3614 02:08:56,440 --> 02:08:58,320 IT WOULD BE GREAT TO SEE THAT. 3615 02:08:58,320 --> 02:09:00,960 >>WE DID IT BY OUR--THE 3616 02:09:00,960 --> 02:09:03,360 POPULATIONS THAT THE WORKING 3617 02:09:03,360 --> 02:09:05,560 GROUP DECIDED TO EXAMINE AND IF 3618 02:09:05,560 --> 02:09:08,440 YOU RECALL THERE WERE SOME 3619 02:09:08,440 --> 02:09:11,000 GROUPS THAT EITHER THERE WAS 3620 02:09:11,000 --> 02:09:13,640 LIMITED DATA OR BE--THERE ARE NO 3621 02:09:13,640 --> 02:09:17,240 CODE WORDS TO BE ABLE TO DO THE 3622 02:09:17,240 --> 02:09:17,440 SEARCH. 3623 02:09:17,440 --> 02:09:21,040 SO WE WERE SORT OF LIMITED BUT 3624 02:09:21,040 --> 02:09:24,160 WE HAD ENOUGH THAT YOU COULD 3625 02:09:24,160 --> 02:09:25,320 THEN TAKE THOSE AND YOU WOULD 3626 02:09:25,320 --> 02:09:28,400 HAVE TO DECIDE, DO YOU CARE? 3627 02:09:28,400 --> 02:09:30,160 WE DID IT ALSO ACROSS THE CANCER 3628 02:09:30,160 --> 02:09:31,280 CONTINUUM SO YOU WOULD NEED TO 3629 02:09:31,280 --> 02:09:36,760 DECIDE IF YOU WANTED THAT OR 3630 02:09:36,760 --> 02:09:38,160 JUST TOTAL BY CANCER CENTER. 3631 02:09:38,160 --> 02:09:39,440 >>YEAH, I THINK IT WOULD BE 3632 02:09:39,440 --> 02:09:40,560 INTERESTING JUST TO SEE BY 3633 02:09:40,560 --> 02:09:42,160 CANCER CENTER, AS JUST THE PLACE 3634 02:09:42,160 --> 02:09:44,840 TO START. 3635 02:09:44,840 --> 02:09:45,120 >>YEAH. 3636 02:09:45,120 --> 02:09:47,840 >>AND I DON'T KNOW IF DENEEZ IS 3637 02:09:47,840 --> 02:09:49,600 STILL ON BUT HER GROUP IS THE 1 3638 02:09:49,600 --> 02:09:51,680 THAT DID THE ANALYSIS. 3639 02:09:51,680 --> 02:09:53,040 >>I HAVE 1 OTHER QUESTION AND 3640 02:09:53,040 --> 02:09:54,920 AGAIN, I GUESS IT'S JUST 3641 02:09:54,920 --> 02:09:56,480 PARTIALLY MY IGNORANCE AND I 3642 02:09:56,480 --> 02:09:58,120 PROBABLY SHOULD KNOW THE ANSWER. 3643 02:09:58,120 --> 02:10:00,520 YOU KNOW WHEN WE LOOK AT SORT OF 3644 02:10:00,520 --> 02:10:01,680 TOTAL RO-1 FUNDING AND THEN WE 3645 02:10:01,680 --> 02:10:05,480 LOOK AT FUNDING FOR ESIs, IT 3646 02:10:05,480 --> 02:10:08,200 ALWAYS SEEMS TO BE LIKE A 5% 3647 02:10:08,200 --> 02:10:09,800 DIFFERENCE, I DON'T KNOW, MAYBE 3648 02:10:09,800 --> 02:10:15,000 I'M MISSING SOMETHING, IS THAT A 3649 02:10:15,000 --> 02:10:16,800 FIXED DELTA OR IS IT AN 3650 02:10:16,800 --> 02:10:18,800 ARBITRARY DELTA? 3651 02:10:18,800 --> 02:10:21,720 MEANING, COULD THAT BE 8% OR 10% 3652 02:10:21,720 --> 02:10:27,480 OR I MEAN IS THAT 5% A SET--I 3653 02:10:27,480 --> 02:10:28,720 SAW DINA NODDING HER HEAD. 3654 02:10:28,720 --> 02:10:32,880 DOES ANYONE KNOW THE ANSWER TO 3655 02:10:32,880 --> 02:10:33,080 THAT? 3656 02:10:33,080 --> 02:10:37,040 >>JOHN THIS, IS DOUG. 3657 02:10:37,040 --> 02:10:38,840 >>HEY, DOUG. 3658 02:10:38,840 --> 02:10:41,720 >>THE 5% IS SOMETHING THAT NCI 3659 02:10:41,720 --> 02:10:45,360 DECIDED TO DO A NUMBER OF YEARS 3660 02:10:45,360 --> 02:10:47,200 AGO. 3661 02:10:47,200 --> 02:10:49,200 THERE IS CONSIDERABLE 3662 02:10:49,200 --> 02:10:51,640 FLEXIBILITY BETWEEN 0 AND LET'S 3663 02:10:51,640 --> 02:10:55,800 SAY 10%. 3664 02:10:55,800 --> 02:10:56,840 I DON'T KNOW WHETHER THERE IS 3665 02:10:56,840 --> 02:10:57,920 SOMETHING YOU WOULD NEED TO 3666 02:10:57,920 --> 02:10:59,560 APPLY TO THE OFFICE OF 3667 02:10:59,560 --> 02:11:00,480 EXTRAMURAL RESEARCH IF YOU WANT 3668 02:11:00,480 --> 02:11:03,040 TO GO TO 30% OR SOMETHING LIKE 3669 02:11:03,040 --> 02:11:03,480 THAT. 3670 02:11:03,480 --> 02:11:03,880 >>[LAUGHTER] 3671 02:11:03,880 --> 02:11:05,280 NO, I WAS JUST WONDERING BECAUSE 3672 02:11:05,280 --> 02:11:13,360 WE ALL SORT OF WISH FOR THIS 15% 3673 02:11:13,360 --> 02:11:14,920 FUNDING INCREASE, IT BECOMES A 3674 02:11:14,920 --> 02:11:18,000 GOAL, BUT THE QUESTION IS IF THE 3675 02:11:18,000 --> 02:11:20,320 OVERALL REMAINSA AT 12 COULD THE 3676 02:11:20,320 --> 02:11:21,840 ESI GO TO 20 AS A CONCESSION OF 3677 02:11:21,840 --> 02:11:27,000 SORTS TO INSURE THAT OUR EARLY 3678 02:11:27,000 --> 02:11:28,160 STAGE INVESTIGATORS CONTINUE TO 3679 02:11:28,160 --> 02:11:28,400 ENGAGE. 3680 02:11:28,400 --> 02:11:30,440 >>THIS WAS A DIRECT RESPONSE TO 3681 02:11:30,440 --> 02:11:35,080 OUR HAVING SUCH A LOW PAY LINE 3682 02:11:35,080 --> 02:11:38,320 FOR INVESTIGATORS IN GENERAL, WE 3683 02:11:38,320 --> 02:11:40,400 WANTED TO ADVANTAGE THE ESIs 3684 02:11:40,400 --> 02:11:45,360 AND IT LAZ --HAS LED TO A 3685 02:11:45,360 --> 02:11:46,480 SUBSTANTIAL INCREASE IN THE 3686 02:11:46,480 --> 02:11:48,160 TOTAL NUMBER OF ESI,A WARDS AND 3687 02:11:48,160 --> 02:11:51,720 THE PERCENTAGE OF ESI AWARDS 3688 02:11:51,720 --> 02:11:54,720 COMPARED TO ALL OF THE AWARDS 3689 02:11:54,720 --> 02:11:55,760 THAT WE MAKE. 3690 02:11:55,760 --> 02:11:57,200 , THAT'S GREAT. 3691 02:11:57,200 --> 02:11:57,520 THANKS, DOUG. 3692 02:11:57,520 --> 02:11:59,440 SO I SEE A FEW HANDS, I WANT TO 3693 02:11:59,440 --> 02:12:04,680 START WITH LOUIS SINCE HE HAS 3694 02:12:04,680 --> 02:12:06,440 NOT HAD A QUESTION TODAY. 3695 02:12:06,440 --> 02:12:08,680 LUIS, YOU MUST BE MUTED. 3696 02:12:08,680 --> 02:12:19,000 WE CAN'T HEAR YOU. 3697 02:12:22,400 --> 02:12:23,040 YOU'RE STILL MUTED. 3698 02:12:23,040 --> 02:12:24,760 I WONDER IF IT'S YOUR MIC. 3699 02:12:24,760 --> 02:12:25,640 TYPE IT IN THE CHAT. 3700 02:12:25,640 --> 02:12:30,520 THAT WOULD BE GREAT. 3701 02:12:30,520 --> 02:12:31,200 HOWARD? 3702 02:12:31,200 --> 02:12:31,480 >>SURE. 3703 02:12:31,480 --> 02:12:37,000 I'M WONDERING TO ADD TO YOUR 3704 02:12:37,000 --> 02:12:40,080 SUGGESTION, JOHN, I WAS THINKING 3705 02:12:40,080 --> 02:12:43,000 ABOUT I THINK IF WOULD BE 3706 02:12:43,000 --> 02:12:45,880 INFORMATIVE TO ALSO UNDERSTAND 3707 02:12:45,880 --> 02:12:46,720 THESE RELATIONSHIPS IN WHO GETS 3708 02:12:46,720 --> 02:12:48,680 TREAT TD AND THE CANCER CENTERS 3709 02:12:48,680 --> 02:12:51,480 TO THE MORE MODERN UPDATED 3710 02:12:51,480 --> 02:12:53,200 TREATMENTS, I'M THINKING 3711 02:12:53,200 --> 02:12:55,360 ESPECIALLY ABOUT CAR-T THERAPIES 3712 02:12:55,360 --> 02:12:56,880 AND THE ATC CENTERS THAT ARE 3713 02:12:56,880 --> 02:13:02,280 ASSIGNED TO BE ABLE TO DELIVER 3714 02:13:02,280 --> 02:13:03,720 THEM. 3715 02:13:03,720 --> 02:13:06,960 THERE WAS AN INTERESTING POSTER 3716 02:13:06,960 --> 02:13:08,200 PRESENTATION AT ASH THIS YEAR 3717 02:13:08,200 --> 02:13:10,840 JUST A MONTH AGO BY FRED LOCK 3718 02:13:10,840 --> 02:13:13,880 WHO'S BEEN FOLLOWING THIS AND 3719 02:13:13,880 --> 02:13:15,480 HAS EXPERIENCE WITH THE 3720 02:13:15,480 --> 02:13:18,360 [INDISCERNIBLE] TRIALS SHOWING 3721 02:13:18,360 --> 02:13:18,840 SOME RELATIONSHIPS 3722 02:13:18,840 --> 02:13:20,480 GEOGRAPHICALLY TO WHO HAS ACCESS 3723 02:13:20,480 --> 02:13:22,680 TO THESE MORE MODERN TYPES OF 3724 02:13:22,680 --> 02:13:24,680 THERAPY AND WHO DOESN'T. 3725 02:13:24,680 --> 02:13:26,400 AND I THINK THIS WOULD FIT WELL 3726 02:13:26,400 --> 02:13:27,760 WITH SOME OF THE THINGS WE WERE 3727 02:13:27,760 --> 02:13:37,000 TALKING ABOUT BEFORE IN THE 3728 02:13:37,000 --> 02:13:37,280 COMMITTEE. 3729 02:13:37,280 --> 02:13:38,800 >>THANKS HOWARD. 3730 02:13:38,800 --> 02:13:39,240 THAT'S GREAT. 3731 02:13:39,240 --> 02:13:41,080 THERE MAY BE TIME I THINK FOR 3732 02:13:41,080 --> 02:13:43,640 THE 1 LAST QUESTION, ANNA, WE'RE 3733 02:13:43,640 --> 02:13:50,040 AT ABOUT 2 MIVENUTES OUT FROM 3734 02:13:50,040 --> 02:13:50,880 ADJOURNING. 3735 02:13:50,880 --> 02:13:51,160 >>ANN? 3736 02:13:51,160 --> 02:13:52,680 >>SO I'M A BROKEN RECORD BUT I 3737 02:13:52,680 --> 02:13:58,200 WILL ASK ONCE AGAIN THAT I THINK 3738 02:13:58,200 --> 02:14:00,360 THAT WE'RE ASLEEP AT THE WHEEL 3739 02:14:00,360 --> 02:14:03,160 IN THIS WHOLE ISSUE OF EARLY 3740 02:14:03,160 --> 02:14:04,440 CANCER DETECTION TESTS. 3741 02:14:04,440 --> 02:14:06,440 IT IS POTENTIALLY TRANSFORMATIVE 3742 02:14:06,440 --> 02:14:08,400 AND I'VE HAD QUESTIONS FROM 3743 02:14:08,400 --> 02:14:09,360 PEOPLE SAYING, WHOSE'S DOING, 3744 02:14:09,360 --> 02:14:12,760 YOU KNOW THE STUDY THAT INCLUDES 3745 02:14:12,760 --> 02:14:15,720 THE SCIENCE WHICH IS PROFOUND, 3746 02:14:15,720 --> 02:14:17,040 THE CLINICAL TRIALS THAT HAVE TO 3747 02:14:17,040 --> 02:14:19,040 BE DONE HERE AND HOW MUCH 3748 02:14:19,040 --> 02:14:21,160 THEY'RE GOING TO COST, THE CARE 3749 02:14:21,160 --> 02:14:23,920 AND DELIVERY THAT NOW THE LEVELS 3750 02:14:23,920 --> 02:14:25,440 OF COMPLEXITY IN CARE DELIVERY 3751 02:14:25,440 --> 02:14:27,400 ARE GOING TO CHANGE ENORMOUSLY 3752 02:14:27,400 --> 02:14:28,120 FOR PEOPLE TAKING CARE OF 3753 02:14:28,120 --> 02:14:29,640 PATIENT WHO IS HAVE CANCER AND 3754 02:14:29,640 --> 02:14:30,920 THOSE WHO WERE TOLD THEY WERE 3755 02:14:30,920 --> 02:14:33,560 GOING TO GET CANCER AND THERE'S 3756 02:14:33,560 --> 02:14:34,520 THIS OVERALL ISSUE OF HOW 3757 02:14:34,520 --> 02:14:37,000 PATIENTS ARE GOING TO RESPOND 3758 02:14:37,000 --> 02:14:39,160 AND WE ALREADY SEE PEOPLE 3759 02:14:39,160 --> 02:14:41,240 REIMBURSING FOR THESE TESTS NOW. 3760 02:14:41,240 --> 02:14:42,400 IT'S LET'S SEE 2 OR 3 HOSPITAL 3761 02:14:42,400 --> 02:14:44,760 SYSTEMS HAVE COME OUT OR BIG 3762 02:14:44,760 --> 02:14:45,920 INSURANCES HAVE COME OUT IN THE 3763 02:14:45,920 --> 02:14:48,240 LAST MONTH. 3764 02:14:48,240 --> 02:14:49,800 I THINK THIS--THIS IS IT'S AN 3765 02:14:49,800 --> 02:14:52,760 NCI ISSUE, I THINK THERE SHOULD 3766 02:14:52,760 --> 02:14:54,280 BE A VERY COMPREHENSIVE STUDY OF 3767 02:14:54,280 --> 02:14:56,240 THIS AND WE HAVE TO FIGURE OUT 3768 02:14:56,240 --> 02:14:58,680 WHICH PIECE OF THIS BELONGS TO 3769 02:14:58,680 --> 02:15:00,080 THE NCI AND WHERE CAN OTHER 3770 02:15:00,080 --> 02:15:01,520 PARTS OF IT GO. 3771 02:15:01,520 --> 02:15:03,000 I THINK WE'RE GOING TO GET AHEAD 3772 02:15:03,000 --> 02:15:05,520 OF THIS 1 AND I DON'T HAVE AN 3773 02:15:05,520 --> 02:15:05,960 ANSWER. 3774 02:15:05,960 --> 02:15:08,280 THIS IS PROBABLY 1 OF THE MOST 3775 02:15:08,280 --> 02:15:09,400 COMPLEX ISSUES THAT'S EVER 3776 02:15:09,400 --> 02:15:10,800 BECOME BEFORE THIS BOARD. 3777 02:15:10,800 --> 02:15:13,000 I HONESTLY THINK WE NEED TO PUT 3778 02:15:13,000 --> 02:15:14,400 OUR STAKE INDEED GROUND HERE AND 3779 02:15:14,400 --> 02:15:15,680 SAY WE'RE DOING SOMETHING. 3780 02:15:15,680 --> 02:15:17,520 >>YEAH, IT'S A BROAD ISSUE 3781 02:15:17,520 --> 02:15:19,360 BECAUSE EVEN IF YOU DETECT IT 3782 02:15:19,360 --> 02:15:21,440 THEN HAVE YOU IT FIGURE OUT WHAT 3783 02:15:21,440 --> 02:15:22,400 DO YOU DO NEXT. 3784 02:15:22,400 --> 02:15:23,920 AND SO, YOU KNOW AGAIN, - IT IS 3785 02:15:23,920 --> 02:15:25,280 A REALLY IMPORTANT ISSUE AND 3786 02:15:25,280 --> 02:15:27,080 IT'S SOMETHING I AM HOPING. 3787 02:15:27,080 --> 02:15:28,000 >>YOU GOTTA START. 3788 02:15:28,000 --> 02:15:28,840 YOU GOTTA START JOHN. 3789 02:15:28,840 --> 02:15:32,160 >>YOU HAVE TO BE DISRUPTIVE. 3790 02:15:32,160 --> 02:15:35,680 >>WE CAN BRING IN THE ACADEMY 3791 02:15:35,680 --> 02:15:36,240 AS WELL. 3792 02:15:36,240 --> 02:15:39,160 >>OKAY, WE'RE RIGHT AT THE 3793 02:15:39,160 --> 02:15:40,800 ADJOURNMENT MARK. 3794 02:15:40,800 --> 02:15:42,800 I SEEN MONICA'S HAND UP, I FEEL 3795 02:15:42,800 --> 02:15:43,080 HORRIBLE. 3796 02:15:43,080 --> 02:15:45,280 >>SO I JUST WANT TO VERY 3797 02:15:45,280 --> 02:15:46,880 QUICKLY ANSWER ANNA BECAUSE WE 3798 02:15:46,880 --> 02:15:49,000 AGREEN CELLS ENTIRELY, WE HAVE A 3799 02:15:49,000 --> 02:15:51,040 VERY DEDICATED TALENTED TEAM 3800 02:15:51,040 --> 02:15:52,560 WORKING ACROSS THE ENTIRE 3801 02:15:52,560 --> 02:15:54,560 COMMUNITY ON TO DO EXACTLY WHAT 3802 02:15:54,560 --> 02:15:56,280 YOU ASKED ANNA, WE DO NOT HAVE 3803 02:15:56,280 --> 02:15:56,960 THE FUNDING. 3804 02:15:56,960 --> 02:15:58,480 WE DO NOT EVEN COME CLOSE TO 3805 02:15:58,480 --> 02:16:00,200 HAVING THE FUNDING TO ACHIEVE 3806 02:16:00,200 --> 02:16:02,880 WHAT YOU'VE ASKED. 3807 02:16:02,880 --> 02:16:03,720 SO WITHOUT SUBSTANTIAL NEW 3808 02:16:03,720 --> 02:16:06,920 FUNDING WE WILL NOT BE ABLE TO 3809 02:16:06,920 --> 02:16:08,920 CONDUCT THAT RESEARCH. 3810 02:16:08,920 --> 02:16:09,280 >>AWESOME. 3811 02:16:09,280 --> 02:16:11,400 >>THOSE TRIALS ARE GOING TO BE 3812 02:16:11,400 --> 02:16:12,360 HORRIBLY EXPENSIVE. 3813 02:16:12,360 --> 02:16:14,160 >>SOUNDS LIKE A GREAT 3814 02:16:14,160 --> 02:16:15,320 OPPORTUNITY FOR PUBLIC-PRIVATE 3815 02:16:15,320 --> 02:16:16,080 PARTNERSHIP. 3816 02:16:16,080 --> 02:16:18,400 SO, WHY DON'T WE GO AHEAD AND 3817 02:16:18,400 --> 02:16:18,680 ADJOURN. 3818 02:16:18,680 --> 02:16:20,080 IF THERE ARE ANY OTHER 3819 02:16:20,080 --> 02:16:22,240 QUESTIONS, PLEASE OR ISSUES OR 3820 02:16:22,240 --> 02:16:23,640 TOPICS PLEASE SEND THEM OVER TO 3821 02:16:23,640 --> 02:16:25,080 EITHER ME OR PAULET AND WE WILL 3822 02:16:25,080 --> 02:16:27,000 MAKE SURE THEY GET ON THE AGENDA 3823 02:16:27,000 --> 02:16:28,240 FOR THE NEXT MEETING. 3824 02:16:28,240 --> 02:16:30,200 SO THIS CONCLUDES THE OPEN 3825 02:16:30,200 --> 02:16:30,680 SESSION. 3826 02:16:30,680 --> 02:16:33,200 THERE WILL BE A 20 MINUTE BREAK. 3827 02:16:33,200 --> 02:16:34,720 ONLY BOARD MEMBERS AND 3828 02:16:34,720 --> 02:16:36,600 DESIGNATED NCI STAFF SHOULD 3829 02:16:36,600 --> 02:16:37,480 REMAIN ON. 3830 02:16:37,480 --> 02:16:39,560 ALL OTHERS SHOULD SIGN OFF NOW. 3831 02:16:39,560 --> 02:16:42,280 AND THOSE THAT ARE ATTENDING THE 3832 02:16:42,280 --> 02:16:44,360 CLOSED SESSION SHOULD SIGN ON 3833 02:16:44,360 --> 02:16:46,440 WITHIN THE NEXT 20 MINUTES USING 3834 02:16:46,440 --> 02:16:47,600 THE TEPERATE WEB EXPECTATIONS 3835 02:16:47,600 --> 02:16:49,960 CONNECTION THAT WAS SENT TO 3836 02:16:49,960 --> 02:16:50,360 EVERYONE. 3837 02:16:50,360 --> 02:16:51,440 SO, THE CLOSED SESSION WILL 3838 02:16:51,440 --> 02:16:52,000 BEGIN PROMPTLY AT 3:50. 3839 02:16:52,000 --> 02:17:08,040 [MEETING ADJOURNED ]